{"config":{"lang":["en"],"prebuild_index":false,"separator":"[\\s\\-]+"},"docs":[{"location":"","text":"Targeting 2019-nCoV: GHDDI Info Sharing Portal This is the public information sharing portal about 2019-nCov/SARS/MERS for the drug discovery community, initiated by GHDDI We're continuously releasing scientific materials to help the scientific community fight this Novel Coronavirus (2019-nCoV) outbreak at Wuhan, including curated data, updated research reports, discussions, etc. You can find these materials on this website. Guide for Discussion You can participate in community discussions here . You're also welcome to join our discussion for any scientific subject, feature request, and bug report. Quick Links GHDDI\u4f1a\u540c\u6e05\u534e\u5927\u5b66\u836f\u5b66\u9662\u73b0\u5411\u5168\u793e\u4f1a\u79d1\u7814\u4eba\u5458\u514d\u8d39\u5f00\u653e\u836f\u7269\u7814\u53d1\u8d44\u6e90\uff0c\u52a9\u529b\u653b\u514b\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2 Who We Are We're from GHDDI(The Global Health Drug Discovery Institute). GHDDI was jointly founded by Tsinghua University, the Bill & Melinda Gates Foundation, and the Beijing Municipal Government. The Institute is a transformative drug discovery and translational platform with advanced biomedical research and development capabilities. It is an independent, not-for-profit institute with a broad interest in addressing global health concerns, regardless of financial incentives, and intends to focus its efforts on tackling the world\u2019s most pressing disease challenges faced by many developing countries. Connect with GHDDI To coordinate and maximize the utility of our resources, please contact us if you hope to collaborate with us or obtain technical support from us, and fill the Online Request Form . Once your request is approved, we will reach out to you ASAP. Thank you! Disclaimer The data from this website is for research purpose only, may not be used for clinical advice. GHDDI is not responsible for any errors or omissions, or for the results obtained from the use of this information. All information in this site is provided \"as is\", with no guarantee of completeness, accuracy, timeliness or of the results obtained from the use of this information.","title":"Home"},{"location":"#targeting-2019-ncov-ghddi-info-sharing-portal","text":"This is the public information sharing portal about 2019-nCov/SARS/MERS for the drug discovery community, initiated by GHDDI We're continuously releasing scientific materials to help the scientific community fight this Novel Coronavirus (2019-nCoV) outbreak at Wuhan, including curated data, updated research reports, discussions, etc. You can find these materials on this website.","title":"Targeting 2019-nCoV: GHDDI Info Sharing Portal"},{"location":"#guide-for-discussion","text":"You can participate in community discussions here . You're also welcome to join our discussion for any scientific subject, feature request, and bug report.","title":"Guide for Discussion"},{"location":"#quick-links","text":"GHDDI\u4f1a\u540c\u6e05\u534e\u5927\u5b66\u836f\u5b66\u9662\u73b0\u5411\u5168\u793e\u4f1a\u79d1\u7814\u4eba\u5458\u514d\u8d39\u5f00\u653e\u836f\u7269\u7814\u53d1\u8d44\u6e90\uff0c\u52a9\u529b\u653b\u514b\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2","title":"Quick Links"},{"location":"#who-we-are","text":"We're from GHDDI(The Global Health Drug Discovery Institute). GHDDI was jointly founded by Tsinghua University, the Bill & Melinda Gates Foundation, and the Beijing Municipal Government. The Institute is a transformative drug discovery and translational platform with advanced biomedical research and development capabilities. It is an independent, not-for-profit institute with a broad interest in addressing global health concerns, regardless of financial incentives, and intends to focus its efforts on tackling the world\u2019s most pressing disease challenges faced by many developing countries.","title":"Who We Are"},{"location":"#connect-with-ghddi","text":"To coordinate and maximize the utility of our resources, please contact us if you hope to collaborate with us or obtain technical support from us, and fill the Online Request Form . Once your request is approved, we will reach out to you ASAP. Thank you!","title":"Connect with GHDDI"},{"location":"#disclaimer","text":"The data from this website is for research purpose only, may not be used for clinical advice. GHDDI is not responsible for any errors or omissions, or for the results obtained from the use of this information. All information in this site is provided \"as is\", with no guarantee of completeness, accuracy, timeliness or of the results obtained from the use of this information.","title":"Disclaimer"},{"location":"CoV_Experiment_Data/","text":"We are releasing the following datasets from our big data platform. We are making our best effort to mine all experimental data of previous coronavirus related studies. If you have other specific data need or have datasets to contribute, please contact us @ here . We will update our datasets periodically to provide more information to help your research combat the disease. Annotated Set A collection of 1690 in vitro and in vivo records for 245 molecules Full dataset A few selected records drug_name tested_activity MOA_summary condition method material parameter operator mean value unit PF-835231 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors 3C-Like Protease (viral) Fluorescent assay Coronavirus (SARS-associated) IC-50 4.00E-09 M Remdesivir Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Nucleobindin-1 (NUCB1) Inhibitors Severe acute respiratory syndrome (SARS-CoV) Viral replication assay Calu3 human lung carcinoma cells (HER2 [ERBB2]-overexpressing) IC-50 1.00E-08 M ARN-398 Ceramidase (nonspecified) inhibition, IN VITRO Acid Ceramidase (ACDase; ASAH1) Inhibitors Ceramidase (nonspecified) Rat enzyme IC-50 1.20E-08 M SR9EK1 Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Severe acute respiratory syndrome (SARS-CoV) Viral replication assay Vero African green monkey kidney cells IC-90 1.25E-08 M Lycorine Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Severe acute respiratory syndrome (SARS-CoV) Dye assay Vero African green monkey kidney cells IC-50 1.57E-08 M SR9EK1 Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Severe acute respiratory syndrome (SARS-CoV) Viral replication assay Vero African green monkey kidney cells IC-99 1.76E-08 M Noscapine Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Tubulin Polymerization Inhibitors;Apoptosis Inducers;Antimitotic Drugs Severe acute respiratory syndrome (SARS-CoV) Cytopathicity assay Vero African green monkey kidney cells IC-90 2.20E-08 g/l Carmofur Ceramidase (nonspecified) inhibition, IN VITRO Thymidylate Synthase Inhibitors;Pyrimidine Antagonists Ceramidase (nonspecified) Rat enzyme IC-50 2.90E-08 M JMF-1507 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors 3C-Like Protease (viral) Fluorescent assay Coronavirus (SARS-associated) Ki 3.00E-08 M Pristimerine Inflammatory disorders remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Inflammatory disorders ELISA assay RAW264.7 mouse macrophages MIC <= 3.13E-08 M Pristimerine Cancer, pancreas (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, pancreas (adenocarcinoma) Cell counting assay MiaPaCa2 human pancreas adenocarcinoma cells CC-50 4.80E-08 M Pyrazofurin Nephrotoxicity induction, IN VITRO Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors Nephrotoxicity Cell viability assay Vero African green monkey kidney cells CC-50 5.20E-08 g/l TG-0205221 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors 3C-Like Protease (viral) Coronavirus (SARS-associated) Ki 5.30E-08 M JMF-1507 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors 3C-Like Protease (viral) Fluorescent assay Coronavirus (SARS-associated) IC-50 6.00E-08 M Pristimerine IL-2 Receptor Complex antagonism, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs IL-2 Receptor Complex Thymidine incorporation assay T-Lymphocytes (spleen), mouse MIC <= 6.25E-08 M Pristimerine Inflammatory disorders remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Inflammatory disorders Nitrite assay RAW264.7 mouse macrophages MIC 6.25E-08 M Pristimerine Cancer, pancreas (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, pancreas (adenocarcinoma) Cell counting assay MiaPaCa2 human pancreas adenocarcinoma cells CC-50 6.39E-08 M Remdesivir Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Nucleobindin-1 (NUCB1) Inhibitors Severe acute respiratory syndrome (SARS-CoV) Epithelial cells (airway), human IC-50 6.90E-08 M Remdesivir Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Nucleobindin-1 (NUCB1) Inhibitors Severe acute respiratory syndrome (SARS-CoV) Viral replication assay Epithelial cells (airway), human IC-50 6.90E-08 M Pristimerine Cancer, pancreas remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, pancreas Cell counting assay CFPAC1 human pancreas cancer cells CC-50 7.70E-08 M Niclosamide Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Cytochrome P450 CYP1A2 Inhibitors;Quorum Sensing (Pseudomonas aeruginosa) Inhibitors;Neuropeptide Y4 (NPY Y4) Receptor Positive Allosteric Modulators;Autophagy Inducers;Wnt Signaling Inhibitors Severe acute respiratory syndrome (SARS-CoV) Cytopathicity assay Vero African green monkey kidney cells IC-50 < 1.00E-07 M Tingenone Cytotoxicity induction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Antioxidants;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs;Free Radical Scavengers Cytotoxicity Dye assay (alamar blue) MRC5 human embryonic lung fibroblasts CC-50 1.00E-07 M Isobavachalcone Tumor Necrosis Factor (TNF-alpha) inhibition, IN VITRO Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Steroid 5alpha-Reductase Inhibitors;Drugs Targeting Beta-Amyloid;Signal Transduction Modulators;Autophagy Inducers;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants Tumor Necrosis Factor (TNF-alpha) Chemiluminescent assay BV2 murine microglia cells MIC <= 1.00E-07 M Tingenone Cancer, mouth (squamous cell) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Antioxidants;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs;Free Radical Scavengers Cancer, mouth (squamous cell) Dye assay (alamar blue) HSC3 human oral squamous cell carcinoma cells CC-50 1.00E-07 M Pristimerine Cancer, colon remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, colon Dye assay (MTT) @ 72 h HCT116 human colon carcinoma cells MIC <= 1.00E-07 M Pristimerine Cancer, colon (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, colon (adenocarcinoma) Dye assay (MTT) @ 72 h SW620 human colon adenocarcinoma cells MIC <= 1.00E-07 M 6',6'-Difluoroaristeromycin Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO S-Adenosyl-L-Homocysteine Hydrolase Inhibitors Severe acute respiratory syndrome (SARS-CoV) Plaque assay VeroE6 African green monkey kidney cells MIC <= 1.00E-07 M Pristimerine Cancer, pancreas (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, pancreas (adenocarcinoma) Cell counting assay BxPC3 human pancreas adenocarcinoma cells CC-50 1.03E-07 M SR9EK2 Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Severe acute respiratory syndrome (SARS-CoV) Viral replication assay Vero African green monkey kidney cells IC-90 1.08E-07 M Azithromycin Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Nonsense Mutation Suppressors;50S Ribosomal Protein Inhibitors Severe acute respiratory syndrome (SARS-CoV) Luciferine/luciferase assay HEK293T human embryonic kidney cells transfected with luciferase IC-50 1.10E-07 M Pristimerine Cytotoxicity induction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cytotoxicity Cell counting assay Pancreatic ductal epithelial cells, human CC-50 1.11E-07 M Pristimerine Cytotoxicity induction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cytotoxicity Cell counting assay Pancreatic ductal epithelial cells, human CC-50 1.11E-07 M Pristimerine NF-kappaB (NFkB) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs NF-kappaB (NFkB) Gene reporter assay OMM1 human uveal melanoma cells MIC <= 1.25E-07 M Pristimerine Inflammatory disorders remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Inflammatory disorders ELISA assay RAW264.7 mouse macrophages MIC 1.25E-07 M Isobavachalcone Dihydroorotate Dehydrogenase (quinone), mitochondrial (DHODH) inhibition, IN VITRO Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Steroid 5alpha-Reductase Inhibitors;Drugs Targeting Beta-Amyloid;Signal Transduction Modulators;Autophagy Inducers;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants Dihydroorotate Dehydrogenase (quinone), mitochondrial (DHODH) 2,6-dichlorophenolindophenol reduction assay Recombinant human enzyme IC-50 1.30E-07 M TG-0205221 Coronavirus acute respiratory syndrome remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors Coronavirus acute respiratory syndrome Plaque assay MRC5 human embryonic lung fibroblasts IC-50 1.40E-07 M SR9EK2 Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Severe acute respiratory syndrome (SARS-CoV) Viral replication assay Vero African green monkey kidney cells IC-99 1.49E-07 M JMF-1521 Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Severe acute respiratory syndrome (SARS-CoV) Cytopathicity assay Vero African green monkey kidney cells IC-50 1.80E-07 M SR9EK1 Nephrotoxicity induction, IN VITRO Nephrotoxicity Dye assay Vero African green monkey kidney cells CC-50 1.91E-07 M Remdesivir Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Nucleobindin-1 (NUCB1) Inhibitors Severe acute respiratory syndrome (SARS-CoV) IC-50 2.00E-07 M Pristimerine Leukemia, acute promyelocytic (M3) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Leukemia, acute promyelocytic (M3) Dye assay (MTT) HL60 human acute promyelocytic leukemia cells CC-50 2.00E-07 M Pristimerine Cancer, prostate (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, prostate (adenocarcinoma) Matrigel-coated plate assay PC3 human prostate adenocarcinoma cells MIC <= 2.00E-07 M Pristimerine Cancer, prostate (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, prostate (adenocarcinoma) Spheres formation assay PC3 human prostate adenocarcinoma cells MIC <= 2.00E-07 M Pristimerine Cancer, prostate (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, prostate (adenocarcinoma) Colony formation assay PC3 human prostate adenocarcinoma cells MIC <= 2.00E-07 M Pristimerine Monoglyceride Lipase inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Monoglyceride Lipase 2-Oleoylglycerol as substrate Recombinant human enzyme IC-50 2.04E-07 M N-3 Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO 3C-Like Protease (NL63 Coronavirus) (HCoV-NL63) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) MCA-Ala-Val-Leu-Gln-Ser-Gly-Phe-Arg-lys(Dnp)-lys-NH2 as substrate Coronavirus Ki 2.30E-07 M Pristimerine NF-kappaB (NFkB) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs NF-kappaB (NFkB) Gene reporter assay Mel270 human uveal melanoma cells MIC 2.50E-07 M Pristimerine NF-kappaB (NFkB) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs NF-kappaB (NFkB) Gene reporter assay OMM2.3 human uveal melanoma cells MIC 2.50E-07 M Pristimerine MMP-9 (Gelatinase B) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs MMP-9 (Gelatinase B) 92.1 human uveal melanoma cells MIC <= 2.50E-07 M Pristimerine Inflammatory disorders remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Inflammatory disorders ELISA assay RAW264.7 mouse macrophages MIC 2.50E-07 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Wound closure assay 92.1 human uveal melanoma cells MIC <= 2.50E-07 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Transwell chamber assay 92.1 human uveal melanoma cells MIC <= 2.50E-07 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Transwell chamber assay OMM1 human uveal melanoma cells MIC <= 2.50E-07 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Transwell chamber assay 92.1 human uveal melanoma cells MIC <= 2.50E-07 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Transwell chamber assay OMM1 human uveal melanoma cells MIC <= 2.50E-07 M N-3 Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO 3C-Like Protease (NL63 Coronavirus) (HCoV-NL63) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) MCA-Ala-Val-Leu-Gln-Ser-Gly-Phe-Arg-lys(Dnp)-lys-NH2 as substrate Coronavirus Ki 2.60E-07 M Betulinic acid GABA(A) BZ Site Receptor affinity, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors GABA(A) BZ Site Receptor Displacement of [3H]-flunitrazepam Brain, rat Ki 2.60E-07 M Pristimerine Tumor Necrosis Factor Ligand Superfamily Member 11 (TNFSF11, RANKL) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Tumor Necrosis Factor Ligand Superfamily Member 11 (TNFSF11, RANKL) RNA assay Fibroblasts (synovial), rat (arthritic) MIC 3.00E-07 M BTB-06256 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (viral) Fluorescent assay Coronavirus (SARS-associated) IC-50 3.00E-07 M GRL-0667 Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Arg-Leu-Arg-Gly-Gly-7-amino-4-methylcoumarin as substrate Coronavirus (SARS-associated) IC-50 3.20E-07 M Pristimerine Cancer, cervix, (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, cervix, (adenocarcinoma) Dye assay (MTT) HeLa human cervix adenocarcinoma cells IC-50 3.20E-07 M Pristimerine Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, breast (adenocarcinoma) ATP assay MDAMB231 human breast adenocarcinoma cells CC-50 3.80E-07 M Sinefungin Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Coactivator Associated Arginine Methyltransferase 1 (CARM1; PRMT4) Inhibitors;Histone-Lysine N-Methyltransferase SETD7 (SET7/9) Inhibitors;Protein-L-Isoaspartate(D-Aspartate) O-Methyltransferase (PCMT1; PIMT) Inhibitors;Epigenetic Modifier Modulators Replicase Polyprotein 1ab (pp1ab) (SARS) Coronavirus (SARS-associated) IC-50 3.83E-07 M Noscapine Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Tubulin Polymerization Inhibitors;Apoptosis Inducers;Antimitotic Drugs Severe acute respiratory syndrome (SARS-CoV) Cell counting assay Vero African green monkey kidney cells IC-50 4.00E-07 g/l Isobavachalcone Tyrosinase (Tyr) inhibition, IN VITRO Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Steroid 5alpha-Reductase Inhibitors;Drugs Targeting Beta-Amyloid;Signal Transduction Modulators;Autophagy Inducers;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants Tyrosinase (Tyr) Thiouracil incorporation assay Melanocytes, human IC-50 4.00E-07 M Pristimerine Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, breast (adenocarcinoma) Dye assay (MTT) MCF7 human breast adenocarcinoma cells (hormone-dependent) CC-50 4.00E-07 M Pristimerine Cancer, prostate (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, prostate (adenocarcinoma) Cell counting assay PC3 human prostate adenocarcinoma cells MIC 4.00E-07 M Tingenone Hepatoblastoma remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Antioxidants;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs;Free Radical Scavengers Hepatoblastoma Dye assay (alamar blue) HepG2 human hepatoblastoma cells CC-50 4.00E-07 M Tingenone Leukemia, acute promyelocytic (M3) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Antioxidants;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs;Free Radical Scavengers Leukemia, acute promyelocytic (M3) Dye assay (alamar blue) HL60 human acute promyelocytic leukemia cells CC-50 4.00E-07 M Baicalein ATP-Dependent DNA Helicases inhibition, IN VITRO Drugs Targeting on Quorum Sensing Signaling;Signal Transduction Modulators;AR Expression Inhibitors;15-Lipoxygenase Inhibitors;Autophagy Inducers;12-Lipoxygenase Inhibitors;Dual Specificity Protein Phosphatase 3 (VHR) Inhibitors;Reverse Transcriptase/Ribonuclease H (HIV-1) Inhibitors;Apoptosis Inducers;Protein Tyrosine Phosphatase (PTP) Inhibitors ATP-Dependent DNA Helicases Fluorescence resonance energy transfer (FRET) assay Coronavirus (SARS-associated) IC-50 4.70E-07 M Pristimerine Cytotoxicity induction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cytotoxicity Flow cytometry assay HEK293 human embryonic kidney cells (ABCB1-overexpressing) MEC <= 5.00E-07 M Pristimerine Hypoxia Inducible Factor 1-alpha (HIF-1alpha) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Hypoxia Inducible Factor 1-alpha (HIF-1alpha) ELISA assay PC3 human prostate adenocarcinoma cells MIC <= 5.00E-07 M Pristimerine Hypoxia Inducible Factor (HIF) (nonspecified subtype) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Hypoxia Inducible Factor (HIF) (nonspecified subtype) ELISA assay PC3 human prostate adenocarcinoma cells MIC <= 5.00E-07 M MAC-5576 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors 3C-Like Protease (viral) Coronavirus (SARS-associated) IC-50 5.00E-07 M Ferruginol Catenin beta-1 activation, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Lipid Peroxidation Inhibitors;Antioxidants;Apoptosis Inducers Catenin beta-1 Chemiluminescent assay Hippocampus (dorsal), mouse (beta-amyloid (42)-treated) MEC 5.00E-07 M Ferruginol Glycogen Synthase Kinase 3 beta (GSK-3beta) induction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Lipid Peroxidation Inhibitors;Antioxidants;Apoptosis Inducers Glycogen Synthase Kinase 3 beta (GSK-3beta) Chemiluminescent assay Hippocampus (dorsal), mouse (beta-amyloid (42)-treated) MEC 5.00E-07 M Pristimerine Survivin (BIRC5) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Survivin (BIRC5) RNA assay OMM1 human uveal melanoma cells MIC <= 5.00E-07 M Pristimerine MMP-9 (Gelatinase B) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs MMP-9 (Gelatinase B) OMM1 human uveal melanoma cells MIC 5.00E-07 M Pristimerine Caspase-9 activation, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Caspase-9 Acetyl-LEHD-p-nitroaniline as a substrate COLO205 human colon carcinoma cells MEC <= 5.00E-07 M Pristimerine Caspase-8 activation, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Caspase-8 Acetyl-IETD-p-nitroaniline as a substrate COLO205 human colon carcinoma cells MEC <= 5.00E-07 M Pristimerine Cancer, prostate (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, prostate (adenocarcinoma) Dye assay (MTT) PC3 human prostate adenocarcinoma cells (hypoxic) MCC <= 5.00E-07 M Tingenone Leukemia, acute promyelocytic (M3) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Antioxidants;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs;Free Radical Scavengers Leukemia, acute promyelocytic (M3) Dye assay (MTT) HL60 human acute promyelocytic leukemia cells CC-50 5.00E-07 M Tingenone Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Antioxidants;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs;Free Radical Scavengers Cancer, breast (adenocarcinoma) Dye assay (alamar blue) MCF7 human breast adenocarcinoma cells (hormone-dependent) CC-50 5.00E-07 M Tingenone Leukemia, myeloid remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Antioxidants;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs;Free Radical Scavengers Leukemia, myeloid Dye assay (alamar blue) K562 human myeloid leukemia cells CC-50 5.00E-07 M Tingenone Melanoma, metastatic remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Antioxidants;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs;Free Radical Scavengers Melanoma, metastatic Dye assay (alamar blue) B16F10 mouse metastatic melanoma cells CC-50 5.00E-07 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Wound closure assay OMM1 human uveal melanoma cells MIC 5.00E-07 M Pristimerine Cancer, colon remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, colon Propidium iodide assay HCT116 human colon carcinoma cells MEC <= 5.00E-07 M Pristimerine Cancer, colon (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, colon (adenocarcinoma) Propidium iodide assay SW620 human colon adenocarcinoma cells MEC <= 5.00E-07 M Pristimerine Cancer, colon remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, colon Propidium iodide assay COLO205 human colon carcinoma cells MEC <= 5.00E-07 M Pristimerine Cancer, colon remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, colon Flow cytometry assay Mitochondria (COLO205 human colon carcinoma cells) MEC <= 5.00E-07 M 6',6'-Difluoroaristeromycin Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO S-Adenosyl-L-Homocysteine Hydrolase Inhibitors Severe acute respiratory syndrome (SARS-CoV) Dye assay (MTS) VeroE6 African green monkey kidney cells IC-50 5.00E-07 M JMF-1521 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (viral) Fluorescent assay Coronavirus (SARS-associated) Ki 5.20E-07 M Pristimerine Cancer, rhinopharyngeal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, rhinopharyngeal Dye assay (MTT) KBv200 human epidermoid carcinoma cells (multidrug-resistant/ABCB1-overexpressing) CC-50 5.20E-07 M Pristimerine Cancer, rhinopharyngeal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, rhinopharyngeal Dye assay (MTT) KB human epidermoid rhinopharyngeal carcinoma cells CC-50 5.40E-07 M Pristimerine Melanoma remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma MDAMB435 human melanoma cells CC-50 5.50E-07 M GRL-0617 Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Arg-Leu-Arg-Gly-Gly-7-amino-4-methylcoumarin as substrate Coronavirus (SARS-associated) IC-50 5.60E-07 M TG-0205221 Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors Severe acute respiratory syndrome (SARS-CoV) Cytopathicity assay Vero African green monkey kidney cells IC-50 6.00E-07 M Pristimerine Cytotoxicity induction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cytotoxicity Dye assay (alamar blue) Mononuclear cells (blood), human CC-50 6.00E-07 M GRL-0617 Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Ubiquitin-7-amino-4-methylcoumarin as substrate Coronavirus (SARS-associated) IC-50 6.00E-07 M GC-373 Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO 3C-Like Protease (Norovirus) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) IC-50 6.00E-07 M Tingenone Cancer, colon remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Antioxidants;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs;Free Radical Scavengers Cancer, colon Dye assay (alamar blue) HCT116 human colon carcinoma cells CC-50 6.00E-07 M Tingenone Cancer, mouth (squamous cell) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Antioxidants;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs;Free Radical Scavengers Cancer, mouth (squamous cell) Dye assay (alamar blue) SCC4 human oral squamous cell carcinoma cells CC-50 6.00E-07 M Pristimerine Cancer, pancreas (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, pancreas (adenocarcinoma) Dye assay (MTS) MiaPaCa2 human pancreas adenocarcinoma cells MCC <= 6.25E-07 M Pristimerine Cancer, pancreas (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, pancreas (adenocarcinoma) Flow cytometry assay PANC1 human pancreas adenocarcinoma cells MEC <= 6.25E-07 M Pristimerine Cancer, pancreas (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, pancreas (adenocarcinoma) Flow cytometry assay MiaPaCa2 human pancreas adenocarcinoma cells MEC <= 6.25E-07 M Betulonic acid Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Lysosomal alpha-Glucosidase (GAA) Inhibitors;E3 Ubiquitin-Protein Ligase Inhibitors Severe acute respiratory syndrome (SARS-CoV) Cytopathicity assay Vero African green monkey kidney cells IC-50 6.30E-07 M Pristimerine Cancer, stomach (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, stomach (adenocarcinoma) Dye assay (MTT) SGC7901 human gastric adenocarcinoma cells IC-50 6.30E-07 M GRL-0667 Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Arg-Leu-Arg-Gly-Gly-7-amino-4-methylcoumarin as substrate Coronavirus (SARS-associated) IC-50 6.70E-07 M Pristimerine Cytotoxicity induction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cytotoxicity Dye assay (MTT) HEK293 human embryonic kidney cells CC-50 6.90E-07 M Betulinic acid Infection, herpes simplex virus remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Signal Transduction Modulators;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Infection, herpes simplex virus Viral replication assay Vero African green monkey kidney cells IC-50 7.00E-07 M Tanshinone I Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Signal Transduction Modulators;AP-1 Transcription Factor Complex Inhibitors;Aryl Hydrocarbon Receptor (AhR) Ligands Replicase Polyprotein 1ab (pp1ab) (SARS) Ubiquitin-7-amino-4-methylcoumarin as substrate Coronavirus (SARS-associated) IC-50 7.00E-07 M Pristimerine Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, breast (adenocarcinoma) ATP assay MCF7 human breast adenocarcinoma cells (hormone-dependent) CC-50 7.50E-07 M Pristimerine Hepatoblastoma remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Hepatoblastoma Dye assay (MTT) HepG2 human hepatoblastoma cells IC-50 7.80E-07 M Pristimerine Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, breast (adenocarcinoma) Spheres formation assay MCF7 human breast adenocarcinoma cells (hormone-dependent) (mammospheres) MIC 7.80E-07 M Iguesterin Proteasome Subunit beta Type-5 (PSMB5) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors Proteasome Subunit beta Type-5 (PSMB5) Fluorescent assay Coronavirus (SARS-associated) Ki 8.00E-07 M Pristimerine Cancer, colon remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, colon Dye assay (MTT) @ 48 h COLO205 human colon carcinoma cells IC-50 8.40E-07 M Pristimerine Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, breast (adenocarcinoma) Dye assay (MTT) MCF7 human breast adenocarcinoma cells (hormone-dependent) CC-50 8.70E-07 M Ferruginol Malaria remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Lipid Peroxidation Inhibitors;Antioxidants;Apoptosis Inducers Malaria Erythrocytes, human IC-50 9.00E-07 M Geldanamycin Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Signal Transduction Modulators;Heat Shock Protein 90 (Hsp90) Inhibitors Severe acute respiratory syndrome (SARS-CoV) IC-50 9.10E-07 M Pristimerine Cytotoxicity induction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cytotoxicity Dye assay (MTT) HEK293 human embryonic kidney cells (ABCB1-overexpressing) CC-50 9.30E-07 M NSC-158362 Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Severe acute respiratory syndrome (SARS-CoV) Viral replication assay MA104 embryonic African green monkey kidney cells IC-50 < 1.00E-06 M NSC-158362 Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Severe acute respiratory syndrome (SARS-CoV) Viral replication assay Vero African green monkey kidney cells IC-50 < 1.00E-06 M Pristimerine Cytotoxicity induction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cytotoxicity Flow cytometry assay HEK293 human embryonic kidney cells MEC 1.00E-06 M Ribavirin Nephrotoxicity induction, IN VITRO Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors;Equilibrative Nucleoside Transporter ENT1 Inhibitors Nephrotoxicity Cell viability assay Vero African green monkey kidney cells CC-50 > 1.00E-06 g/l Pristimerine Cytotoxicity induction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cytotoxicity Dye assay (MTS) RAW264.7 mouse macrophages MCC 1.00E-06 M Pristimerine Cytotoxicity induction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cytotoxicity Dye assay (MTS) RAW264.7 mouse macrophages MEC 1.00E-06 M Betulinic acid Cytotoxicity induction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cytotoxicity Dye assay (MTT) Macrophage cells (bone marrow), mouse MCC <= 1.00E-06 M Pristimerine Sphingosine Kinase 1 (SPK1) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Sphingosine Kinase 1 (SPK1) ELISA assay PC3 human prostate adenocarcinoma cells (hypoxic) MIC 1.00E-06 M Isobavachalcone Interleukin-6 (IL-6) inhibition, IN VITRO Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Steroid 5alpha-Reductase Inhibitors;Drugs Targeting Beta-Amyloid;Signal Transduction Modulators;Autophagy Inducers;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants Interleukin-6 (IL-6) Chemiluminescent assay BV2 murine microglia cells MIC 1.00E-06 M Pristimerine Multidrug Resistance Protein 1 (MDR-1) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Multidrug Resistance Protein 1 (MDR-1) Flow cytometry assay HEK293 human embryonic kidney cells (ABCB1-overexpressing) MIC 1.00E-06 M Betulinic acid DNA Topoisomerase II (nonspecified subtype) inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors DNA Topoisomerase II (nonspecified subtype) DNA relaxation assay Human enzyme IC-50 > 1.00E-06 M Psoralidin 5-Hydroxytryptamine Receptor 1A (5-HT1A) agonism, IN VITRO Estrogen Receptor (ER) beta Agonists;Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;Estrogen Receptor (ER) alpha Agonists;5-Lipoxygenase Inhibitors;Signal Transduction Modulators;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Caspase Activators;Apoptosis Inducers 5-Hydroxytryptamine Receptor 1A (5-HT1A) Chemiluminescent assay Cortical neurons (primary), mouse MEC <= 1.00E-06 M JMF-1521 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (viral) Fluorescent assay Coronavirus (SARS-associated) IC-50 1.00E-06 M Pristimerine Survivin (BIRC5) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Survivin (BIRC5) RNA assay 92.1 human uveal melanoma cells MIC 1.00E-06 M Pristimerine Caspase-3 activation, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Caspase-3 Acetyl-DEVD-p-nitroaniline as a substrate HCT116 human colon carcinoma cells MEC 1.00E-06 M Pristimerine Caspase-3 activation, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Caspase-3 Acetyl-DEVD-p-nitroaniline as a substrate SW620 human colon adenocarcinoma cells MEC 1.00E-06 M Pristimerine Caspase-3 activation, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Caspase-3 Acetyl-DEVD-p-nitroaniline as a substrate COLO205 human colon carcinoma cells MEC 1.00E-06 M Pristimerine Caspase-9 activation, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Caspase-9 Acetyl-LEHD-p-nitroaniline as a substrate HCT116 human colon carcinoma cells MEC 1.00E-06 M Pristimerine Caspase-9 activation, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Caspase-9 Acetyl-LEHD-p-nitroaniline as a substrate SW620 human colon adenocarcinoma cells MEC 1.00E-06 M Pristimerine Caspase-8 activation, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Caspase-8 Acetyl-IETD-p-nitroaniline as a substrate SW620 human colon adenocarcinoma cells MEC 1.00E-06 M Pristimerine Cancer, prostate (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, prostate (adenocarcinoma) Dye assay (MTT) PC3 human prostate adenocarcinoma cells MCC 1.00E-06 M Isobavachalcone Neuroinflammation remission/reduction, IN VITRO Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Steroid 5alpha-Reductase Inhibitors;Drugs Targeting Beta-Amyloid;Signal Transduction Modulators;Autophagy Inducers;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants Neuroinflammation Nitrite assay BV2 murine microglia cells MIC 1.00E-06 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Flow cytometry assay 92.1 human uveal melanoma cells MEC <= 1.00E-06 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Flow cytometry assay OMM1 human uveal melanoma cells MEC <= 1.00E-06 M Isobavachalcone Dementia, Alzheimer type protection, IN VITRO Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Steroid 5alpha-Reductase Inhibitors;Drugs Targeting Beta-Amyloid;Signal Transduction Modulators;Autophagy Inducers;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants Dementia, Alzheimer type Dye assay (MTT) SHSY5Y human dopaminergic neuroblastoma cells MIC <= 1.00E-06 M Psoralidin Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO Estrogen Receptor (ER) beta Agonists;Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;Estrogen Receptor (ER) alpha Agonists;5-Lipoxygenase Inhibitors;Signal Transduction Modulators;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Caspase Activators;Apoptosis Inducers Cancer, breast (adenocarcinoma) Dye assay (MTT) MDAMB231 human breast adenocarcinoma cells (ALDH-positive) MCC <= 1.00E-06 M Betulinic acid Osteoporosis remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Osteoporosis Spectrophotometric assay Macrophage cells (bone marrow), mouse IC-50 <= 1.00E-06 M Betulinic acid Cytotoxicity remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cytotoxicity Dye assay (MTT) hFOB1.19 human fetal osteoblasts (SV40 large Tantigen-transformed) MCC <= 1.00E-06 M Betulinic acid Cytotoxicity remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cytotoxicity Dye assay (MTT) hFOB1.19 human fetal osteoblasts (SV40 large Tantigen-transformed) MCC <= 1.00E-06 M Betulinic acid Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (adenocarcinoma) Dye assay (MTT) @ 72 h MDAMB231 human breast adenocarcinoma cells MIC <= 1.00E-06 M Pristimerine Cancer, colon remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, colon Flow cytometry assay Mitochondria (HCT116 human colon carcinoma cells) MEC 1.00E-06 M Pristimerine Cancer, colon (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, colon (adenocarcinoma) Flow cytometry assay Mitochondria (SW620 human colon adenocarcinoma cells) MEC 1.00E-06 M Mucroporin-M1 Cytotoxicity induction, IN VITRO Cell Membrane Disrupting Agents Cytotoxicity Dye assay (MTT) MDBK Madin-Darby bovine kidney epithelial cells CC-50 1.03E-06 M Psoralidin Estrogen Receptor alpha (ERalpha) affinity, IN VITRO Estrogen Receptor (ER) beta Agonists;Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;Estrogen Receptor (ER) alpha Agonists;5-Lipoxygenase Inhibitors;Signal Transduction Modulators;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Caspase Activators;Apoptosis Inducers Estrogen Receptor alpha (ERalpha) Displacement of [3H]-estradiol Recombinant human receptor IC-50 1.03E-06 M Pristimerine Cancer, lung (non-small cell) (NSCLC) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, lung (non-small cell) (NSCLC) Dye assay (MTT) A549 human non-small-cell lung carcinoma cells IC-50 1.03E-06 M Pristimerine Cancer, colon (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, colon (adenocarcinoma) Dye assay (MTT) @ 48 h SW620 human colon adenocarcinoma cells IC-50 1.04E-06 M Betulinic acid G-Protein Coupled Bile Acid Receptor BG37 (TGR5) agonism, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors G-Protein Coupled Bile Acid Receptor BG37 (TGR5) Gene reporter assay CHO Chinese hamster ovary cells transfected with human GPBA (TGR5) receptor EC-50 1.10E-06 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Dye assay (MTS) 92.1 human uveal melanoma cells CC-50 1.10E-06 M (-)-Savinin Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Drugs Acting on Tumor Necrosis Factor (TNF) Receptors Severe acute respiratory syndrome (SARS-CoV) Cytopathicity assay Vero African green monkey kidney cells IC-50 1.13E-06 M Pristimerine Cancer, liver (hepatocellular carcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, liver (hepatocellular carcinoma) Dye assay (MTT) BEL7402 human hepatocellular carcinoma cells IC-50 1.16E-06 M DTPMPA ATPase (nonspecified subtype) inhibition, IN VITRO Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors ATPase (nonspecified subtype) Phosphate release assay Coronavirus (SARS-associated) IC-50 1.19E-06 M Dihydrotan Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Hypoxia Inducible Factor 1-alpha (HIF-1alpha) Inhibitors;Immune Checkpoint Inhibitors;Indoleamine 2,3-dioxygenase 1 (IDO1; IDO) Inhibitors;Acetylcholinesterase (AChE) Inhibitors;Nitric Oxide (NO) Production Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Ubiquitin-7-amino-4-methylcoumarin as substrate Coronavirus (SARS-associated) IC-50 1.20E-06 M Pristimerine Cancer, colon remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, colon Dye assay (MTT) @ 48 h HCT116 human colon carcinoma cells IC-50 1.22E-06 M SR9EK3 Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Severe acute respiratory syndrome (SARS-CoV) Viral replication assay Vero African green monkey kidney cells IC-90 1.23E-06 M Pristimerine Cancer, pancreas (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, pancreas (adenocarcinoma) Dye assay (MTS) PANC1 human pancreas adenocarcinoma cells MCC 1.25E-06 M Pristimerine Cancer, endometrium (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, endometrium (adenocarcinoma) Flow cytometry assay MDAH2774 human endometrium adenocarcinoma cells MEC 1.25E-06 M Pristimerine Cancer, prostate remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, prostate Dye assay (MTS) LNCaP human prostate carcinoma cells (androgen-dependent) MCC 1.25E-06 M Pristimerine Cancer, prostate (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, prostate (adenocarcinoma) Dye assay (MTS) PC3 human prostate adenocarcinoma cells MCC 1.25E-06 M Pristimerine Cancer, prostate remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, prostate Flow cytometry assay LNCaP human prostate carcinoma cells (androgen-dependent) MEC 1.25E-06 M Pristimerine Cancer, prostate (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, prostate (adenocarcinoma) Flow cytometry assay PC3 human prostate adenocarcinoma cells MEC 1.25E-06 M Pristimerine Sarcoma, synovial remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Sarcoma, synovial Dye assay (MTT) SW982 human synovial sarcoma cells CC-50 1.28E-06 M Ferruginol Malaria remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Lipid Peroxidation Inhibitors;Antioxidants;Apoptosis Inducers Malaria IC-50 1.33E-06 M Isobavachalcone Dihydroorotate Dehydrogenase (quinone), mitochondrial (DHODH) affinity, IN VITRO Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Steroid 5alpha-Reductase Inhibitors;Drugs Targeting Beta-Amyloid;Signal Transduction Modulators;Autophagy Inducers;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants Dihydroorotate Dehydrogenase (quinone), mitochondrial (DHODH) Isothermal microcalorimetric test Recombinant human enzyme Kd 1.33E-06 M Ferruginol Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Lipid Peroxidation Inhibitors;Antioxidants;Apoptosis Inducers Severe acute respiratory syndrome (SARS-CoV) Cytopathicity assay Vero African green monkey kidney cells IC-50 1.39E-06 M Ferroquine Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Severe acute respiratory syndrome (SARS-CoV) Vero African green monkey kidney cells IC-50 1.40E-06 M Betulinic acid Infection, HIV remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Infection, HIV Antigen assay H9 human T-cell leukemia cells IC-50 1.40E-06 M Betulinic acid Infection, HIV remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Infection, HIV Viral replication assay H9 human T-cell leukemia cells IC-50 1.40E-06 M Ferruginol Fatty acid oxidation disorders remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Lipid Peroxidation Inhibitors;Antioxidants;Apoptosis Inducers Fatty acid oxidation disorders TBARS formation assay Erythrocytes, human IC-50 1.40E-06 M Betulinic acid Infection, HIV remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Infection, HIV Viral replication assay H9 human T-cell leukemia cells IC-50 1.40E-06 M Betulinic acid Infection, HIV remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Infection, HIV Viral replication assay H9 human T-cell leukemia cells IC-50 1.40E-06 M Isobavachalcone Cancer remission/reduction, IN VITRO Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Steroid 5alpha-Reductase Inhibitors;Drugs Targeting Beta-Amyloid;Signal Transduction Modulators;Autophagy Inducers;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants Cancer Endothelial cells (lymphatic), rat (temperature-sensitive) IC-50 1.41E-06 M Betulinic acid Malaria remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Signal Transduction Modulators;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Malaria Fluorescent assay Erythrocytes, human IC-50 1.42E-06 M Betulinic acid Malaria remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;Apoptosis Inducers;NF-kappaB (NFKB) Activators;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Malaria Fluorescent assay Erythrocytes, human IC-50 1.42E-06 M ML-188 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors 3C-Like Protease (viral) Coronavirus (SARS-associated) IC-50 1.50E-06 M ML-188 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors 3C-Like Protease (viral) Coronavirus (SARS-associated) IC-50 1.50E-06 M Betulinic acid Osteoporosis remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Osteoporosis Tartrate-resistant acid phosphatase assay Macrophage cells (bone marrow), mouse IC-50 1.60E-06 M Sinefungin RNA (Guanine-7-) Methyltransferase inhibition, IN VITRO Coactivator Associated Arginine Methyltransferase 1 (CARM1; PRMT4) Inhibitors;Histone-Lysine N-Methyltransferase SETD7 (SET7/9) Inhibitors;Protein-L-Isoaspartate(D-Aspartate) O-Methyltransferase (PCMT1; PIMT) Inhibitors;Epigenetic Modifier Modulators RNA (Guanine-7-) Methyltransferase Yeast-based assay Coronavirus (SARS-associated) IC-50 1.62E-06 M SR9EK3 Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Severe acute respiratory syndrome (SARS-CoV) Viral replication assay Vero African green monkey kidney cells IC-99 1.63E-06 M Betulinic acid alpha-1 Adrenergic Receptors (nonspecified subtype) antagonism, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors alpha-1 Adrenergic Receptors (nonspecified subtype) Artery (aorta, thoracic), rat IC-50 1.67E-06 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Dye assay (MTS) Mel270 human uveal melanoma cells CC-50 1.70E-06 M Betulinic acid Cancer, stomach remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, stomach Colony formation assay GES-1 human gastric epithelial cells (methyl-N-nitroso-guanidine-treated) IC-50 1.72E-06 M Pristimerine Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, breast (adenocarcinoma) ATP assay MCF7 human breast adenocarcinoma cells (hormone-dependent) (mammospheres) CC-50 1.75E-06 M Psoralidin Estrogen Receptor (nonspecified subtype) agonism, IN VITRO Estrogen Receptor (ER) beta Agonists;Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;Estrogen Receptor (ER) alpha Agonists;5-Lipoxygenase Inhibitors;Signal Transduction Modulators;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Caspase Activators;Apoptosis Inducers Estrogen Receptor (nonspecified subtype) Luciferine/luciferase assay MCF7 human breast adenocarcinoma cells (hormone-dependent) EC-50 1.85E-06 M Betulinic acid Aldo-Keto Reductase Family 1 Member B10 (ARL-1) inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Aldo-Keto Reductase Family 1 Member B10 (ARL-1) Fluorescent assay IC-50 2.00E-06 M Pristimerine Caspase-8 activation, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Caspase-8 Acetyl-IETD-p-nitroaniline as a substrate HCT116 human colon carcinoma cells MEC 2.00E-06 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Flow cytometry assay Mel270 human uveal melanoma cells MEC 2.00E-06 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Flow cytometry assay OMM2.3 human uveal melanoma cells MEC 2.00E-06 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Dye assay (MTS) OMM1 human uveal melanoma cells CC-50 2.20E-06 M Betulinic acid Oxidative stress remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Oxidative stress Ferricytochrome c reduction assay Neutrophils, human IC-50 2.23E-06 M Betulinic acid G-Protein Coupled Bile Acid Receptor BG37 (TGR5) agonism, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors G-Protein Coupled Bile Acid Receptor BG37 (TGR5) cAMP accumulation assay HEK293 human embryonic kidney cells transfected with human GPBA (TGR5) receptor EC-50 2.25E-06 M Kaempferol 3-O-alpha-L-arabinofuranoside Hypothetical Protein Sars3a inhibition, IN VITRO Hedgehog Signaling Inhibitors;Antioxidants Hypothetical Protein Sars3a Voltage-clamp assay (-60 mV) Oocytes (Xenopus) transfected with SARS associated coronavirus 3a protein IC-50 2.30E-06 M Bananin ATPase (nonspecified subtype) inhibition, IN VITRO Chelating Agents ATPase (nonspecified subtype) Coronavirus (SARS-associated) IC-50 2.30E-06 M Dieckol 3C-Like Protease (viral) inhibition, IN VITRO Reverse Transcriptase/Ribonuclease H (HIV-1) Inhibitors;beta-Secretase 1 (BACE1) Inhibitors;Acetylcholinesterase (AChE) Inhibitors 3C-Like Protease (viral) Fluorescence resonance energy transfer (FRET) assay Coronavirus (SARS-associated) Ki 2.40E-06 M Betulinic acid Osteoporosis remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Osteoporosis Macrophage cells (bone marrow), mouse IC-50 <= 2.40E-06 M Pristimerine Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, breast (adenocarcinoma) Cell counting assay SKBr3 human breast adenocarcinoma cells (HER2 [ERBB2]-overexpressing) CC-50 2.40E-06 M Isobavachalcone Signal Transducer and Activator of Transcription 3 (STAT3) inhibition, IN VITRO Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Steroid 5alpha-Reductase Inhibitors;Drugs Targeting Beta-Amyloid;Signal Transduction Modulators;Autophagy Inducers;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants Signal Transducer and Activator of Transcription 3 (STAT3) Luciferine/luciferase assay Hep3B human hepatocellular carcinoma cells IC-50 2.45E-06 M Ferruginol Malaria remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Lipid Peroxidation Inhibitors;Antioxidants;Apoptosis Inducers Malaria IC-50 2.47E-06 M Betulinic acid HIV-1 Protease inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors HIV-1 Protease HIV IC-50 2.50E-06 M Betulinic acid Zinc Finger and BTB Domain Containing 10 induction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Zinc Finger and BTB Domain Containing 10 Luciferine/luciferase assay MDAMB231 human breast adenocarcinoma cells MEC 2.50E-06 M Betulinic acid SP Transcritption Factors inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors SP Transcritption Factors Luciferine/luciferase assay MDAMB231 human breast adenocarcinoma cells MIC 2.50E-06 M Betulinic acid MicroRNA 27a inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors MicroRNA 27a RNA assay MDAMB231 human breast adenocarcinoma cells MIC 2.50E-06 M Betulinic acid Vascular Endothelial Growth Factors (VEGF) (nonspecified subtype) inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Vascular Endothelial Growth Factors (VEGF) (nonspecified subtype) Luciferine/luciferase assay MDAMB231 human breast adenocarcinoma cells MIC 2.50E-06 M Betulinic acid Vascular Endothelial Growth Factor Receptor (VEGFR) (nonspecified subtype) inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Vascular Endothelial Growth Factor Receptor (VEGFR) (nonspecified subtype) Luciferine/luciferase assay MDAMB231 human breast adenocarcinoma cells MIC 2.50E-06 M Pristimerine Cancer, ovary remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, ovary Flow cytometry assay OVCAR5 human ovary carcinoma cells MEC 2.50E-06 M Pristimerine Cancer, ovary remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, ovary Flow cytometry assay Mitochondria (OVCAR5 human ovary carcinoma cells) MEC 2.50E-06 M Pristimerine Cancer, endometrium (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, endometrium (adenocarcinoma) Flow cytometry assay Mitochondria (MDAH2774 human endometrium adenocarcinoma cells) MEC 2.50E-06 M Betulinic acid Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (adenocarcinoma) Flow cytometry assay MCF7 human breast adenocarcinoma cells (hormone-dependent) MEC <= 2.50E-06 M Betulinic acid Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (adenocarcinoma) Flow cytometry assay MDAMB231 human breast adenocarcinoma cells MIC <= 2.50E-06 M Betulinic acid Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (adenocarcinoma) Flow cytometry assay MCF7 human breast adenocarcinoma cells (hormone-dependent) MIC <= 2.50E-06 M Betulinic acid Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (adenocarcinoma) Flow cytometry assay MDAMB231 human breast adenocarcinoma cells MIC <= 2.50E-06 M Betulinic acid Cancer, breast remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast Cell counting assay MDAMB453 human breast carcinoma cells MIC 2.50E-06 M Betulinic acid Melanoma remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Melanoma Cell counting assay MDAMB435 human melanoma cells MIC 2.50E-06 M Betulinic acid Cancer, breast remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast Cell counting assay MDAMB453 human breast carcinoma cells MIC 2.50E-06 M Betulinic acid Cancer, breast remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast Cell counting assay MDAMB468 human breast carcinoma cells MIC 2.50E-06 M Betulinic acid Cancer, breast remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast Cell counting assay Hs578T human breast carcinoma cells MIC 2.50E-06 M Betulinic acid Cancer, breast (in situ ductal carcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (in situ ductal carcinoma) Cell counting assay BT474 human breast ductal carcinoma cells (HER2 [ERBB2]-overexpressing) MIC 2.50E-06 M Pristimerine Glioma remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Glioma Dye assay (MTT) C6 rat glioma cells CC-50 2.50E-06 M Iguesterin Proteasome Subunit beta Type-5 (PSMB5) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors Proteasome Subunit beta Type-5 (PSMB5) Fluorescent assay Coronavirus (SARS-associated) IC-50 2.60E-06 M Dieckol 3C-Like Protease (viral) inhibition, IN VITRO Reverse Transcriptase/Ribonuclease H (HIV-1) Inhibitors;beta-Secretase 1 (BACE1) Inhibitors;Acetylcholinesterase (AChE) Inhibitors 3C-Like Protease (viral) Fluorescence resonance energy transfer (FRET) assay Coronavirus (SARS-associated) IC-50 2.70E-06 M Ferruginol Malaria remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Lipid Peroxidation Inhibitors;Antioxidants;Apoptosis Inducers Malaria IC-50 2.90E-06 M Pristimerine Cancer, mouth (squamous cell) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, mouth (squamous cell) Dye assay (alamar blue) HSC3 human oral squamous cell carcinoma cells CC-50 2.90E-06 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Dye assay (MTS) OMM2.3 human uveal melanoma cells CC-50 2.90E-06 M Hirsutenone Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;LDL Antioxidants;Signal Transduction Modulators;Antiinflammatory Drugs;Free Radical Scavengers;Nitric Oxide (NO) Production Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Ubiquitin-7-amino-4-methylcoumarin as substrate Coronavirus (SARS-associated) IC-50 3.00E-06 M Bananin ATP-Dependent DNA Helicases inhibition, IN VITRO Chelating Agents ATP-Dependent DNA Helicases Coronavirus (SARS-associated) IC-50 3.00E-06 M Tingenone Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Antioxidants;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs;Free Radical Scavengers Cancer, breast (adenocarcinoma) Dye assay (MTT) MCF7 human breast adenocarcinoma cells (hormone-dependent) CC-50 3.00E-06 M Betulinic acid Cancer, lung (non-small cell) (NSCLC) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, lung (non-small cell) (NSCLC) Dye assay (MTT) A549 human non-small-cell lung carcinoma cells CC-50 3.00E-06 M Pristimerine Proteasome Subunit beta Type-5 (PSMB5) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Proteasome Subunit beta Type-5 (PSMB5) Fluorescent assay Coronavirus (SARS-associated) Ki 3.10E-06 M Pristimerine Leukemia, myeloid remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Leukemia, myeloid K562 human myeloid leukemia cells CC-50 3.20E-06 M Pristimerine HLA Class I Histocompatibility antigen, B-7 alpha chain (HLA-B) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs HLA Class I Histocompatibility antigen, B-7 alpha chain (HLA-B) Luciferine/luciferase assay HeLa human cervix adenocarcinoma cells IC-50 3.25E-06 M Betulinic acid Cancer, colon (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, colon (adenocarcinoma) Dye assay (MTT) HT29 human colon adenocarcinoma cells IC-50 3.40E-06 M Pristimerine Cancer, cervix, (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, cervix, (adenocarcinoma) Dye assay (MTT) HeLa human cervix adenocarcinoma cells CC-50 3.42E-06 M GC-373 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (Norovirus) Inhibitors 3C-Like Protease (viral) Fluorescence resonance energy transfer (FRET) assay Coronavirus (SARS-associated) IC-50 3.48E-06 M GC-373 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (Norovirus) Inhibitors 3C-Like Protease (viral) Fluorescence resonance energy transfer (FRET) assay Coronavirus (SARS-associated) IC-50 3.48E-06 M Betulinic acid Protein Tyrosine Phosphatase 1B (PTP-1B) inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Protein Tyrosine Phosphatase 1B (PTP-1B) p-Nitrophenyl phosphate as substrate IC-50 3.49E-06 M Pristimerine Cytotoxicity induction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cytotoxicity Dye assay (alamar blue) MRC5 human embryonic lung fibroblasts CC-50 3.50E-06 M Psoralidin Lysosomal alpha-Glucosidase inhibition, IN VITRO Estrogen Receptor (ER) beta Agonists;Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;Estrogen Receptor (ER) alpha Agonists;5-Lipoxygenase Inhibitors;Signal Transduction Modulators;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Caspase Activators;Apoptosis Inducers Lysosomal alpha-Glucosidase p-Nitrophenyl alpha-D-glucopyranoside as substrate IC-50 3.50E-06 M Mucroporin-M1 Influenza A remission/reduction, IN VITRO Cell Membrane Disrupting Agents Influenza A Plaque assay IC-50 3.52E-06 M SR9EK2 Nephrotoxicity induction, IN VITRO Nephrotoxicity Dye assay Vero African green monkey kidney cells CC-50 3.60E-06 M Betulinic acid Infection, cytomegalovirus remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Signal Transduction Modulators;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Infection, cytomegalovirus Fluorescent assay Fibroblasts (foreskin), human IC-50 3.62E-06 M Betulinic acid Infection, cytomegalovirus remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;Apoptosis Inducers;NF-kappaB (NFKB) Activators;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Infection, cytomegalovirus Fluorescent assay Fibroblasts (foreskin), human IC-50 3.62E-06 M Psoralidin Estrogen Receptor alpha (ERalpha) agonism, IN VITRO Estrogen Receptor (ER) beta Agonists;Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;Estrogen Receptor (ER) alpha Agonists;5-Lipoxygenase Inhibitors;Signal Transduction Modulators;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Caspase Activators;Apoptosis Inducers Estrogen Receptor alpha (ERalpha) Luciferine/luciferase assay CV1 African green monkey kidney fibroblasts transfected with ERalpha receptor EC-50 3.68E-06 M Betulinic acid Malaria remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Signal Transduction Modulators;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Malaria Radioactivity assay IC-50 3.70E-06 M Papyriflavonol A Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Signal Transduction Modulators;Phospholipase A2 (PLA2) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Fluorescent assay Coronavirus (SARS-associated) IC-50 3.70E-06 M Noscapine Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Tubulin Polymerization Inhibitors;Apoptosis Inducers;Antimitotic Drugs Severe acute respiratory syndrome (SARS-CoV) Dye assay (neutral red) Vero African green monkey kidney cells IC-50 3.80E-06 g/l Psoralidin Cytotoxicity induction, IN VITRO Estrogen Receptor (ER) beta Agonists;Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;Estrogen Receptor (ER) alpha Agonists;5-Lipoxygenase Inhibitors;Signal Transduction Modulators;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Caspase Activators;Apoptosis Inducers Cytotoxicity Dye assay (MTT) RWPE1 human prostate epithelial cells MCC 4.00E-06 M Tingenone Proteasome Subunit beta Type-5 (PSMB5) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Antioxidants;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs;Free Radical Scavengers Proteasome Subunit beta Type-5 (PSMB5) Fluorescent assay Coronavirus (SARS-associated) Ki 4.00E-06 M Psoralidin Cancer, prostate remission/reduction, IN VITRO Estrogen Receptor (ER) beta Agonists;Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;Estrogen Receptor (ER) alpha Agonists;5-Lipoxygenase Inhibitors;Signal Transduction Modulators;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Caspase Activators;Apoptosis Inducers Cancer, prostate Bromodeoxyuridine incorporation assay Epithelial cells (prostate), human (cadmium-transformed) MIC 4.00E-06 M Chloroquine phosphate Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Apoptosis Inducers Severe acute respiratory syndrome (SARS-CoV) Viral replication assay Vero African green monkey kidney cells IC-50 4.10E-06 M Chloroquine phosphate Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Apoptosis Inducers Severe acute respiratory syndrome (SARS-CoV) Dye assay (MTS) VeroE6 African green monkey kidney cells IC-50 4.10E-06 M Chloroquine phosphate Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Apoptosis Inducers Severe acute respiratory syndrome (SARS-CoV) Viral replication assay IC-50 4.10E-06 M Hirsutenone 3C-Like Protease (viral) inhibition, IN VITRO Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;LDL Antioxidants;Signal Transduction Modulators;Antiinflammatory Drugs;Free Radical Scavengers;Nitric Oxide (NO) Production Inhibitors 3C-Like Protease (viral) Fluorescent assay Coronavirus (SARS-associated) IC-50 4.10E-06 M Hirsutenone Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;LDL Antioxidants;Signal Transduction Modulators;Antiinflammatory Drugs;Free Radical Scavengers;Nitric Oxide (NO) Production Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Arg-Leu-Arg-Gly-Gly-7-amino-4-methylcoumarin as substrate Coronavirus (SARS-associated) IC-50 4.10E-06 M ML-300 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors 3C-Like Protease (viral) Coronavirus (SARS-associated) IC-50 4.11E-06 M (-)-Savinin Cancer, ovary (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Drugs Acting on Tumor Necrosis Factor (TNF) Receptors Cancer, ovary (adenocarcinoma) Dye assay (sulforhodamine B) SKOV3 human ovary adenocarcinoma cells CC-50 4.16E-06 M Tripterin Proteasome Subunit beta Type-5 (PSMB5) inhibition, IN VITRO Signal Transduction Modulators;Heat Shock Protein 90 (Hsp90) Inhibitors;Lipid Peroxidation Inhibitors;Cytokine Production Inhibitors;Apoptosis Inducers;Enoyl-(Acyl Carrier Protein) Reductase (FabI) (Plasmodium falciparum) Inhibitors;Antioxidants;Myc Proto-Oncogene Protein (c-Myc)/Myc-Associated Factor X (Max) Interaction Inhibitors Proteasome Subunit beta Type-5 (PSMB5) Fluorescent assay Coronavirus (SARS-associated) Ki 4.20E-06 M Psoralidin Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Estrogen Receptor (ER) beta Agonists;Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;Estrogen Receptor (ER) alpha Agonists;5-Lipoxygenase Inhibitors;Signal Transduction Modulators;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Caspase Activators;Apoptosis Inducers Replicase Polyprotein 1ab (pp1ab) (SARS) Arg-Leu-Arg-Gly-Gly-7-amino-4-methylcoumarin as substrate Coronavirus (SARS-associated) IC-50 4.20E-06 M GC-376 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (Norovirus) Inhibitors 3C-Like Protease (viral) Fluorescence resonance energy transfer (FRET) assay Coronavirus (SARS-associated) IC-50 4.35E-06 M GC-376 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (Norovirus) Inhibitors 3C-Like Protease (viral) Fluorescence resonance energy transfer (FRET) assay Coronavirus (SARS-associated) IC-50 4.35E-06 M (-)-Savinin Melanoma remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Drugs Acting on Tumor Necrosis Factor (TNF) Receptors Melanoma Dye assay (sulforhodamine B) SKMEL2 human melanoma cells CC-50 4.37E-06 M Pristimerine Glioblastoma remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Glioblastoma Dye assay (MTT) U251 human glioblastoma cells CC-50 4.50E-06 M Betulinic acid Cytotoxicity induction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cytotoxicity Dye assay (MTT) HeLa human cervix adenocarcinoma cells (CD4+/CCR5+) transfected with HIV-1 LTRbeta-gal-positive CC-50 4.52E-06 M Betulinic acid Cytotoxicity induction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cytotoxicity Dye assay (MTT) HeLa human cervix adenocarcinoma cells (CD4+/CCR5+) transfected with HIV-1 LTRbeta-gal-positive CC-50 4.52E-06 M Xanthoangelol B Anemia, hemolytic remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Cysteine Protease Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants;Sensor Histidine Kinase (Bacterial) Inhibitors;Plasminogen Activator Inhibitor (PAI-1) Inhibitors;Nitric Oxide (NO) Production Inhibitors;Free Radical Scavengers Anemia, hemolytic Erythrocytes, human IC-50 4.62E-06 M (-)-Savinin Cancer, colon (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Drugs Acting on Tumor Necrosis Factor (TNF) Receptors Cancer, colon (adenocarcinoma) Dye assay (sulforhodamine B) HCT15 human colon adenocarcinoma cells CC-50 4.82E-06 M Imatinib mesylate Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Tyrosine-Protein Kinase ABL1 Inhibitors;Bcr-Abl (Bcr-Abl1) Kinase Inhibitors;PDGFRalpha Inhibitors;PDGFRbeta Inhibitors;Signal Transduction Modulators;Breast Cancer-Resistant Protein (BCRP; ABCG2) Inhibitors;KIT (C-KIT) Inhibitors;CSF1R (c-FMS) Inhibitors;Apoptosis Inducers;Angiogenesis Inhibitors Severe acute respiratory syndrome (SARS-CoV) RNA assay Calu3 human lung carcinoma cells (c-erbB2-overexpressing) MIC > 5.00E-06 M Betulinic acid DNA Topoisomerase II alpha inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors DNA Topoisomerase II alpha DNA decatenation assay Human enzyme IC-50 5.00E-06 M Psoralidin Activity-Regulated Cytoskeleton-Associated Protein activation, IN VITRO Estrogen Receptor (ER) beta Agonists;Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;Estrogen Receptor (ER) alpha Agonists;5-Lipoxygenase Inhibitors;Signal Transduction Modulators;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Caspase Activators;Apoptosis Inducers Activity-Regulated Cytoskeleton-Associated Protein RNA assay Cortical neurons (primary), mouse MEC 5.00E-06 M Psoralidin Early Growth Response 1 (EGR1) induction, IN VITRO Estrogen Receptor (ER) beta Agonists;Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;Estrogen Receptor (ER) alpha Agonists;5-Lipoxygenase Inhibitors;Signal Transduction Modulators;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Caspase Activators;Apoptosis Inducers Early Growth Response 1 (EGR1) RNA assay Cortical neurons (primary), mouse MEC 5.00E-06 M Betulinic acid Caveolin 1 (CAV1) induction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Caveolin 1 (CAV1) Chemiluminescent assay MDAMB231 human breast adenocarcinoma cells MEC 5.00E-06 M Betulinic acid L-Lactate Dehydrogenase A chain (LDH-A) inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors L-Lactate Dehydrogenase A chain (LDH-A) Chemiluminescent assay MCF7 human breast adenocarcinoma cells (hormone-dependent) MIC 5.00E-06 M Betulinic acid [Pyruvate Dehydrogenase (Acetyl-Transferring)] Kinase isozyme 1, mitochondrial (PDK1) inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors [Pyruvate Dehydrogenase (Acetyl-Transferring)] Kinase isozyme 1, mitochondrial (PDK1) Chemiluminescent assay MCF7 human breast adenocarcinoma cells (hormone-dependent) MIC 5.00E-06 M Betulinic acid [Pyruvate Dehydrogenase (Acetyl-Transferring)] Kinase isozyme 1, mitochondrial (PDK1) inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors [Pyruvate Dehydrogenase (Acetyl-Transferring)] Kinase isozyme 1, mitochondrial (PDK1) Chemiluminescent assay MDAMB231 human breast adenocarcinoma cells MIC 5.00E-06 M Betulinic acid [Pyruvate Dehydrogenase (Acetyl-Transferring)] Kinase isozyme 1, mitochondrial (PDK1) inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors [Pyruvate Dehydrogenase (Acetyl-Transferring)] Kinase isozyme 1, mitochondrial (PDK1) Chemiluminescent assay MDAMB231 human breast adenocarcinoma cells MIC 5.00E-06 M Betulinic acid Transcription Factor p65 inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Transcription Factor p65 Chemiluminescent assay MCF7 human breast adenocarcinoma cells (hormone-dependent) MIC 5.00E-06 M Betulinic acid Hypoxia Inducible Factor (HIF) (nonspecified subtype) inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Hypoxia Inducible Factor (HIF) (nonspecified subtype) ELISA assay PC3 human prostate adenocarcinoma cells MIC <= 5.00E-06 M Betulinic acid Hypoxia Inducible Factor (HIF) (nonspecified subtype) inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Hypoxia Inducible Factor (HIF) (nonspecified subtype) Chemiluminescent assay PC3 human prostate adenocarcinoma cells MIC <= 5.00E-06 M Pristimerine Fatty Acid Synthase inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Fatty Acid Synthase Acetyl-CoA incorporation assay SKBr3 human breast adenocarcinoma cells (HER2 [ERBB2]-overexpressing) MIC 5.00E-06 M Cinanserin hydrochloride 3C-Like Protease (viral) inhibition, IN VITRO Serotonin Receptor Antagonists;Signal Transduction Modulators 3C-Like Protease (viral) Coronavirus (SARS-associated) IC-50 5.00E-06 M Tomentin E Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Arg-Leu-Arg-Gly-Gly-7-amino-4-methylcoumarin as substrate Coronavirus (SARS-associated) IC-50 5.00E-06 M Betulinic acid Apoptosis Regulator Bcl-2 induction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Apoptosis Regulator Bcl-2 Chemiluminescent assay H9c2 rat cardiac myoblasts (hypoxic/reoxygenated) MEC <= 5.00E-06 M Betulinic acid Caspase-3 inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Caspase-3 Acetyl-Asp-Glu-Val-Asp-p-nitroanilide as substrate H9c2 rat cardiac myoblasts MIC <= 5.00E-06 M Betulinic acid Apoptosis Regulator BAX inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Apoptosis Regulator BAX Chemiluminescent assay H9c2 rat cardiac myoblasts MIC <= 5.00E-06 M Betulinic acid Transcriptional Repressor Protein YY1 inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Transcriptional Repressor Protein YY1 Luciferine/luciferase assay MDAMB453 human breast carcinoma cells MIC 5.00E-06 M Betulinic acid Membrane-Associated Tyrosine- and Threonine-Specific cdc2-Inhibitory Kinase induction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Membrane-Associated Tyrosine- and Threonine-Specific cdc2-Inhibitory Kinase RNA assay MDAMB231 human breast adenocarcinoma cells MEC 5.00E-06 M Betulinic acid SP Transcritption Factors inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors SP Transcritption Factors Luciferine/luciferase assay MDAMB231 human breast adenocarcinoma cells MIC 5.00E-06 M Betulinic acid Transcription Factor Sp1 inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Transcription Factor Sp1 RNA assay MDAMB231 human breast adenocarcinoma cells MIC 5.00E-06 M Betulinic acid Transcription Factor Sp3 inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Transcription Factor Sp3 RNA assay MDAMB231 human breast adenocarcinoma cells MIC 5.00E-06 M Betulinic acid Transcription Factor Sp4 inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Transcription Factor Sp4 RNA assay MDAMB231 human breast adenocarcinoma cells MIC 5.00E-06 M Betulinic acid Wee1-Like Protein Kinase 1 (Wee1) inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Wee1-Like Protein Kinase 1 (Wee1) RNA assay MDAMB231 human breast adenocarcinoma cells MIC 5.00E-06 M Isobavachalcone Cancer, liver (hepatocellular carcinoma) remission/reduction, IN VITRO Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Steroid 5alpha-Reductase Inhibitors;Drugs Targeting Beta-Amyloid;Signal Transduction Modulators;Autophagy Inducers;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants Cancer, liver (hepatocellular carcinoma) Colony formation assay Hep3B human hepatocellular carcinoma cells MIC <= 5.00E-06 M Pristimerine Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, breast (adenocarcinoma) Flow cytometry assay SKBr3 human breast adenocarcinoma cells (HER2 [ERBB2]-overexpressing) MEC 5.00E-06 M Betulinic acid Oxidative stress remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Oxidative stress Chemiluminescent assay H9c2 rat cardiac myoblasts MIC <= 5.00E-06 M Betulinic acid Oxidative stress remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Oxidative stress TBARS formation assay H9c2 rat cardiac myoblasts MIC <= 5.00E-06 M Betulinic acid Oxidative stress remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Oxidative stress Hydroxylamine as substrate H9c2 rat cardiac myoblasts (hypoxic/reoxygenated) MIC <= 5.00E-06 M Betulinic acid Oxidative stress remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Oxidative stress Spectrophotometric assay H9c2 rat cardiac myoblasts (hypoxic/reoxygenated) MIC <= 5.00E-06 M Betulinic acid Oxidative stress remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Oxidative stress Spectrophotometric assay H9c2 rat cardiac myoblasts MIC <= 5.00E-06 M Betulinic acid Cancer, breast (in situ ductal carcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (in situ ductal carcinoma) Cell counting assay BT474 human breast ductal carcinoma cells (HER2 [ERBB2]-overexpressing) MIC 5.00E-06 M Betulinic acid Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (adenocarcinoma) Flow cytometry assay MDAMB231 human breast adenocarcinoma cells MEC 5.00E-06 M Betulinic acid Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (adenocarcinoma) Cell counting assay MDAMB231 human breast adenocarcinoma cells MIC 5.00E-06 M Betulinic acid Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (adenocarcinoma) Dye assay (MTT) MDAMB231 human breast adenocarcinoma cells MCC 5.00E-06 M Betulinic acid Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (adenocarcinoma) Dye assay (MTT) MDAMB231 human breast adenocarcinoma cells MCC 5.00E-06 M Betulinic acid Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (adenocarcinoma) Dye assay (MTT) @ 24 h MDAMB231 human breast adenocarcinoma cells MIC 5.00E-06 M Betulinic acid Cancer, lung (non-small cell) (NSCLC) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, lung (non-small cell) (NSCLC) Transwell chamber assay H1299 human non-small-cell lung cancer cells MIC 5.00E-06 M Betulinic acid Cancer, lung (non-small cell) (NSCLC) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, lung (non-small cell) (NSCLC) Wound closure assay H1299 human non-small-cell lung cancer cells MIC 5.00E-06 M Pristimerine Glioblastoma remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Glioblastoma Dye assay (MTT) U87MG human glioblastoma cells CC-50 5.00E-06 M Betulinic acid Cancer, esophagus remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, esophagus Cell viability assay YES2 human esophagus cancer cells IC-50 5.09E-06 M Betulinic acid Malaria remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Signal Transduction Modulators;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Malaria Flow cytometry assay Erythrocytes, human IC-50 5.20E-06 M Betulinic acid Infection, HIV remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Infection, HIV beta-Galactosidase assay HeLa human cervix adenocarcinoma cells (CD4+/CCR5+) transfected with HIV-1 LTRbeta-gal-positive IC-50 5.32E-06 M Betulinic acid Infection, HIV remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Infection, HIV beta-Galactosidase assay HeLa human cervix adenocarcinoma cells (CD4+/CCR5+) transfected with HIV-1 LTRbeta-gal-positive IC-50 5.32E-06 M Pristimerine Proteasome Subunit beta Type-5 (PSMB5) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Proteasome Subunit beta Type-5 (PSMB5) Fluorescent assay Coronavirus (SARS-associated) IC-50 5.50E-06 M SSYA-10-001 NTPase inhibition, IN VITRO NTPase Fluorescent assay Coronavirus (SARS-associated) IC-50 5.60E-06 M Curcumin Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;CCND1 Expression Inhibitors;Glucose-6-Phosphatase Inhibitors;P-Glycoprotein (MDR-1; ABCB1) Inhibitors;HIV Integrase Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Signal Transduction Modulators;Antiinflammatory Drugs;Histone N-Acetyltransferase (HAT) Inhibitors;Microtubule-Associated Protein Tau (PHF-tau; MAPT) Aggregation Inhibitors;AP-1 Transcription Factor Complex Inhibitors;DNA Methyltransferase 1 (DNMT1) Inhibitors;Apoptosis Inducers;Prostaglandin G/H Synthase 1 (PTGS1; COX-1) Inhibitors;Antioxidants;Angiogenesis Inhibitors;EGFR Expression Inhibitors;Cell Division Protein FtsZ (Bacterial) Inhibitors;Free Radical Scavengers;Lipoxygenase Inhibitors;Wnt Signaling Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Arg-Leu-Arg-Gly-Gly-7-amino-4-methylcoumarin as substrate Coronavirus (SARS-associated) IC-50 5.70E-06 M RH-01 Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO 3C-Like Protease (NL63 Coronavirus) (HCoV-NL63) Inhibitors;3C-Like Protease (EMC Coronavirus) (HCoV-EMC) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Coronavirus IC-50 5.72E-06 M (-)-Savinin Cancer, lung (non-small cell) (NSCLC) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Drugs Acting on Tumor Necrosis Factor (TNF) Receptors Cancer, lung (non-small cell) (NSCLC) Dye assay (sulforhodamine B) A549 human non-small-cell lung carcinoma cells CC-50 5.75E-06 M Ferruginol Leishmaniasis remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Lipid Peroxidation Inhibitors;Antioxidants;Apoptosis Inducers Leishmaniasis Amastigote assay IC-50 5.90E-06 M Loperamide hydrochloride Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Signal Transduction Modulators;mu-Opioid Receptor Agonists;Atrial Natriuretic Peptide B (NPR2; Guanylate Cyclase B) Receptor Antagonists Severe acute respiratory syndrome (SARS-CoV) Dye assay (MTS) VeroE6 African green monkey kidney cells IC-50 5.90E-06 M Loperamide hydrochloride Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Signal Transduction Modulators;mu-Opioid Receptor Agonists;Atrial Natriuretic Peptide B (NPR2; Guanylate Cyclase B) Receptor Antagonists Severe acute respiratory syndrome (SARS-CoV) Viral replication assay IC-50 5.90E-06 M Papyriflavonol A Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Signal Transduction Modulators;Phospholipase A2 (PLA2) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Uncompetitive inhibition mode Coronavirus (SARS-associated) Ki 5.90E-06 M SG-85 Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO 3C-Like Protease (NL63 Coronavirus) (HCoV-NL63) Inhibitors;3C Protease (Enterovirus 71) Inhibitors;3C-Like Protease (EMC Coronavirus) (HCoV-EMC) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Coronavirus IC-50 6.06E-06 M SR9EK3 Nephrotoxicity induction, IN VITRO Nephrotoxicity Dye assay Vero African green monkey kidney cells CC-50 6.15E-06 M Pristimerine Melanoma, metastatic remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, metastatic Dye assay (alamar blue) B16F10 mouse metastatic melanoma cells CC-50 6.30E-06 M Betulinic acid Cancer, colon (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, colon (adenocarcinoma) Dye assay (sulforhodamine B) SW480 human colon adenocarcinoma cells CC-50 6.40E-06 M Betulinic acid Cancer, colon (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, colon (adenocarcinoma) Dye assay (sulforhodamine B) SW480 human colon adenocarcinoma cells CC-50 6.40E-06 M Betulinic acid Cancer, colon (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, colon (adenocarcinoma) Dye assay (sulforhodamine B) SW480 human colon adenocarcinoma cells CC-50 6.40E-06 M Betulinic acid Cancer, colon (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, colon (adenocarcinoma) Dye assay (sulforhodamine B) SW480 human colon adenocarcinoma cells CC-50 6.48E-06 M Betulinic acid Cancer, colon (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, colon (adenocarcinoma) Dye assay (sulforhodamine B) SW480 human colon adenocarcinoma cells CC-50 6.48E-06 M Chloroquine Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Severe acute respiratory syndrome (SARS-CoV) Vero African green monkey kidney cells IC-50 6.50E-06 M Betulinic acid Cancer, lung (non-small cell) (NSCLC) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, lung (non-small cell) (NSCLC) Dye assay A549 human non-small-cell lung carcinoma cells CC-50 6.65E-06 M Betulinic acid Cancer, thyroid, anaplastic remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, thyroid, anaplastic Dye assay (sulforhodamine B) 8505C human anaplastic thyroid carcinoma cells CC-50 6.70E-06 M Betulinic acid Cancer, thyroid, anaplastic remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, thyroid, anaplastic Dye assay (sulforhodamine B) 8505C human anaplastic thyroid carcinoma cells CC-50 6.70E-06 M Betulinic acid Cancer, thyroid, anaplastic remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, thyroid, anaplastic Dye assay (sulforhodamine B) 8505C human anaplastic thyroid carcinoma cells CC-50 6.70E-06 M Betulinic acid Cancer, thyroid, anaplastic remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, thyroid, anaplastic Dye assay (sulforhodamine B) 8505C human anaplastic thyroid carcinoma cells CC-50 6.70E-06 M Betulinic acid Cancer, thyroid, anaplastic remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, thyroid, anaplastic Dye assay (sulforhodamine B) 8505C human anaplastic thyroid carcinoma cells CC-50 6.70E-06 M Betulinic acid Cancer, thyroid, anaplastic remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, thyroid, anaplastic Dye assay (sulforhodamine B) 8505C human anaplastic thyroid carcinoma cells CC-50 6.70E-06 M Betulinic acid Cancer, thyroid, anaplastic remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, thyroid, anaplastic Dye assay (sulforhodamine B) 8505C human anaplastic thyroid carcinoma cells CC-50 6.70E-06 M Psoralidin Estrogen Receptor beta (ERbeta) agonism, IN VITRO Estrogen Receptor (ER) beta Agonists;Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;Estrogen Receptor (ER) alpha Agonists;5-Lipoxygenase Inhibitors;Signal Transduction Modulators;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Caspase Activators;Apoptosis Inducers Estrogen Receptor beta (ERbeta) Luciferine/luciferase assay CV1 African green monkey kidney fibroblasts transfected with ERbeta receptor EC-50 6.88E-06 M Quercetin Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Catechol-O-Methyl Transferase (COMT) Inhibitors;Drugs Targeting on Quorum Sensing Signaling;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;MAO-A Inhibitors;NAD-Dependent Protein Deacetylase Sirtuin-1 (SIRT1) Activators;Signal Transduction Modulators;Lysosomal alpha-Glucosidase (GAA) Inhibitors;Xanthine Oxidase Inhibitors;EGFR (HER1; erbB1) Inhibitors;Cytokine Production Inhibitors;Antioxidants;Steryl-Sulfatase (STS) Inhibitors;Aldose Reductase Inhibitors;Sodium Channel Protein Type 5 Subunit alpha (Nav1.5) Channel Blockers;Free Radical Scavengers;Epigenetic Modifier Modulators;Wnt Signaling Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Uncompetitive inhibition mode Coronavirus (SARS-associated) Ki 7.00E-06 M Betulinic acid Melanoma remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Melanoma Dye assay (MTS) SKMEL2 human melanoma cells CC-50 7.00E-06 M Pristimerine Cancer, stomach remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, stomach N87 human gastric carcinoma cells CC-50 7.00E-06 M Mucroporin-M1 Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Cell Membrane Disrupting Agents Severe acute respiratory syndrome (SARS-CoV) Plaque assay HeLa human cervix adenocarcinoma cells IC-50 7.12E-06 M Betulinic acid Cancer, thyroid, anaplastic remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, thyroid, anaplastic Dye assay (sulforhodamine B) 8505C human anaplastic thyroid carcinoma cells CC-50 7.26E-06 M Betulinic acid Cancer, thyroid, anaplastic remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, thyroid, anaplastic Dye assay (sulforhodamine B) 8505C human anaplastic thyroid carcinoma cells CC-50 7.26E-06 M Isobavachalcone Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Steroid 5alpha-Reductase Inhibitors;Drugs Targeting Beta-Amyloid;Signal Transduction Modulators;Autophagy Inducers;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants Replicase Polyprotein 1ab (pp1ab) (SARS) Arg-Leu-Arg-Gly-Gly-7-amino-4-methylcoumarin as substrate Coronavirus (SARS-associated) IC-50 7.30E-06 M Papyriflavonol A Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Signal Transduction Modulators;Phospholipase A2 (PLA2) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Fluorescent assay Coronavirus (SARS-associated) IC-50 7.60E-06 M Betulinic acid Cancer, lung (non-small cell) (NSCLC) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, lung (non-small cell) (NSCLC) Dye assay (sulforhodamine B) A549 human non-small-cell lung carcinoma cells CC-50 7.60E-06 M Betulinic acid Cancer, breast (in situ ductal carcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (in situ ductal carcinoma) Clonogenic assay T47D human breast ductal carcinoma cells CC-50 7.66E-06 M Pristimerine Hepatoblastoma remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Hepatoblastoma Dye assay (alamar blue) HepG2 human hepatoblastoma cells CC-50 7.80E-06 M Pristimerine Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, breast (adenocarcinoma) Dye assay (alamar blue) MCF7 human breast adenocarcinoma cells (hormone-dependent) CC-50 7.90E-06 M Isobavachalcone Cancer, ovary remission/reduction, IN VITRO Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Steroid 5alpha-Reductase Inhibitors;Drugs Targeting Beta-Amyloid;Signal Transduction Modulators;Autophagy Inducers;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants Cancer, ovary Dye assay (MTT) OVCAR8 human ovary carcinoma cells CC-50 7.92E-06 M Broussochalcone A Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Signal Transduction Modulators;Protein Kinase C (PKC) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Uncompetitive inhibition mode Coronavirus (SARS-associated) Ki 8.00E-06 M Quercetin NTPase inhibition, IN VITRO Catechol-O-Methyl Transferase (COMT) Inhibitors;Drugs Targeting on Quorum Sensing Signaling;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;MAO-A Inhibitors;NAD-Dependent Protein Deacetylase Sirtuin-1 (SIRT1) Activators;Signal Transduction Modulators;Lysosomal alpha-Glucosidase (GAA) Inhibitors;Xanthine Oxidase Inhibitors;EGFR (HER1; erbB1) Inhibitors;Cytokine Production Inhibitors;Antioxidants;Steryl-Sulfatase (STS) Inhibitors;Aldose Reductase Inhibitors;Sodium Channel Protein Type 5 Subunit alpha (Nav1.5) Channel Blockers;Free Radical Scavengers;Epigenetic Modifier Modulators;Wnt Signaling Inhibitors NTPase Fluorescent assay Coronavirus (SARS-associated) IC-50 8.10E-06 M Betulinic acid Melanoma remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Melanoma Dye assay (sulforhodamine B) 518A2 human melanoma cells CC-50 8.13E-06 M Betulinic acid Melanoma remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Melanoma Dye assay (sulforhodamine B) 518A2 human melanoma cells CC-50 8.13E-06 M Betulonic acid 3C-Like Protease (viral) inhibition, IN VITRO E3 Ubiquitin-Protein Ligase SIAH2 Inhibitors;Lysosomal alpha-Glucosidase (GAA) Inhibitors 3C-Like Protease (viral) Spectrophotometric assay Coronavirus (SARS-associated) Ki 8.20E-06 M Eckol 3C-Like Protease (viral) inhibition, IN VITRO Lipid Peroxidation Inhibitors;Tyrosinase Inhibitors;Free Radical Scavengers 3C-Like Protease (viral) Fluorescence resonance energy transfer (FRET) assay Coronavirus (SARS-associated) Ki 8.20E-06 M Unannotated Set A collection of 816 records for 479 molecules from various sources. We current don't have the capability to annotate the sources or confirm the correctness of all datasets. This dataset may contains missing values and \"dirty\" data. Please use the data carefully and make your own effort to confirm the data source (journals, patents, websites) and extract useful (signal) information from the set. Some datasets use standardlized value PX=-log[M]. Full dataset Some subsets extracted: PX>6(measurement <1uM) active set IC50 values for 562 molecules Ki inhibition constant for 207 molecules Inhibition rate for 153 molecules EC50 values for 30 molecules pKi values for 14 molecules SMILES of 986 molecules tested for coronavirus, but we are not sure if they are active or inactive SMILES Literature Mining A comprehensive literature mining result kindly provided by Causaly , focusing on chemicals/drugs, genes and molecular mechanisms. This data includes 2090 relationships, 1229 aggregrate relationships, and 976 articles based on a search query of \"Chemicals&Drugs,Genes,Cellular&Molecular Mechanisms [AFFECTING] [Genus:Coronavirus]\" with the data source coming from MEDLINE and PubMedCentral. This search resulted in several Target Concepts including: sars coronavirus, middle east respiratory syndrome coronavirus, human coronavirus, etc. Full dataset The following figure is the keyword relationship network: Full Image The aggregate relationship data can be found in this dataset This data describes source concept items and classifies them into different categories. Some relevant categories include: Amino Acid Peptide Protein, Biologically Active Substance, Chemical, Nucleic Acid, etc. Literature articles and relationships data gives a list of 977 relevant articles and shows the evidence of the relationship from the original article. Dataset Literature evidence data lists all relevant source concepts (biological substances, chemicals, etc) and its relation to an article. Overall, there are over 2000 relevant pieces of information relevant to coronavirus. Dataset A few selected records Source Concept Source Concept Categories Relationship Type Target Concept Count of Evidence Evidence contains clinical studies? Count of Evidence per rel type cyclosporine \"Amino Acid, Peptide, or Protein\" DOWNREGULATE genus: coronavirus 11 no DOWNREGULATE: 11 \"rna, small interfering\" Biologically Active Substance DOWNREGULATE sars coronavirus 9 no DOWNREGULATE: 9 linoleic acid Biologically Active Substance DOWNREGULATE middle east respiratory syndrome coronavirus 3 no \"DOWNREGULATE: 2, UPREGULATE: 1\" resveratrol Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 7 no \"DOWNREGULATE: 6, UPREGULATE: 1\" chloroquine Organic Chemical DOWNREGULATE sars coronavirus 14 no \"DOWNREGULATE: 12, UPREGULATE: 2\" human leukocyte interferon \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 17 no \"DOWNREGULATE: 11, UNIDIRECTIONAL: 4, UPREGULATE: 1, NEG_UNIDIRECTIONAL: 1\" gs-5734 \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE genus: coronavirus 4 no DOWNREGULATE: 4 zinc Biologically Active Substance DOWNREGULATE sars coronavirus 4 no DOWNREGULATE: 4 linoleic acid Biologically Active Substance DOWNREGULATE human coronavirus 229e 2 no \"UPREGULATE: 1, DOWNREGULATE: 1\" fk-506 Organic Chemical DOWNREGULATE human coronavirus nl63 2 no DOWNREGULATE: 2 human leukocyte interferon \"Amino Acid, Peptide, or Protein\" DOWNREGULATE genus: coronavirus 8 no \"DOWNREGULATE: 5, UNIDIRECTIONAL: 2, UPREGULATE: 1\" lopinavir Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 4 no DOWNREGULATE: 4 ribavirin \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE middle east respiratory syndrome coronavirus 6 no \"DOWNREGULATE: 5, UNIDIRECTIONAL: 1\" cyclosporine \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 3 no DOWNREGULATE: 3 gs-5734 \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE sars coronavirus 3 no DOWNREGULATE: 3 recombinant interferon alfa \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 5 no \"DOWNREGULATE: 4, UNIDIRECTIONAL: 1\" \"5-(n,n-hexamethylene)amiloride\" Organic Chemical DOWNREGULATE human coronavirus 229e 4 no DOWNREGULATE: 4 chlorpromazine Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 3 no DOWNREGULATE: 3 chloroquine Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 3 no DOWNREGULATE: 3 interferon type i \"Amino Acid, Peptide, or Protein\" DOWNREGULATE genus: coronavirus 5 no \"DOWNREGULATE: 3, UNIDIRECTIONAL: 1, UPREGULATE: 1\" monoclonal antibodies \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 6 no \"DOWNREGULATE: 3, UNIDIRECTIONAL: 2, UPREGULATE: 1\" glycyrrhizic acid Organic Chemical DOWNREGULATE sars coronavirus 3 no DOWNREGULATE: 3 protease inhibitors Pharmacologic Substance DOWNREGULATE sars coronavirus 3 no DOWNREGULATE: 3 kinase inhibitor [epc] Pharmacologic Substance DOWNREGULATE middle east respiratory syndrome coronavirus 2 no DOWNREGULATE: 2 chloroquine Organic Chemical DOWNREGULATE genus: coronavirus 3 no \"DOWNREGULATE: 2, UNIDIRECTIONAL: 1\" emodin Biologically Active Substance DOWNREGULATE sars coronavirus 2 no DOWNREGULATE: 2 emodin Biologically Active Substance DOWNREGULATE \"coronavirus oc43, human\" 2 no DOWNREGULATE: 2 beta-thujaplicin Organic Chemical DOWNREGULATE genus: coronavirus 2 no DOWNREGULATE: 2 ubiquitin \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 3 no DOWNREGULATE: 3 nucleoside analogs \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE genus: coronavirus 3 no \"DOWNREGULATE: 2, UNIDIRECTIONAL: 1\" proteasome inhibitor Pharmacologic Substance DOWNREGULATE sars coronavirus 2 no DOWNREGULATE: 2 mycophenolic acid Antibiotic DOWNREGULATE middle east respiratory syndrome coronavirus 2 no DOWNREGULATE: 2 loperamide Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 2 no DOWNREGULATE: 2 cyclophilins \"Amino Acid, Peptide, or Protein\" DOWNREGULATE genus: coronavirus 2 no \"DOWNREGULATE: 1, UPREGULATE: 1\" cytokine \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 3 no \"DOWNREGULATE: 2, UNIDIRECTIONAL: 1\" lopinavir Organic Chemical DOWNREGULATE sars coronavirus 2 no DOWNREGULATE: 2 cyclosporine \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 2 no DOWNREGULATE: 2 alisporivir \"Amino Acid, Peptide, or Protein\" DOWNREGULATE genus: coronavirus 2 no DOWNREGULATE: 2 glycosyltransferase \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 2 no DOWNREGULATE: 2 methyltransferase \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 2 no DOWNREGULATE: 2 u 18666a Organic Chemical DOWNREGULATE \"coronavirus, feline\" 2 no DOWNREGULATE: 2 \"5-(n,n-hexamethylene)amiloride\" Organic Chemical DOWNREGULATE genus: coronavirus 2 no DOWNREGULATE: 2 niclosamide Organic Chemical DOWNREGULATE sars coronavirus 2 no DOWNREGULATE: 2 \"dpp4 protein, human\" \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 5 no \"DOWNREGULATE: 3, UPREGULATE: 1, UNIDIRECTIONAL: 1\" glycoproteins \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 2 no \"DOWNREGULATE: 1, UPREGULATE: 1\" fumaric acid Organic Chemical DOWNREGULATE genus: coronavirus 2 no DOWNREGULATE: 2 protease inhibitors Pharmacologic Substance DOWNREGULATE genus: coronavirus 2 no DOWNREGULATE: 2 adenoviral vector \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE sars coronavirus 2 no DOWNREGULATE: 2 tapi-2 Organic Chemical DOWNREGULATE sars coronavirus 2 no DOWNREGULATE: 2 monoclonal antibodies \"Amino Acid, Peptide, or Protein\" DOWNREGULATE porcine respiratory coronavirus 2 no DOWNREGULATE: 2 s antibody \"Amino Acid, Peptide, or Protein\" DOWNREGULATE bovine coronavirus 2 no DOWNREGULATE: 2 interferon-alpha2b \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 3 no \"DOWNREGULATE: 2, UNIDIRECTIONAL: 1\" human immunodeficiency virus 1 fusion inhibitor [epc] Pharmacologic Substance DOWNREGULATE middle east respiratory syndrome coronavirus 2 no DOWNREGULATE: 2 ribavirin \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE sars coronavirus 12 no \"DOWNREGULATE: 5, NEG_DOWNREGULATE: 4, UNIDIRECTIONAL: 2, UPREGULATE: 1\" platelets product Pharmacologic Substance DOWNREGULATE middle east respiratory syndrome coronavirus 2 no DOWNREGULATE: 2 tylophorine Organic Chemical DOWNREGULATE genus: coronavirus 2 no \"UPREGULATE: 1, DOWNREGULATE: 1\" riboflavin Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 2 no DOWNREGULATE: 2 recombinant interferon beta \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 \"antibodies, neutralizing\" \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 5 no \"DOWNREGULATE: 2, UPREGULATE: 1, NEG_UPREGULATE: 1, NEG_DOWNREGULATE: 1\" ribavirin \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE genus: coronavirus 2 no DOWNREGULATE: 2 immune sera \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 2 no DOWNREGULATE: 2 nim-811 \"Amino Acid, Peptide, or Protein\" DOWNREGULATE human coronavirus nl63 1 no DOWNREGULATE: 1 alisporivir \"Amino Acid, Peptide, or Protein\" DOWNREGULATE human coronavirus nl63 1 no DOWNREGULATE: 1 fk-506 Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 fk-506 Organic Chemical DOWNREGULATE human coronavirus 229e 1 no DOWNREGULATE: 1 s-nitroso-n-acetylpenicillamine Biologically Active Substance DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 hiv protease inhibitors Pharmacologic Substance DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 nelfinavir Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 phospholipase c \"Amino Acid, Peptide, or Protein\" DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 disulfiram Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 disulfiram Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 scorpion venoms Biologically Active Substance DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 interferon gamma [epc] \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 acetylglucosamine Organic Chemical DOWNREGULATE \"coronavirus oc43, human\" 1 no DOWNREGULATE: 1 gs-5734 \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE human coronavirus 1 no DOWNREGULATE: 1 terconazole Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 terconazole Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 phenanthrenes Organic Chemical DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 pyrithione Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 chloroquine Organic Chemical DOWNREGULATE \"coronavirus oc43, human\" 1 no DOWNREGULATE: 1 saikosaponin b2 Organic Chemical DOWNREGULATE human coronavirus 1 no DOWNREGULATE: 1 isobavachalcone Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 herbacetin Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 helichrysetin Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 isoquercitrin Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 fc receptor \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 alisporivir \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 decanoylrvkrchloromethylketone \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 gs-5734 \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 nucleoside analogs \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 nucleoside analogs \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 nucleoside analogs \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE human coronavirus 1 no DOWNREGULATE: 1 cardiotonic agents Pharmacologic Substance DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 sodium Biologically Active Substance DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 aminoquinoline antimalarial (product) Organic Chemical DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 interleukins \"Amino Acid, Peptide, or Protein\" DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 thiothixene Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 clomipramine Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 thioxanthenes Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 clomipramine Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 thiothixene Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 thioxanthenes Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 adenosine deaminase \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 chloroquine Organic Chemical DOWNREGULATE human coronavirus 1 no DOWNREGULATE: 1 tetra(4-n-methylpyridyl)porphine Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 alisporivir \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 teicoplanin \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 dalbavancin \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 telavancin \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 oritavancin \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 \"antibodies, monoclonal, humanized\" \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 ssya10-001 Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 protease inhibitors Pharmacologic Substance DOWNREGULATE \"coronavirus, feline\" 1 no DOWNREGULATE: 1 mercaptopurine \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 thioguanine Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 ssya10-001 Organic Chemical DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 pj-34 Organic Chemical DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 sb 203580 Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 interferon-alpha2b \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 synthetic peptide \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 chinese herbs Pharmacologic Substance DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 nitric oxide Biologically Active Substance DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 amiloride Organic Chemical DOWNREGULATE human coronavirus 229e 1 no DOWNREGULATE: 1 amiodarone Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 cystatins \"Amino Acid, Peptide, or Protein\" DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 glycine \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 anthelmintics Pharmacologic Substance DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 anthelmintics Pharmacologic Substance DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 interferon beta-1a \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 polypeptide c \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 hexachlorophene Organic Chemical DOWNREGULATE bovine coronavirus 1 no DOWNREGULATE: 1 hexachlorophene Organic Chemical DOWNREGULATE human enteric coronavirus 1 no DOWNREGULATE: 1 hexachlorophene Organic Chemical DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 palmitic acid Biologically Active Substance DOWNREGULATE human coronavirus 229e 1 no DOWNREGULATE: 1 mouse monoclonal antibody \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 gemcitabine \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 sotrastaurin Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 protein kinase c inhibitor Pharmacologic Substance DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 toremifene citrate Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 bcx4430 Biologically Active Substance DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 \"ifitm1 protein, human\" \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 glucose Biologically Active Substance DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 antiviral agents Pharmacologic Substance DOWNREGULATE human coronavirus 1 no DOWNREGULATE: 1 iota-carrageenan Biologically Active Substance DOWNREGULATE \"coronavirus oc43, human\" 1 no DOWNREGULATE: 1 protease inhibitors Pharmacologic Substance DOWNREGULATE tylonycteris bat coronavirus hku4 1 no DOWNREGULATE: 1 omacetaxine Organic Chemical DOWNREGULATE bovine coronavirus 1 no DOWNREGULATE: 1 omacetaxine Organic Chemical DOWNREGULATE human enteric coronavirus 1 no DOWNREGULATE: 1 omacetaxine Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 dna helicases \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 cysteine proteases \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 e 64 Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 camostate-mesilate Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 camostate-mesilate Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 e 64 Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 kinase inhibitor [epc] Pharmacologic Substance DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 protease inhibitors Pharmacologic Substance DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 bacillus intermedius ribonuclease \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 bacillus intermedius ribonuclease \"Amino Acid, Peptide, or Protein\" DOWNREGULATE human coronavirus 1 no DOWNREGULATE: 1 nafamostat Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 ritonavir Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 \"m protein, multiple myeloma\" \"Amino Acid, Peptide, or Protein\" DOWNREGULATE porcine respiratory coronavirus 1 no DOWNREGULATE: 1 u 18666a Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 human leukocyte interferon \"Amino Acid, Peptide, or Protein\" DOWNREGULATE human coronavirus 229e 1 no DOWNREGULATE: 1 glycyrrhizic acid Organic Chemical DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 nitazoxanide Organic Chemical DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 m nos antibody \"Amino Acid, Peptide, or Protein\" DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 antiviral agents Pharmacologic Substance DOWNREGULATE \"coronavirus, feline\" 1 no DOWNREGULATE: 1 camostat Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 baicalin Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 baicalein Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 zinc Biologically Active Substance DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 enzyme inhibitor drugs Pharmacologic Substance DOWNREGULATE human coronavirus hku1 1 no DOWNREGULATE: 1 paired basic amino acid cleaving enzyme \"Amino Acid, Peptide, or Protein\" DOWNREGULATE human coronavirus hku1 1 no DOWNREGULATE: 1 short hairpin rna \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 eosinophil cationic protein \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 mizoribine \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 aziridine Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 ritonavir Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 recombinant interferon beta-1a \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 veratridine Biologically Active Substance DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 dactinomycin \"Amino Acid, Peptide, or Protein\" DOWNREGULATE \"coronavirus, feline\" 1 no DOWNREGULATE: 1 stallimycin \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 recombinant interferon alfa \"Amino Acid, Peptide, or Protein\" DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 cytokine \"Amino Acid, Peptide, or Protein\" DOWNREGULATE human coronavirus 229e 1 no DOWNREGULATE: 1 protein domain Amino Acid Sequence DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 immunoglobulin domains Amino Acid Sequence DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 heparitin sulfate Biologically Active Substance DOWNREGULATE betacoronavirus 1 no DOWNREGULATE: 1 itraconazole Organic Chemical DOWNREGULATE \"coronavirus, feline\" 1 no DOWNREGULATE: 1 recombinant interferon beta \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 cysteine proteases \"Amino Acid, Peptide, or Protein\" DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 papillomavirus transforming protein e6 \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 memantine Organic Chemical DOWNREGULATE \"coronavirus oc43, human\" 1 no DOWNREGULATE: 1 heparin Biologically Active Substance DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 ethanol Organic Chemical DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 structural protein \"Amino Acid, Peptide, or Protein\" DOWNREGULATE \"coronavirus, feline\" 1 no DOWNREGULATE: 1 structural protein \"Amino Acid, Peptide, or Protein\" DOWNREGULATE \"coronavirus, canine\" 1 no DOWNREGULATE: 1 leupeptin \"Amino Acid, Peptide, or Protein\" DOWNREGULATE human coronavirus 229e 1 no DOWNREGULATE: 1 protein antibody \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 azauridine \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 guanidine hydrochloride Organic Chemical DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 resveratrol Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus rna 1 no DOWNREGULATE: 1 \"antibodies, anti-idiotypic\" \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 phenothiazine Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 recombinant interleukin-4 \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 recombinant rantes \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 \"tnf protein, human\" \"Amino Acid, Peptide, or Protein\" DOWNREGULATE human coronavirus 229e 1 no DOWNREGULATE: 1 polyanion Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 ads j1 Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 prostaglandin-endoperoxide synthase \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 plant extracts Biologically Active Substance DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 hla complex \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 macrolides Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus rna 2 no \"NEG_UPREGULATE: 1, NEG_DOWNREGULATE: 1\" \"antibodies, anti-idiotypic\" \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 4 no \"DOWNREGULATE: 2, NEG_UPREGULATE: 2\" ssaa09e3 Organic Chemical DOWNREGULATE sars coronavirus 1 no NEG_DOWNREGULATE: 1 caspase \"Amino Acid, Peptide, or Protein\" DOWNREGULATE \"coronavirus, canine\" 1 no NEG_DOWNREGULATE: 1 phospholipase d \"Amino Acid, Peptide, or Protein\" DOWNREGULATE genus: coronavirus 1 no NEG_DOWNREGULATE: 1 proteolytic enzyme \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 2 no \"UPREGULATE: 1, NEG_DOWNREGULATE: 1\" dipeptidyl-peptidase iv inhibitors Pharmacologic Substance DOWNREGULATE middle east respiratory syndrome coronavirus 3 no \"NEG_DOWNREGULATE: 2, NEG_UNIDIRECTIONAL: 1\"","title":"Data Mining"},{"location":"CoV_Experiment_Data/#annotated-set","text":"A collection of 1690 in vitro and in vivo records for 245 molecules Full dataset A few selected records drug_name tested_activity MOA_summary condition method material parameter operator mean value unit PF-835231 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors 3C-Like Protease (viral) Fluorescent assay Coronavirus (SARS-associated) IC-50 4.00E-09 M Remdesivir Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Nucleobindin-1 (NUCB1) Inhibitors Severe acute respiratory syndrome (SARS-CoV) Viral replication assay Calu3 human lung carcinoma cells (HER2 [ERBB2]-overexpressing) IC-50 1.00E-08 M ARN-398 Ceramidase (nonspecified) inhibition, IN VITRO Acid Ceramidase (ACDase; ASAH1) Inhibitors Ceramidase (nonspecified) Rat enzyme IC-50 1.20E-08 M SR9EK1 Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Severe acute respiratory syndrome (SARS-CoV) Viral replication assay Vero African green monkey kidney cells IC-90 1.25E-08 M Lycorine Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Severe acute respiratory syndrome (SARS-CoV) Dye assay Vero African green monkey kidney cells IC-50 1.57E-08 M SR9EK1 Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Severe acute respiratory syndrome (SARS-CoV) Viral replication assay Vero African green monkey kidney cells IC-99 1.76E-08 M Noscapine Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Tubulin Polymerization Inhibitors;Apoptosis Inducers;Antimitotic Drugs Severe acute respiratory syndrome (SARS-CoV) Cytopathicity assay Vero African green monkey kidney cells IC-90 2.20E-08 g/l Carmofur Ceramidase (nonspecified) inhibition, IN VITRO Thymidylate Synthase Inhibitors;Pyrimidine Antagonists Ceramidase (nonspecified) Rat enzyme IC-50 2.90E-08 M JMF-1507 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors 3C-Like Protease (viral) Fluorescent assay Coronavirus (SARS-associated) Ki 3.00E-08 M Pristimerine Inflammatory disorders remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Inflammatory disorders ELISA assay RAW264.7 mouse macrophages MIC <= 3.13E-08 M Pristimerine Cancer, pancreas (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, pancreas (adenocarcinoma) Cell counting assay MiaPaCa2 human pancreas adenocarcinoma cells CC-50 4.80E-08 M Pyrazofurin Nephrotoxicity induction, IN VITRO Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors Nephrotoxicity Cell viability assay Vero African green monkey kidney cells CC-50 5.20E-08 g/l TG-0205221 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors 3C-Like Protease (viral) Coronavirus (SARS-associated) Ki 5.30E-08 M JMF-1507 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors 3C-Like Protease (viral) Fluorescent assay Coronavirus (SARS-associated) IC-50 6.00E-08 M Pristimerine IL-2 Receptor Complex antagonism, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs IL-2 Receptor Complex Thymidine incorporation assay T-Lymphocytes (spleen), mouse MIC <= 6.25E-08 M Pristimerine Inflammatory disorders remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Inflammatory disorders Nitrite assay RAW264.7 mouse macrophages MIC 6.25E-08 M Pristimerine Cancer, pancreas (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, pancreas (adenocarcinoma) Cell counting assay MiaPaCa2 human pancreas adenocarcinoma cells CC-50 6.39E-08 M Remdesivir Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Nucleobindin-1 (NUCB1) Inhibitors Severe acute respiratory syndrome (SARS-CoV) Epithelial cells (airway), human IC-50 6.90E-08 M Remdesivir Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Nucleobindin-1 (NUCB1) Inhibitors Severe acute respiratory syndrome (SARS-CoV) Viral replication assay Epithelial cells (airway), human IC-50 6.90E-08 M Pristimerine Cancer, pancreas remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, pancreas Cell counting assay CFPAC1 human pancreas cancer cells CC-50 7.70E-08 M Niclosamide Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Cytochrome P450 CYP1A2 Inhibitors;Quorum Sensing (Pseudomonas aeruginosa) Inhibitors;Neuropeptide Y4 (NPY Y4) Receptor Positive Allosteric Modulators;Autophagy Inducers;Wnt Signaling Inhibitors Severe acute respiratory syndrome (SARS-CoV) Cytopathicity assay Vero African green monkey kidney cells IC-50 < 1.00E-07 M Tingenone Cytotoxicity induction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Antioxidants;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs;Free Radical Scavengers Cytotoxicity Dye assay (alamar blue) MRC5 human embryonic lung fibroblasts CC-50 1.00E-07 M Isobavachalcone Tumor Necrosis Factor (TNF-alpha) inhibition, IN VITRO Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Steroid 5alpha-Reductase Inhibitors;Drugs Targeting Beta-Amyloid;Signal Transduction Modulators;Autophagy Inducers;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants Tumor Necrosis Factor (TNF-alpha) Chemiluminescent assay BV2 murine microglia cells MIC <= 1.00E-07 M Tingenone Cancer, mouth (squamous cell) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Antioxidants;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs;Free Radical Scavengers Cancer, mouth (squamous cell) Dye assay (alamar blue) HSC3 human oral squamous cell carcinoma cells CC-50 1.00E-07 M Pristimerine Cancer, colon remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, colon Dye assay (MTT) @ 72 h HCT116 human colon carcinoma cells MIC <= 1.00E-07 M Pristimerine Cancer, colon (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, colon (adenocarcinoma) Dye assay (MTT) @ 72 h SW620 human colon adenocarcinoma cells MIC <= 1.00E-07 M 6',6'-Difluoroaristeromycin Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO S-Adenosyl-L-Homocysteine Hydrolase Inhibitors Severe acute respiratory syndrome (SARS-CoV) Plaque assay VeroE6 African green monkey kidney cells MIC <= 1.00E-07 M Pristimerine Cancer, pancreas (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, pancreas (adenocarcinoma) Cell counting assay BxPC3 human pancreas adenocarcinoma cells CC-50 1.03E-07 M SR9EK2 Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Severe acute respiratory syndrome (SARS-CoV) Viral replication assay Vero African green monkey kidney cells IC-90 1.08E-07 M Azithromycin Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Nonsense Mutation Suppressors;50S Ribosomal Protein Inhibitors Severe acute respiratory syndrome (SARS-CoV) Luciferine/luciferase assay HEK293T human embryonic kidney cells transfected with luciferase IC-50 1.10E-07 M Pristimerine Cytotoxicity induction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cytotoxicity Cell counting assay Pancreatic ductal epithelial cells, human CC-50 1.11E-07 M Pristimerine Cytotoxicity induction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cytotoxicity Cell counting assay Pancreatic ductal epithelial cells, human CC-50 1.11E-07 M Pristimerine NF-kappaB (NFkB) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs NF-kappaB (NFkB) Gene reporter assay OMM1 human uveal melanoma cells MIC <= 1.25E-07 M Pristimerine Inflammatory disorders remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Inflammatory disorders ELISA assay RAW264.7 mouse macrophages MIC 1.25E-07 M Isobavachalcone Dihydroorotate Dehydrogenase (quinone), mitochondrial (DHODH) inhibition, IN VITRO Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Steroid 5alpha-Reductase Inhibitors;Drugs Targeting Beta-Amyloid;Signal Transduction Modulators;Autophagy Inducers;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants Dihydroorotate Dehydrogenase (quinone), mitochondrial (DHODH) 2,6-dichlorophenolindophenol reduction assay Recombinant human enzyme IC-50 1.30E-07 M TG-0205221 Coronavirus acute respiratory syndrome remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors Coronavirus acute respiratory syndrome Plaque assay MRC5 human embryonic lung fibroblasts IC-50 1.40E-07 M SR9EK2 Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Severe acute respiratory syndrome (SARS-CoV) Viral replication assay Vero African green monkey kidney cells IC-99 1.49E-07 M JMF-1521 Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Severe acute respiratory syndrome (SARS-CoV) Cytopathicity assay Vero African green monkey kidney cells IC-50 1.80E-07 M SR9EK1 Nephrotoxicity induction, IN VITRO Nephrotoxicity Dye assay Vero African green monkey kidney cells CC-50 1.91E-07 M Remdesivir Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Nucleobindin-1 (NUCB1) Inhibitors Severe acute respiratory syndrome (SARS-CoV) IC-50 2.00E-07 M Pristimerine Leukemia, acute promyelocytic (M3) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Leukemia, acute promyelocytic (M3) Dye assay (MTT) HL60 human acute promyelocytic leukemia cells CC-50 2.00E-07 M Pristimerine Cancer, prostate (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, prostate (adenocarcinoma) Matrigel-coated plate assay PC3 human prostate adenocarcinoma cells MIC <= 2.00E-07 M Pristimerine Cancer, prostate (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, prostate (adenocarcinoma) Spheres formation assay PC3 human prostate adenocarcinoma cells MIC <= 2.00E-07 M Pristimerine Cancer, prostate (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, prostate (adenocarcinoma) Colony formation assay PC3 human prostate adenocarcinoma cells MIC <= 2.00E-07 M Pristimerine Monoglyceride Lipase inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Monoglyceride Lipase 2-Oleoylglycerol as substrate Recombinant human enzyme IC-50 2.04E-07 M N-3 Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO 3C-Like Protease (NL63 Coronavirus) (HCoV-NL63) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) MCA-Ala-Val-Leu-Gln-Ser-Gly-Phe-Arg-lys(Dnp)-lys-NH2 as substrate Coronavirus Ki 2.30E-07 M Pristimerine NF-kappaB (NFkB) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs NF-kappaB (NFkB) Gene reporter assay Mel270 human uveal melanoma cells MIC 2.50E-07 M Pristimerine NF-kappaB (NFkB) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs NF-kappaB (NFkB) Gene reporter assay OMM2.3 human uveal melanoma cells MIC 2.50E-07 M Pristimerine MMP-9 (Gelatinase B) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs MMP-9 (Gelatinase B) 92.1 human uveal melanoma cells MIC <= 2.50E-07 M Pristimerine Inflammatory disorders remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Inflammatory disorders ELISA assay RAW264.7 mouse macrophages MIC 2.50E-07 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Wound closure assay 92.1 human uveal melanoma cells MIC <= 2.50E-07 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Transwell chamber assay 92.1 human uveal melanoma cells MIC <= 2.50E-07 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Transwell chamber assay OMM1 human uveal melanoma cells MIC <= 2.50E-07 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Transwell chamber assay 92.1 human uveal melanoma cells MIC <= 2.50E-07 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Transwell chamber assay OMM1 human uveal melanoma cells MIC <= 2.50E-07 M N-3 Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO 3C-Like Protease (NL63 Coronavirus) (HCoV-NL63) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) MCA-Ala-Val-Leu-Gln-Ser-Gly-Phe-Arg-lys(Dnp)-lys-NH2 as substrate Coronavirus Ki 2.60E-07 M Betulinic acid GABA(A) BZ Site Receptor affinity, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors GABA(A) BZ Site Receptor Displacement of [3H]-flunitrazepam Brain, rat Ki 2.60E-07 M Pristimerine Tumor Necrosis Factor Ligand Superfamily Member 11 (TNFSF11, RANKL) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Tumor Necrosis Factor Ligand Superfamily Member 11 (TNFSF11, RANKL) RNA assay Fibroblasts (synovial), rat (arthritic) MIC 3.00E-07 M BTB-06256 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (viral) Fluorescent assay Coronavirus (SARS-associated) IC-50 3.00E-07 M GRL-0667 Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Arg-Leu-Arg-Gly-Gly-7-amino-4-methylcoumarin as substrate Coronavirus (SARS-associated) IC-50 3.20E-07 M Pristimerine Cancer, cervix, (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, cervix, (adenocarcinoma) Dye assay (MTT) HeLa human cervix adenocarcinoma cells IC-50 3.20E-07 M Pristimerine Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, breast (adenocarcinoma) ATP assay MDAMB231 human breast adenocarcinoma cells CC-50 3.80E-07 M Sinefungin Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Coactivator Associated Arginine Methyltransferase 1 (CARM1; PRMT4) Inhibitors;Histone-Lysine N-Methyltransferase SETD7 (SET7/9) Inhibitors;Protein-L-Isoaspartate(D-Aspartate) O-Methyltransferase (PCMT1; PIMT) Inhibitors;Epigenetic Modifier Modulators Replicase Polyprotein 1ab (pp1ab) (SARS) Coronavirus (SARS-associated) IC-50 3.83E-07 M Noscapine Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Tubulin Polymerization Inhibitors;Apoptosis Inducers;Antimitotic Drugs Severe acute respiratory syndrome (SARS-CoV) Cell counting assay Vero African green monkey kidney cells IC-50 4.00E-07 g/l Isobavachalcone Tyrosinase (Tyr) inhibition, IN VITRO Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Steroid 5alpha-Reductase Inhibitors;Drugs Targeting Beta-Amyloid;Signal Transduction Modulators;Autophagy Inducers;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants Tyrosinase (Tyr) Thiouracil incorporation assay Melanocytes, human IC-50 4.00E-07 M Pristimerine Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, breast (adenocarcinoma) Dye assay (MTT) MCF7 human breast adenocarcinoma cells (hormone-dependent) CC-50 4.00E-07 M Pristimerine Cancer, prostate (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, prostate (adenocarcinoma) Cell counting assay PC3 human prostate adenocarcinoma cells MIC 4.00E-07 M Tingenone Hepatoblastoma remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Antioxidants;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs;Free Radical Scavengers Hepatoblastoma Dye assay (alamar blue) HepG2 human hepatoblastoma cells CC-50 4.00E-07 M Tingenone Leukemia, acute promyelocytic (M3) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Antioxidants;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs;Free Radical Scavengers Leukemia, acute promyelocytic (M3) Dye assay (alamar blue) HL60 human acute promyelocytic leukemia cells CC-50 4.00E-07 M Baicalein ATP-Dependent DNA Helicases inhibition, IN VITRO Drugs Targeting on Quorum Sensing Signaling;Signal Transduction Modulators;AR Expression Inhibitors;15-Lipoxygenase Inhibitors;Autophagy Inducers;12-Lipoxygenase Inhibitors;Dual Specificity Protein Phosphatase 3 (VHR) Inhibitors;Reverse Transcriptase/Ribonuclease H (HIV-1) Inhibitors;Apoptosis Inducers;Protein Tyrosine Phosphatase (PTP) Inhibitors ATP-Dependent DNA Helicases Fluorescence resonance energy transfer (FRET) assay Coronavirus (SARS-associated) IC-50 4.70E-07 M Pristimerine Cytotoxicity induction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cytotoxicity Flow cytometry assay HEK293 human embryonic kidney cells (ABCB1-overexpressing) MEC <= 5.00E-07 M Pristimerine Hypoxia Inducible Factor 1-alpha (HIF-1alpha) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Hypoxia Inducible Factor 1-alpha (HIF-1alpha) ELISA assay PC3 human prostate adenocarcinoma cells MIC <= 5.00E-07 M Pristimerine Hypoxia Inducible Factor (HIF) (nonspecified subtype) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Hypoxia Inducible Factor (HIF) (nonspecified subtype) ELISA assay PC3 human prostate adenocarcinoma cells MIC <= 5.00E-07 M MAC-5576 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors 3C-Like Protease (viral) Coronavirus (SARS-associated) IC-50 5.00E-07 M Ferruginol Catenin beta-1 activation, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Lipid Peroxidation Inhibitors;Antioxidants;Apoptosis Inducers Catenin beta-1 Chemiluminescent assay Hippocampus (dorsal), mouse (beta-amyloid (42)-treated) MEC 5.00E-07 M Ferruginol Glycogen Synthase Kinase 3 beta (GSK-3beta) induction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Lipid Peroxidation Inhibitors;Antioxidants;Apoptosis Inducers Glycogen Synthase Kinase 3 beta (GSK-3beta) Chemiluminescent assay Hippocampus (dorsal), mouse (beta-amyloid (42)-treated) MEC 5.00E-07 M Pristimerine Survivin (BIRC5) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Survivin (BIRC5) RNA assay OMM1 human uveal melanoma cells MIC <= 5.00E-07 M Pristimerine MMP-9 (Gelatinase B) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs MMP-9 (Gelatinase B) OMM1 human uveal melanoma cells MIC 5.00E-07 M Pristimerine Caspase-9 activation, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Caspase-9 Acetyl-LEHD-p-nitroaniline as a substrate COLO205 human colon carcinoma cells MEC <= 5.00E-07 M Pristimerine Caspase-8 activation, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Caspase-8 Acetyl-IETD-p-nitroaniline as a substrate COLO205 human colon carcinoma cells MEC <= 5.00E-07 M Pristimerine Cancer, prostate (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, prostate (adenocarcinoma) Dye assay (MTT) PC3 human prostate adenocarcinoma cells (hypoxic) MCC <= 5.00E-07 M Tingenone Leukemia, acute promyelocytic (M3) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Antioxidants;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs;Free Radical Scavengers Leukemia, acute promyelocytic (M3) Dye assay (MTT) HL60 human acute promyelocytic leukemia cells CC-50 5.00E-07 M Tingenone Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Antioxidants;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs;Free Radical Scavengers Cancer, breast (adenocarcinoma) Dye assay (alamar blue) MCF7 human breast adenocarcinoma cells (hormone-dependent) CC-50 5.00E-07 M Tingenone Leukemia, myeloid remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Antioxidants;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs;Free Radical Scavengers Leukemia, myeloid Dye assay (alamar blue) K562 human myeloid leukemia cells CC-50 5.00E-07 M Tingenone Melanoma, metastatic remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Antioxidants;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs;Free Radical Scavengers Melanoma, metastatic Dye assay (alamar blue) B16F10 mouse metastatic melanoma cells CC-50 5.00E-07 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Wound closure assay OMM1 human uveal melanoma cells MIC 5.00E-07 M Pristimerine Cancer, colon remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, colon Propidium iodide assay HCT116 human colon carcinoma cells MEC <= 5.00E-07 M Pristimerine Cancer, colon (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, colon (adenocarcinoma) Propidium iodide assay SW620 human colon adenocarcinoma cells MEC <= 5.00E-07 M Pristimerine Cancer, colon remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, colon Propidium iodide assay COLO205 human colon carcinoma cells MEC <= 5.00E-07 M Pristimerine Cancer, colon remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, colon Flow cytometry assay Mitochondria (COLO205 human colon carcinoma cells) MEC <= 5.00E-07 M 6',6'-Difluoroaristeromycin Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO S-Adenosyl-L-Homocysteine Hydrolase Inhibitors Severe acute respiratory syndrome (SARS-CoV) Dye assay (MTS) VeroE6 African green monkey kidney cells IC-50 5.00E-07 M JMF-1521 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (viral) Fluorescent assay Coronavirus (SARS-associated) Ki 5.20E-07 M Pristimerine Cancer, rhinopharyngeal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, rhinopharyngeal Dye assay (MTT) KBv200 human epidermoid carcinoma cells (multidrug-resistant/ABCB1-overexpressing) CC-50 5.20E-07 M Pristimerine Cancer, rhinopharyngeal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, rhinopharyngeal Dye assay (MTT) KB human epidermoid rhinopharyngeal carcinoma cells CC-50 5.40E-07 M Pristimerine Melanoma remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma MDAMB435 human melanoma cells CC-50 5.50E-07 M GRL-0617 Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Arg-Leu-Arg-Gly-Gly-7-amino-4-methylcoumarin as substrate Coronavirus (SARS-associated) IC-50 5.60E-07 M TG-0205221 Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors Severe acute respiratory syndrome (SARS-CoV) Cytopathicity assay Vero African green monkey kidney cells IC-50 6.00E-07 M Pristimerine Cytotoxicity induction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cytotoxicity Dye assay (alamar blue) Mononuclear cells (blood), human CC-50 6.00E-07 M GRL-0617 Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Ubiquitin-7-amino-4-methylcoumarin as substrate Coronavirus (SARS-associated) IC-50 6.00E-07 M GC-373 Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO 3C-Like Protease (Norovirus) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) IC-50 6.00E-07 M Tingenone Cancer, colon remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Antioxidants;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs;Free Radical Scavengers Cancer, colon Dye assay (alamar blue) HCT116 human colon carcinoma cells CC-50 6.00E-07 M Tingenone Cancer, mouth (squamous cell) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Antioxidants;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs;Free Radical Scavengers Cancer, mouth (squamous cell) Dye assay (alamar blue) SCC4 human oral squamous cell carcinoma cells CC-50 6.00E-07 M Pristimerine Cancer, pancreas (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, pancreas (adenocarcinoma) Dye assay (MTS) MiaPaCa2 human pancreas adenocarcinoma cells MCC <= 6.25E-07 M Pristimerine Cancer, pancreas (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, pancreas (adenocarcinoma) Flow cytometry assay PANC1 human pancreas adenocarcinoma cells MEC <= 6.25E-07 M Pristimerine Cancer, pancreas (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, pancreas (adenocarcinoma) Flow cytometry assay MiaPaCa2 human pancreas adenocarcinoma cells MEC <= 6.25E-07 M Betulonic acid Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Lysosomal alpha-Glucosidase (GAA) Inhibitors;E3 Ubiquitin-Protein Ligase Inhibitors Severe acute respiratory syndrome (SARS-CoV) Cytopathicity assay Vero African green monkey kidney cells IC-50 6.30E-07 M Pristimerine Cancer, stomach (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, stomach (adenocarcinoma) Dye assay (MTT) SGC7901 human gastric adenocarcinoma cells IC-50 6.30E-07 M GRL-0667 Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Arg-Leu-Arg-Gly-Gly-7-amino-4-methylcoumarin as substrate Coronavirus (SARS-associated) IC-50 6.70E-07 M Pristimerine Cytotoxicity induction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cytotoxicity Dye assay (MTT) HEK293 human embryonic kidney cells CC-50 6.90E-07 M Betulinic acid Infection, herpes simplex virus remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Signal Transduction Modulators;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Infection, herpes simplex virus Viral replication assay Vero African green monkey kidney cells IC-50 7.00E-07 M Tanshinone I Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Signal Transduction Modulators;AP-1 Transcription Factor Complex Inhibitors;Aryl Hydrocarbon Receptor (AhR) Ligands Replicase Polyprotein 1ab (pp1ab) (SARS) Ubiquitin-7-amino-4-methylcoumarin as substrate Coronavirus (SARS-associated) IC-50 7.00E-07 M Pristimerine Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, breast (adenocarcinoma) ATP assay MCF7 human breast adenocarcinoma cells (hormone-dependent) CC-50 7.50E-07 M Pristimerine Hepatoblastoma remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Hepatoblastoma Dye assay (MTT) HepG2 human hepatoblastoma cells IC-50 7.80E-07 M Pristimerine Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, breast (adenocarcinoma) Spheres formation assay MCF7 human breast adenocarcinoma cells (hormone-dependent) (mammospheres) MIC 7.80E-07 M Iguesterin Proteasome Subunit beta Type-5 (PSMB5) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors Proteasome Subunit beta Type-5 (PSMB5) Fluorescent assay Coronavirus (SARS-associated) Ki 8.00E-07 M Pristimerine Cancer, colon remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, colon Dye assay (MTT) @ 48 h COLO205 human colon carcinoma cells IC-50 8.40E-07 M Pristimerine Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, breast (adenocarcinoma) Dye assay (MTT) MCF7 human breast adenocarcinoma cells (hormone-dependent) CC-50 8.70E-07 M Ferruginol Malaria remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Lipid Peroxidation Inhibitors;Antioxidants;Apoptosis Inducers Malaria Erythrocytes, human IC-50 9.00E-07 M Geldanamycin Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Signal Transduction Modulators;Heat Shock Protein 90 (Hsp90) Inhibitors Severe acute respiratory syndrome (SARS-CoV) IC-50 9.10E-07 M Pristimerine Cytotoxicity induction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cytotoxicity Dye assay (MTT) HEK293 human embryonic kidney cells (ABCB1-overexpressing) CC-50 9.30E-07 M NSC-158362 Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Severe acute respiratory syndrome (SARS-CoV) Viral replication assay MA104 embryonic African green monkey kidney cells IC-50 < 1.00E-06 M NSC-158362 Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Severe acute respiratory syndrome (SARS-CoV) Viral replication assay Vero African green monkey kidney cells IC-50 < 1.00E-06 M Pristimerine Cytotoxicity induction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cytotoxicity Flow cytometry assay HEK293 human embryonic kidney cells MEC 1.00E-06 M Ribavirin Nephrotoxicity induction, IN VITRO Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors;Equilibrative Nucleoside Transporter ENT1 Inhibitors Nephrotoxicity Cell viability assay Vero African green monkey kidney cells CC-50 > 1.00E-06 g/l Pristimerine Cytotoxicity induction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cytotoxicity Dye assay (MTS) RAW264.7 mouse macrophages MCC 1.00E-06 M Pristimerine Cytotoxicity induction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cytotoxicity Dye assay (MTS) RAW264.7 mouse macrophages MEC 1.00E-06 M Betulinic acid Cytotoxicity induction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cytotoxicity Dye assay (MTT) Macrophage cells (bone marrow), mouse MCC <= 1.00E-06 M Pristimerine Sphingosine Kinase 1 (SPK1) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Sphingosine Kinase 1 (SPK1) ELISA assay PC3 human prostate adenocarcinoma cells (hypoxic) MIC 1.00E-06 M Isobavachalcone Interleukin-6 (IL-6) inhibition, IN VITRO Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Steroid 5alpha-Reductase Inhibitors;Drugs Targeting Beta-Amyloid;Signal Transduction Modulators;Autophagy Inducers;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants Interleukin-6 (IL-6) Chemiluminescent assay BV2 murine microglia cells MIC 1.00E-06 M Pristimerine Multidrug Resistance Protein 1 (MDR-1) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Multidrug Resistance Protein 1 (MDR-1) Flow cytometry assay HEK293 human embryonic kidney cells (ABCB1-overexpressing) MIC 1.00E-06 M Betulinic acid DNA Topoisomerase II (nonspecified subtype) inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors DNA Topoisomerase II (nonspecified subtype) DNA relaxation assay Human enzyme IC-50 > 1.00E-06 M Psoralidin 5-Hydroxytryptamine Receptor 1A (5-HT1A) agonism, IN VITRO Estrogen Receptor (ER) beta Agonists;Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;Estrogen Receptor (ER) alpha Agonists;5-Lipoxygenase Inhibitors;Signal Transduction Modulators;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Caspase Activators;Apoptosis Inducers 5-Hydroxytryptamine Receptor 1A (5-HT1A) Chemiluminescent assay Cortical neurons (primary), mouse MEC <= 1.00E-06 M JMF-1521 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (viral) Fluorescent assay Coronavirus (SARS-associated) IC-50 1.00E-06 M Pristimerine Survivin (BIRC5) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Survivin (BIRC5) RNA assay 92.1 human uveal melanoma cells MIC 1.00E-06 M Pristimerine Caspase-3 activation, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Caspase-3 Acetyl-DEVD-p-nitroaniline as a substrate HCT116 human colon carcinoma cells MEC 1.00E-06 M Pristimerine Caspase-3 activation, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Caspase-3 Acetyl-DEVD-p-nitroaniline as a substrate SW620 human colon adenocarcinoma cells MEC 1.00E-06 M Pristimerine Caspase-3 activation, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Caspase-3 Acetyl-DEVD-p-nitroaniline as a substrate COLO205 human colon carcinoma cells MEC 1.00E-06 M Pristimerine Caspase-9 activation, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Caspase-9 Acetyl-LEHD-p-nitroaniline as a substrate HCT116 human colon carcinoma cells MEC 1.00E-06 M Pristimerine Caspase-9 activation, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Caspase-9 Acetyl-LEHD-p-nitroaniline as a substrate SW620 human colon adenocarcinoma cells MEC 1.00E-06 M Pristimerine Caspase-8 activation, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Caspase-8 Acetyl-IETD-p-nitroaniline as a substrate SW620 human colon adenocarcinoma cells MEC 1.00E-06 M Pristimerine Cancer, prostate (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, prostate (adenocarcinoma) Dye assay (MTT) PC3 human prostate adenocarcinoma cells MCC 1.00E-06 M Isobavachalcone Neuroinflammation remission/reduction, IN VITRO Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Steroid 5alpha-Reductase Inhibitors;Drugs Targeting Beta-Amyloid;Signal Transduction Modulators;Autophagy Inducers;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants Neuroinflammation Nitrite assay BV2 murine microglia cells MIC 1.00E-06 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Flow cytometry assay 92.1 human uveal melanoma cells MEC <= 1.00E-06 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Flow cytometry assay OMM1 human uveal melanoma cells MEC <= 1.00E-06 M Isobavachalcone Dementia, Alzheimer type protection, IN VITRO Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Steroid 5alpha-Reductase Inhibitors;Drugs Targeting Beta-Amyloid;Signal Transduction Modulators;Autophagy Inducers;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants Dementia, Alzheimer type Dye assay (MTT) SHSY5Y human dopaminergic neuroblastoma cells MIC <= 1.00E-06 M Psoralidin Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO Estrogen Receptor (ER) beta Agonists;Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;Estrogen Receptor (ER) alpha Agonists;5-Lipoxygenase Inhibitors;Signal Transduction Modulators;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Caspase Activators;Apoptosis Inducers Cancer, breast (adenocarcinoma) Dye assay (MTT) MDAMB231 human breast adenocarcinoma cells (ALDH-positive) MCC <= 1.00E-06 M Betulinic acid Osteoporosis remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Osteoporosis Spectrophotometric assay Macrophage cells (bone marrow), mouse IC-50 <= 1.00E-06 M Betulinic acid Cytotoxicity remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cytotoxicity Dye assay (MTT) hFOB1.19 human fetal osteoblasts (SV40 large Tantigen-transformed) MCC <= 1.00E-06 M Betulinic acid Cytotoxicity remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cytotoxicity Dye assay (MTT) hFOB1.19 human fetal osteoblasts (SV40 large Tantigen-transformed) MCC <= 1.00E-06 M Betulinic acid Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (adenocarcinoma) Dye assay (MTT) @ 72 h MDAMB231 human breast adenocarcinoma cells MIC <= 1.00E-06 M Pristimerine Cancer, colon remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, colon Flow cytometry assay Mitochondria (HCT116 human colon carcinoma cells) MEC 1.00E-06 M Pristimerine Cancer, colon (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, colon (adenocarcinoma) Flow cytometry assay Mitochondria (SW620 human colon adenocarcinoma cells) MEC 1.00E-06 M Mucroporin-M1 Cytotoxicity induction, IN VITRO Cell Membrane Disrupting Agents Cytotoxicity Dye assay (MTT) MDBK Madin-Darby bovine kidney epithelial cells CC-50 1.03E-06 M Psoralidin Estrogen Receptor alpha (ERalpha) affinity, IN VITRO Estrogen Receptor (ER) beta Agonists;Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;Estrogen Receptor (ER) alpha Agonists;5-Lipoxygenase Inhibitors;Signal Transduction Modulators;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Caspase Activators;Apoptosis Inducers Estrogen Receptor alpha (ERalpha) Displacement of [3H]-estradiol Recombinant human receptor IC-50 1.03E-06 M Pristimerine Cancer, lung (non-small cell) (NSCLC) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, lung (non-small cell) (NSCLC) Dye assay (MTT) A549 human non-small-cell lung carcinoma cells IC-50 1.03E-06 M Pristimerine Cancer, colon (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, colon (adenocarcinoma) Dye assay (MTT) @ 48 h SW620 human colon adenocarcinoma cells IC-50 1.04E-06 M Betulinic acid G-Protein Coupled Bile Acid Receptor BG37 (TGR5) agonism, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors G-Protein Coupled Bile Acid Receptor BG37 (TGR5) Gene reporter assay CHO Chinese hamster ovary cells transfected with human GPBA (TGR5) receptor EC-50 1.10E-06 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Dye assay (MTS) 92.1 human uveal melanoma cells CC-50 1.10E-06 M (-)-Savinin Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Drugs Acting on Tumor Necrosis Factor (TNF) Receptors Severe acute respiratory syndrome (SARS-CoV) Cytopathicity assay Vero African green monkey kidney cells IC-50 1.13E-06 M Pristimerine Cancer, liver (hepatocellular carcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, liver (hepatocellular carcinoma) Dye assay (MTT) BEL7402 human hepatocellular carcinoma cells IC-50 1.16E-06 M DTPMPA ATPase (nonspecified subtype) inhibition, IN VITRO Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors ATPase (nonspecified subtype) Phosphate release assay Coronavirus (SARS-associated) IC-50 1.19E-06 M Dihydrotan Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Hypoxia Inducible Factor 1-alpha (HIF-1alpha) Inhibitors;Immune Checkpoint Inhibitors;Indoleamine 2,3-dioxygenase 1 (IDO1; IDO) Inhibitors;Acetylcholinesterase (AChE) Inhibitors;Nitric Oxide (NO) Production Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Ubiquitin-7-amino-4-methylcoumarin as substrate Coronavirus (SARS-associated) IC-50 1.20E-06 M Pristimerine Cancer, colon remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, colon Dye assay (MTT) @ 48 h HCT116 human colon carcinoma cells IC-50 1.22E-06 M SR9EK3 Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Severe acute respiratory syndrome (SARS-CoV) Viral replication assay Vero African green monkey kidney cells IC-90 1.23E-06 M Pristimerine Cancer, pancreas (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, pancreas (adenocarcinoma) Dye assay (MTS) PANC1 human pancreas adenocarcinoma cells MCC 1.25E-06 M Pristimerine Cancer, endometrium (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, endometrium (adenocarcinoma) Flow cytometry assay MDAH2774 human endometrium adenocarcinoma cells MEC 1.25E-06 M Pristimerine Cancer, prostate remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, prostate Dye assay (MTS) LNCaP human prostate carcinoma cells (androgen-dependent) MCC 1.25E-06 M Pristimerine Cancer, prostate (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, prostate (adenocarcinoma) Dye assay (MTS) PC3 human prostate adenocarcinoma cells MCC 1.25E-06 M Pristimerine Cancer, prostate remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, prostate Flow cytometry assay LNCaP human prostate carcinoma cells (androgen-dependent) MEC 1.25E-06 M Pristimerine Cancer, prostate (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, prostate (adenocarcinoma) Flow cytometry assay PC3 human prostate adenocarcinoma cells MEC 1.25E-06 M Pristimerine Sarcoma, synovial remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Sarcoma, synovial Dye assay (MTT) SW982 human synovial sarcoma cells CC-50 1.28E-06 M Ferruginol Malaria remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Lipid Peroxidation Inhibitors;Antioxidants;Apoptosis Inducers Malaria IC-50 1.33E-06 M Isobavachalcone Dihydroorotate Dehydrogenase (quinone), mitochondrial (DHODH) affinity, IN VITRO Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Steroid 5alpha-Reductase Inhibitors;Drugs Targeting Beta-Amyloid;Signal Transduction Modulators;Autophagy Inducers;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants Dihydroorotate Dehydrogenase (quinone), mitochondrial (DHODH) Isothermal microcalorimetric test Recombinant human enzyme Kd 1.33E-06 M Ferruginol Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Lipid Peroxidation Inhibitors;Antioxidants;Apoptosis Inducers Severe acute respiratory syndrome (SARS-CoV) Cytopathicity assay Vero African green monkey kidney cells IC-50 1.39E-06 M Ferroquine Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Severe acute respiratory syndrome (SARS-CoV) Vero African green monkey kidney cells IC-50 1.40E-06 M Betulinic acid Infection, HIV remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Infection, HIV Antigen assay H9 human T-cell leukemia cells IC-50 1.40E-06 M Betulinic acid Infection, HIV remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Infection, HIV Viral replication assay H9 human T-cell leukemia cells IC-50 1.40E-06 M Ferruginol Fatty acid oxidation disorders remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Lipid Peroxidation Inhibitors;Antioxidants;Apoptosis Inducers Fatty acid oxidation disorders TBARS formation assay Erythrocytes, human IC-50 1.40E-06 M Betulinic acid Infection, HIV remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Infection, HIV Viral replication assay H9 human T-cell leukemia cells IC-50 1.40E-06 M Betulinic acid Infection, HIV remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Infection, HIV Viral replication assay H9 human T-cell leukemia cells IC-50 1.40E-06 M Isobavachalcone Cancer remission/reduction, IN VITRO Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Steroid 5alpha-Reductase Inhibitors;Drugs Targeting Beta-Amyloid;Signal Transduction Modulators;Autophagy Inducers;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants Cancer Endothelial cells (lymphatic), rat (temperature-sensitive) IC-50 1.41E-06 M Betulinic acid Malaria remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Signal Transduction Modulators;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Malaria Fluorescent assay Erythrocytes, human IC-50 1.42E-06 M Betulinic acid Malaria remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;Apoptosis Inducers;NF-kappaB (NFKB) Activators;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Malaria Fluorescent assay Erythrocytes, human IC-50 1.42E-06 M ML-188 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors 3C-Like Protease (viral) Coronavirus (SARS-associated) IC-50 1.50E-06 M ML-188 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors 3C-Like Protease (viral) Coronavirus (SARS-associated) IC-50 1.50E-06 M Betulinic acid Osteoporosis remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Osteoporosis Tartrate-resistant acid phosphatase assay Macrophage cells (bone marrow), mouse IC-50 1.60E-06 M Sinefungin RNA (Guanine-7-) Methyltransferase inhibition, IN VITRO Coactivator Associated Arginine Methyltransferase 1 (CARM1; PRMT4) Inhibitors;Histone-Lysine N-Methyltransferase SETD7 (SET7/9) Inhibitors;Protein-L-Isoaspartate(D-Aspartate) O-Methyltransferase (PCMT1; PIMT) Inhibitors;Epigenetic Modifier Modulators RNA (Guanine-7-) Methyltransferase Yeast-based assay Coronavirus (SARS-associated) IC-50 1.62E-06 M SR9EK3 Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Severe acute respiratory syndrome (SARS-CoV) Viral replication assay Vero African green monkey kidney cells IC-99 1.63E-06 M Betulinic acid alpha-1 Adrenergic Receptors (nonspecified subtype) antagonism, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors alpha-1 Adrenergic Receptors (nonspecified subtype) Artery (aorta, thoracic), rat IC-50 1.67E-06 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Dye assay (MTS) Mel270 human uveal melanoma cells CC-50 1.70E-06 M Betulinic acid Cancer, stomach remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, stomach Colony formation assay GES-1 human gastric epithelial cells (methyl-N-nitroso-guanidine-treated) IC-50 1.72E-06 M Pristimerine Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, breast (adenocarcinoma) ATP assay MCF7 human breast adenocarcinoma cells (hormone-dependent) (mammospheres) CC-50 1.75E-06 M Psoralidin Estrogen Receptor (nonspecified subtype) agonism, IN VITRO Estrogen Receptor (ER) beta Agonists;Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;Estrogen Receptor (ER) alpha Agonists;5-Lipoxygenase Inhibitors;Signal Transduction Modulators;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Caspase Activators;Apoptosis Inducers Estrogen Receptor (nonspecified subtype) Luciferine/luciferase assay MCF7 human breast adenocarcinoma cells (hormone-dependent) EC-50 1.85E-06 M Betulinic acid Aldo-Keto Reductase Family 1 Member B10 (ARL-1) inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Aldo-Keto Reductase Family 1 Member B10 (ARL-1) Fluorescent assay IC-50 2.00E-06 M Pristimerine Caspase-8 activation, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Caspase-8 Acetyl-IETD-p-nitroaniline as a substrate HCT116 human colon carcinoma cells MEC 2.00E-06 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Flow cytometry assay Mel270 human uveal melanoma cells MEC 2.00E-06 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Flow cytometry assay OMM2.3 human uveal melanoma cells MEC 2.00E-06 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Dye assay (MTS) OMM1 human uveal melanoma cells CC-50 2.20E-06 M Betulinic acid Oxidative stress remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Oxidative stress Ferricytochrome c reduction assay Neutrophils, human IC-50 2.23E-06 M Betulinic acid G-Protein Coupled Bile Acid Receptor BG37 (TGR5) agonism, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors G-Protein Coupled Bile Acid Receptor BG37 (TGR5) cAMP accumulation assay HEK293 human embryonic kidney cells transfected with human GPBA (TGR5) receptor EC-50 2.25E-06 M Kaempferol 3-O-alpha-L-arabinofuranoside Hypothetical Protein Sars3a inhibition, IN VITRO Hedgehog Signaling Inhibitors;Antioxidants Hypothetical Protein Sars3a Voltage-clamp assay (-60 mV) Oocytes (Xenopus) transfected with SARS associated coronavirus 3a protein IC-50 2.30E-06 M Bananin ATPase (nonspecified subtype) inhibition, IN VITRO Chelating Agents ATPase (nonspecified subtype) Coronavirus (SARS-associated) IC-50 2.30E-06 M Dieckol 3C-Like Protease (viral) inhibition, IN VITRO Reverse Transcriptase/Ribonuclease H (HIV-1) Inhibitors;beta-Secretase 1 (BACE1) Inhibitors;Acetylcholinesterase (AChE) Inhibitors 3C-Like Protease (viral) Fluorescence resonance energy transfer (FRET) assay Coronavirus (SARS-associated) Ki 2.40E-06 M Betulinic acid Osteoporosis remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Osteoporosis Macrophage cells (bone marrow), mouse IC-50 <= 2.40E-06 M Pristimerine Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, breast (adenocarcinoma) Cell counting assay SKBr3 human breast adenocarcinoma cells (HER2 [ERBB2]-overexpressing) CC-50 2.40E-06 M Isobavachalcone Signal Transducer and Activator of Transcription 3 (STAT3) inhibition, IN VITRO Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Steroid 5alpha-Reductase Inhibitors;Drugs Targeting Beta-Amyloid;Signal Transduction Modulators;Autophagy Inducers;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants Signal Transducer and Activator of Transcription 3 (STAT3) Luciferine/luciferase assay Hep3B human hepatocellular carcinoma cells IC-50 2.45E-06 M Ferruginol Malaria remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Lipid Peroxidation Inhibitors;Antioxidants;Apoptosis Inducers Malaria IC-50 2.47E-06 M Betulinic acid HIV-1 Protease inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors HIV-1 Protease HIV IC-50 2.50E-06 M Betulinic acid Zinc Finger and BTB Domain Containing 10 induction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Zinc Finger and BTB Domain Containing 10 Luciferine/luciferase assay MDAMB231 human breast adenocarcinoma cells MEC 2.50E-06 M Betulinic acid SP Transcritption Factors inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors SP Transcritption Factors Luciferine/luciferase assay MDAMB231 human breast adenocarcinoma cells MIC 2.50E-06 M Betulinic acid MicroRNA 27a inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors MicroRNA 27a RNA assay MDAMB231 human breast adenocarcinoma cells MIC 2.50E-06 M Betulinic acid Vascular Endothelial Growth Factors (VEGF) (nonspecified subtype) inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Vascular Endothelial Growth Factors (VEGF) (nonspecified subtype) Luciferine/luciferase assay MDAMB231 human breast adenocarcinoma cells MIC 2.50E-06 M Betulinic acid Vascular Endothelial Growth Factor Receptor (VEGFR) (nonspecified subtype) inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Vascular Endothelial Growth Factor Receptor (VEGFR) (nonspecified subtype) Luciferine/luciferase assay MDAMB231 human breast adenocarcinoma cells MIC 2.50E-06 M Pristimerine Cancer, ovary remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, ovary Flow cytometry assay OVCAR5 human ovary carcinoma cells MEC 2.50E-06 M Pristimerine Cancer, ovary remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, ovary Flow cytometry assay Mitochondria (OVCAR5 human ovary carcinoma cells) MEC 2.50E-06 M Pristimerine Cancer, endometrium (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, endometrium (adenocarcinoma) Flow cytometry assay Mitochondria (MDAH2774 human endometrium adenocarcinoma cells) MEC 2.50E-06 M Betulinic acid Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (adenocarcinoma) Flow cytometry assay MCF7 human breast adenocarcinoma cells (hormone-dependent) MEC <= 2.50E-06 M Betulinic acid Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (adenocarcinoma) Flow cytometry assay MDAMB231 human breast adenocarcinoma cells MIC <= 2.50E-06 M Betulinic acid Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (adenocarcinoma) Flow cytometry assay MCF7 human breast adenocarcinoma cells (hormone-dependent) MIC <= 2.50E-06 M Betulinic acid Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (adenocarcinoma) Flow cytometry assay MDAMB231 human breast adenocarcinoma cells MIC <= 2.50E-06 M Betulinic acid Cancer, breast remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast Cell counting assay MDAMB453 human breast carcinoma cells MIC 2.50E-06 M Betulinic acid Melanoma remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Melanoma Cell counting assay MDAMB435 human melanoma cells MIC 2.50E-06 M Betulinic acid Cancer, breast remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast Cell counting assay MDAMB453 human breast carcinoma cells MIC 2.50E-06 M Betulinic acid Cancer, breast remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast Cell counting assay MDAMB468 human breast carcinoma cells MIC 2.50E-06 M Betulinic acid Cancer, breast remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast Cell counting assay Hs578T human breast carcinoma cells MIC 2.50E-06 M Betulinic acid Cancer, breast (in situ ductal carcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (in situ ductal carcinoma) Cell counting assay BT474 human breast ductal carcinoma cells (HER2 [ERBB2]-overexpressing) MIC 2.50E-06 M Pristimerine Glioma remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Glioma Dye assay (MTT) C6 rat glioma cells CC-50 2.50E-06 M Iguesterin Proteasome Subunit beta Type-5 (PSMB5) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors Proteasome Subunit beta Type-5 (PSMB5) Fluorescent assay Coronavirus (SARS-associated) IC-50 2.60E-06 M Dieckol 3C-Like Protease (viral) inhibition, IN VITRO Reverse Transcriptase/Ribonuclease H (HIV-1) Inhibitors;beta-Secretase 1 (BACE1) Inhibitors;Acetylcholinesterase (AChE) Inhibitors 3C-Like Protease (viral) Fluorescence resonance energy transfer (FRET) assay Coronavirus (SARS-associated) IC-50 2.70E-06 M Ferruginol Malaria remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Lipid Peroxidation Inhibitors;Antioxidants;Apoptosis Inducers Malaria IC-50 2.90E-06 M Pristimerine Cancer, mouth (squamous cell) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, mouth (squamous cell) Dye assay (alamar blue) HSC3 human oral squamous cell carcinoma cells CC-50 2.90E-06 M Pristimerine Melanoma, uveal remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, uveal Dye assay (MTS) OMM2.3 human uveal melanoma cells CC-50 2.90E-06 M Hirsutenone Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;LDL Antioxidants;Signal Transduction Modulators;Antiinflammatory Drugs;Free Radical Scavengers;Nitric Oxide (NO) Production Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Ubiquitin-7-amino-4-methylcoumarin as substrate Coronavirus (SARS-associated) IC-50 3.00E-06 M Bananin ATP-Dependent DNA Helicases inhibition, IN VITRO Chelating Agents ATP-Dependent DNA Helicases Coronavirus (SARS-associated) IC-50 3.00E-06 M Tingenone Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Antioxidants;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs;Free Radical Scavengers Cancer, breast (adenocarcinoma) Dye assay (MTT) MCF7 human breast adenocarcinoma cells (hormone-dependent) CC-50 3.00E-06 M Betulinic acid Cancer, lung (non-small cell) (NSCLC) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, lung (non-small cell) (NSCLC) Dye assay (MTT) A549 human non-small-cell lung carcinoma cells CC-50 3.00E-06 M Pristimerine Proteasome Subunit beta Type-5 (PSMB5) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Proteasome Subunit beta Type-5 (PSMB5) Fluorescent assay Coronavirus (SARS-associated) Ki 3.10E-06 M Pristimerine Leukemia, myeloid remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Leukemia, myeloid K562 human myeloid leukemia cells CC-50 3.20E-06 M Pristimerine HLA Class I Histocompatibility antigen, B-7 alpha chain (HLA-B) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs HLA Class I Histocompatibility antigen, B-7 alpha chain (HLA-B) Luciferine/luciferase assay HeLa human cervix adenocarcinoma cells IC-50 3.25E-06 M Betulinic acid Cancer, colon (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, colon (adenocarcinoma) Dye assay (MTT) HT29 human colon adenocarcinoma cells IC-50 3.40E-06 M Pristimerine Cancer, cervix, (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, cervix, (adenocarcinoma) Dye assay (MTT) HeLa human cervix adenocarcinoma cells CC-50 3.42E-06 M GC-373 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (Norovirus) Inhibitors 3C-Like Protease (viral) Fluorescence resonance energy transfer (FRET) assay Coronavirus (SARS-associated) IC-50 3.48E-06 M GC-373 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (Norovirus) Inhibitors 3C-Like Protease (viral) Fluorescence resonance energy transfer (FRET) assay Coronavirus (SARS-associated) IC-50 3.48E-06 M Betulinic acid Protein Tyrosine Phosphatase 1B (PTP-1B) inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Protein Tyrosine Phosphatase 1B (PTP-1B) p-Nitrophenyl phosphate as substrate IC-50 3.49E-06 M Pristimerine Cytotoxicity induction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cytotoxicity Dye assay (alamar blue) MRC5 human embryonic lung fibroblasts CC-50 3.50E-06 M Psoralidin Lysosomal alpha-Glucosidase inhibition, IN VITRO Estrogen Receptor (ER) beta Agonists;Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;Estrogen Receptor (ER) alpha Agonists;5-Lipoxygenase Inhibitors;Signal Transduction Modulators;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Caspase Activators;Apoptosis Inducers Lysosomal alpha-Glucosidase p-Nitrophenyl alpha-D-glucopyranoside as substrate IC-50 3.50E-06 M Mucroporin-M1 Influenza A remission/reduction, IN VITRO Cell Membrane Disrupting Agents Influenza A Plaque assay IC-50 3.52E-06 M SR9EK2 Nephrotoxicity induction, IN VITRO Nephrotoxicity Dye assay Vero African green monkey kidney cells CC-50 3.60E-06 M Betulinic acid Infection, cytomegalovirus remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Signal Transduction Modulators;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Infection, cytomegalovirus Fluorescent assay Fibroblasts (foreskin), human IC-50 3.62E-06 M Betulinic acid Infection, cytomegalovirus remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;Apoptosis Inducers;NF-kappaB (NFKB) Activators;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Infection, cytomegalovirus Fluorescent assay Fibroblasts (foreskin), human IC-50 3.62E-06 M Psoralidin Estrogen Receptor alpha (ERalpha) agonism, IN VITRO Estrogen Receptor (ER) beta Agonists;Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;Estrogen Receptor (ER) alpha Agonists;5-Lipoxygenase Inhibitors;Signal Transduction Modulators;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Caspase Activators;Apoptosis Inducers Estrogen Receptor alpha (ERalpha) Luciferine/luciferase assay CV1 African green monkey kidney fibroblasts transfected with ERalpha receptor EC-50 3.68E-06 M Betulinic acid Malaria remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Signal Transduction Modulators;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Malaria Radioactivity assay IC-50 3.70E-06 M Papyriflavonol A Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Signal Transduction Modulators;Phospholipase A2 (PLA2) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Fluorescent assay Coronavirus (SARS-associated) IC-50 3.70E-06 M Noscapine Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Tubulin Polymerization Inhibitors;Apoptosis Inducers;Antimitotic Drugs Severe acute respiratory syndrome (SARS-CoV) Dye assay (neutral red) Vero African green monkey kidney cells IC-50 3.80E-06 g/l Psoralidin Cytotoxicity induction, IN VITRO Estrogen Receptor (ER) beta Agonists;Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;Estrogen Receptor (ER) alpha Agonists;5-Lipoxygenase Inhibitors;Signal Transduction Modulators;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Caspase Activators;Apoptosis Inducers Cytotoxicity Dye assay (MTT) RWPE1 human prostate epithelial cells MCC 4.00E-06 M Tingenone Proteasome Subunit beta Type-5 (PSMB5) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Antioxidants;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs;Free Radical Scavengers Proteasome Subunit beta Type-5 (PSMB5) Fluorescent assay Coronavirus (SARS-associated) Ki 4.00E-06 M Psoralidin Cancer, prostate remission/reduction, IN VITRO Estrogen Receptor (ER) beta Agonists;Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;Estrogen Receptor (ER) alpha Agonists;5-Lipoxygenase Inhibitors;Signal Transduction Modulators;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Caspase Activators;Apoptosis Inducers Cancer, prostate Bromodeoxyuridine incorporation assay Epithelial cells (prostate), human (cadmium-transformed) MIC 4.00E-06 M Chloroquine phosphate Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Apoptosis Inducers Severe acute respiratory syndrome (SARS-CoV) Viral replication assay Vero African green monkey kidney cells IC-50 4.10E-06 M Chloroquine phosphate Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Apoptosis Inducers Severe acute respiratory syndrome (SARS-CoV) Dye assay (MTS) VeroE6 African green monkey kidney cells IC-50 4.10E-06 M Chloroquine phosphate Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Apoptosis Inducers Severe acute respiratory syndrome (SARS-CoV) Viral replication assay IC-50 4.10E-06 M Hirsutenone 3C-Like Protease (viral) inhibition, IN VITRO Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;LDL Antioxidants;Signal Transduction Modulators;Antiinflammatory Drugs;Free Radical Scavengers;Nitric Oxide (NO) Production Inhibitors 3C-Like Protease (viral) Fluorescent assay Coronavirus (SARS-associated) IC-50 4.10E-06 M Hirsutenone Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;LDL Antioxidants;Signal Transduction Modulators;Antiinflammatory Drugs;Free Radical Scavengers;Nitric Oxide (NO) Production Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Arg-Leu-Arg-Gly-Gly-7-amino-4-methylcoumarin as substrate Coronavirus (SARS-associated) IC-50 4.10E-06 M ML-300 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors 3C-Like Protease (viral) Coronavirus (SARS-associated) IC-50 4.11E-06 M (-)-Savinin Cancer, ovary (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Drugs Acting on Tumor Necrosis Factor (TNF) Receptors Cancer, ovary (adenocarcinoma) Dye assay (sulforhodamine B) SKOV3 human ovary adenocarcinoma cells CC-50 4.16E-06 M Tripterin Proteasome Subunit beta Type-5 (PSMB5) inhibition, IN VITRO Signal Transduction Modulators;Heat Shock Protein 90 (Hsp90) Inhibitors;Lipid Peroxidation Inhibitors;Cytokine Production Inhibitors;Apoptosis Inducers;Enoyl-(Acyl Carrier Protein) Reductase (FabI) (Plasmodium falciparum) Inhibitors;Antioxidants;Myc Proto-Oncogene Protein (c-Myc)/Myc-Associated Factor X (Max) Interaction Inhibitors Proteasome Subunit beta Type-5 (PSMB5) Fluorescent assay Coronavirus (SARS-associated) Ki 4.20E-06 M Psoralidin Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Estrogen Receptor (ER) beta Agonists;Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;Estrogen Receptor (ER) alpha Agonists;5-Lipoxygenase Inhibitors;Signal Transduction Modulators;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Caspase Activators;Apoptosis Inducers Replicase Polyprotein 1ab (pp1ab) (SARS) Arg-Leu-Arg-Gly-Gly-7-amino-4-methylcoumarin as substrate Coronavirus (SARS-associated) IC-50 4.20E-06 M GC-376 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (Norovirus) Inhibitors 3C-Like Protease (viral) Fluorescence resonance energy transfer (FRET) assay Coronavirus (SARS-associated) IC-50 4.35E-06 M GC-376 3C-Like Protease (viral) inhibition, IN VITRO 3C-Like Protease (Norovirus) Inhibitors 3C-Like Protease (viral) Fluorescence resonance energy transfer (FRET) assay Coronavirus (SARS-associated) IC-50 4.35E-06 M (-)-Savinin Melanoma remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Drugs Acting on Tumor Necrosis Factor (TNF) Receptors Melanoma Dye assay (sulforhodamine B) SKMEL2 human melanoma cells CC-50 4.37E-06 M Pristimerine Glioblastoma remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Glioblastoma Dye assay (MTT) U251 human glioblastoma cells CC-50 4.50E-06 M Betulinic acid Cytotoxicity induction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cytotoxicity Dye assay (MTT) HeLa human cervix adenocarcinoma cells (CD4+/CCR5+) transfected with HIV-1 LTRbeta-gal-positive CC-50 4.52E-06 M Betulinic acid Cytotoxicity induction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cytotoxicity Dye assay (MTT) HeLa human cervix adenocarcinoma cells (CD4+/CCR5+) transfected with HIV-1 LTRbeta-gal-positive CC-50 4.52E-06 M Xanthoangelol B Anemia, hemolytic remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Cysteine Protease Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants;Sensor Histidine Kinase (Bacterial) Inhibitors;Plasminogen Activator Inhibitor (PAI-1) Inhibitors;Nitric Oxide (NO) Production Inhibitors;Free Radical Scavengers Anemia, hemolytic Erythrocytes, human IC-50 4.62E-06 M (-)-Savinin Cancer, colon (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Drugs Acting on Tumor Necrosis Factor (TNF) Receptors Cancer, colon (adenocarcinoma) Dye assay (sulforhodamine B) HCT15 human colon adenocarcinoma cells CC-50 4.82E-06 M Imatinib mesylate Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Tyrosine-Protein Kinase ABL1 Inhibitors;Bcr-Abl (Bcr-Abl1) Kinase Inhibitors;PDGFRalpha Inhibitors;PDGFRbeta Inhibitors;Signal Transduction Modulators;Breast Cancer-Resistant Protein (BCRP; ABCG2) Inhibitors;KIT (C-KIT) Inhibitors;CSF1R (c-FMS) Inhibitors;Apoptosis Inducers;Angiogenesis Inhibitors Severe acute respiratory syndrome (SARS-CoV) RNA assay Calu3 human lung carcinoma cells (c-erbB2-overexpressing) MIC > 5.00E-06 M Betulinic acid DNA Topoisomerase II alpha inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors DNA Topoisomerase II alpha DNA decatenation assay Human enzyme IC-50 5.00E-06 M Psoralidin Activity-Regulated Cytoskeleton-Associated Protein activation, IN VITRO Estrogen Receptor (ER) beta Agonists;Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;Estrogen Receptor (ER) alpha Agonists;5-Lipoxygenase Inhibitors;Signal Transduction Modulators;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Caspase Activators;Apoptosis Inducers Activity-Regulated Cytoskeleton-Associated Protein RNA assay Cortical neurons (primary), mouse MEC 5.00E-06 M Psoralidin Early Growth Response 1 (EGR1) induction, IN VITRO Estrogen Receptor (ER) beta Agonists;Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;Estrogen Receptor (ER) alpha Agonists;5-Lipoxygenase Inhibitors;Signal Transduction Modulators;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Caspase Activators;Apoptosis Inducers Early Growth Response 1 (EGR1) RNA assay Cortical neurons (primary), mouse MEC 5.00E-06 M Betulinic acid Caveolin 1 (CAV1) induction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Caveolin 1 (CAV1) Chemiluminescent assay MDAMB231 human breast adenocarcinoma cells MEC 5.00E-06 M Betulinic acid L-Lactate Dehydrogenase A chain (LDH-A) inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors L-Lactate Dehydrogenase A chain (LDH-A) Chemiluminescent assay MCF7 human breast adenocarcinoma cells (hormone-dependent) MIC 5.00E-06 M Betulinic acid [Pyruvate Dehydrogenase (Acetyl-Transferring)] Kinase isozyme 1, mitochondrial (PDK1) inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors [Pyruvate Dehydrogenase (Acetyl-Transferring)] Kinase isozyme 1, mitochondrial (PDK1) Chemiluminescent assay MCF7 human breast adenocarcinoma cells (hormone-dependent) MIC 5.00E-06 M Betulinic acid [Pyruvate Dehydrogenase (Acetyl-Transferring)] Kinase isozyme 1, mitochondrial (PDK1) inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors [Pyruvate Dehydrogenase (Acetyl-Transferring)] Kinase isozyme 1, mitochondrial (PDK1) Chemiluminescent assay MDAMB231 human breast adenocarcinoma cells MIC 5.00E-06 M Betulinic acid [Pyruvate Dehydrogenase (Acetyl-Transferring)] Kinase isozyme 1, mitochondrial (PDK1) inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors [Pyruvate Dehydrogenase (Acetyl-Transferring)] Kinase isozyme 1, mitochondrial (PDK1) Chemiluminescent assay MDAMB231 human breast adenocarcinoma cells MIC 5.00E-06 M Betulinic acid Transcription Factor p65 inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Transcription Factor p65 Chemiluminescent assay MCF7 human breast adenocarcinoma cells (hormone-dependent) MIC 5.00E-06 M Betulinic acid Hypoxia Inducible Factor (HIF) (nonspecified subtype) inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Hypoxia Inducible Factor (HIF) (nonspecified subtype) ELISA assay PC3 human prostate adenocarcinoma cells MIC <= 5.00E-06 M Betulinic acid Hypoxia Inducible Factor (HIF) (nonspecified subtype) inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Hypoxia Inducible Factor (HIF) (nonspecified subtype) Chemiluminescent assay PC3 human prostate adenocarcinoma cells MIC <= 5.00E-06 M Pristimerine Fatty Acid Synthase inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Fatty Acid Synthase Acetyl-CoA incorporation assay SKBr3 human breast adenocarcinoma cells (HER2 [ERBB2]-overexpressing) MIC 5.00E-06 M Cinanserin hydrochloride 3C-Like Protease (viral) inhibition, IN VITRO Serotonin Receptor Antagonists;Signal Transduction Modulators 3C-Like Protease (viral) Coronavirus (SARS-associated) IC-50 5.00E-06 M Tomentin E Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Arg-Leu-Arg-Gly-Gly-7-amino-4-methylcoumarin as substrate Coronavirus (SARS-associated) IC-50 5.00E-06 M Betulinic acid Apoptosis Regulator Bcl-2 induction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Apoptosis Regulator Bcl-2 Chemiluminescent assay H9c2 rat cardiac myoblasts (hypoxic/reoxygenated) MEC <= 5.00E-06 M Betulinic acid Caspase-3 inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Caspase-3 Acetyl-Asp-Glu-Val-Asp-p-nitroanilide as substrate H9c2 rat cardiac myoblasts MIC <= 5.00E-06 M Betulinic acid Apoptosis Regulator BAX inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Apoptosis Regulator BAX Chemiluminescent assay H9c2 rat cardiac myoblasts MIC <= 5.00E-06 M Betulinic acid Transcriptional Repressor Protein YY1 inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Transcriptional Repressor Protein YY1 Luciferine/luciferase assay MDAMB453 human breast carcinoma cells MIC 5.00E-06 M Betulinic acid Membrane-Associated Tyrosine- and Threonine-Specific cdc2-Inhibitory Kinase induction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Membrane-Associated Tyrosine- and Threonine-Specific cdc2-Inhibitory Kinase RNA assay MDAMB231 human breast adenocarcinoma cells MEC 5.00E-06 M Betulinic acid SP Transcritption Factors inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors SP Transcritption Factors Luciferine/luciferase assay MDAMB231 human breast adenocarcinoma cells MIC 5.00E-06 M Betulinic acid Transcription Factor Sp1 inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Transcription Factor Sp1 RNA assay MDAMB231 human breast adenocarcinoma cells MIC 5.00E-06 M Betulinic acid Transcription Factor Sp3 inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Transcription Factor Sp3 RNA assay MDAMB231 human breast adenocarcinoma cells MIC 5.00E-06 M Betulinic acid Transcription Factor Sp4 inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Transcription Factor Sp4 RNA assay MDAMB231 human breast adenocarcinoma cells MIC 5.00E-06 M Betulinic acid Wee1-Like Protein Kinase 1 (Wee1) inhibition, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Wee1-Like Protein Kinase 1 (Wee1) RNA assay MDAMB231 human breast adenocarcinoma cells MIC 5.00E-06 M Isobavachalcone Cancer, liver (hepatocellular carcinoma) remission/reduction, IN VITRO Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Steroid 5alpha-Reductase Inhibitors;Drugs Targeting Beta-Amyloid;Signal Transduction Modulators;Autophagy Inducers;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants Cancer, liver (hepatocellular carcinoma) Colony formation assay Hep3B human hepatocellular carcinoma cells MIC <= 5.00E-06 M Pristimerine Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, breast (adenocarcinoma) Flow cytometry assay SKBr3 human breast adenocarcinoma cells (HER2 [ERBB2]-overexpressing) MEC 5.00E-06 M Betulinic acid Oxidative stress remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Oxidative stress Chemiluminescent assay H9c2 rat cardiac myoblasts MIC <= 5.00E-06 M Betulinic acid Oxidative stress remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Oxidative stress TBARS formation assay H9c2 rat cardiac myoblasts MIC <= 5.00E-06 M Betulinic acid Oxidative stress remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Oxidative stress Hydroxylamine as substrate H9c2 rat cardiac myoblasts (hypoxic/reoxygenated) MIC <= 5.00E-06 M Betulinic acid Oxidative stress remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Oxidative stress Spectrophotometric assay H9c2 rat cardiac myoblasts (hypoxic/reoxygenated) MIC <= 5.00E-06 M Betulinic acid Oxidative stress remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Oxidative stress Spectrophotometric assay H9c2 rat cardiac myoblasts MIC <= 5.00E-06 M Betulinic acid Cancer, breast (in situ ductal carcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (in situ ductal carcinoma) Cell counting assay BT474 human breast ductal carcinoma cells (HER2 [ERBB2]-overexpressing) MIC 5.00E-06 M Betulinic acid Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (adenocarcinoma) Flow cytometry assay MDAMB231 human breast adenocarcinoma cells MEC 5.00E-06 M Betulinic acid Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (adenocarcinoma) Cell counting assay MDAMB231 human breast adenocarcinoma cells MIC 5.00E-06 M Betulinic acid Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (adenocarcinoma) Dye assay (MTT) MDAMB231 human breast adenocarcinoma cells MCC 5.00E-06 M Betulinic acid Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (adenocarcinoma) Dye assay (MTT) MDAMB231 human breast adenocarcinoma cells MCC 5.00E-06 M Betulinic acid Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (adenocarcinoma) Dye assay (MTT) @ 24 h MDAMB231 human breast adenocarcinoma cells MIC 5.00E-06 M Betulinic acid Cancer, lung (non-small cell) (NSCLC) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, lung (non-small cell) (NSCLC) Transwell chamber assay H1299 human non-small-cell lung cancer cells MIC 5.00E-06 M Betulinic acid Cancer, lung (non-small cell) (NSCLC) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, lung (non-small cell) (NSCLC) Wound closure assay H1299 human non-small-cell lung cancer cells MIC 5.00E-06 M Pristimerine Glioblastoma remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Glioblastoma Dye assay (MTT) U87MG human glioblastoma cells CC-50 5.00E-06 M Betulinic acid Cancer, esophagus remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, esophagus Cell viability assay YES2 human esophagus cancer cells IC-50 5.09E-06 M Betulinic acid Malaria remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Signal Transduction Modulators;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Malaria Flow cytometry assay Erythrocytes, human IC-50 5.20E-06 M Betulinic acid Infection, HIV remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Infection, HIV beta-Galactosidase assay HeLa human cervix adenocarcinoma cells (CD4+/CCR5+) transfected with HIV-1 LTRbeta-gal-positive IC-50 5.32E-06 M Betulinic acid Infection, HIV remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Infection, HIV beta-Galactosidase assay HeLa human cervix adenocarcinoma cells (CD4+/CCR5+) transfected with HIV-1 LTRbeta-gal-positive IC-50 5.32E-06 M Pristimerine Proteasome Subunit beta Type-5 (PSMB5) inhibition, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Proteasome Subunit beta Type-5 (PSMB5) Fluorescent assay Coronavirus (SARS-associated) IC-50 5.50E-06 M SSYA-10-001 NTPase inhibition, IN VITRO NTPase Fluorescent assay Coronavirus (SARS-associated) IC-50 5.60E-06 M Curcumin Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;CCND1 Expression Inhibitors;Glucose-6-Phosphatase Inhibitors;P-Glycoprotein (MDR-1; ABCB1) Inhibitors;HIV Integrase Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Signal Transduction Modulators;Antiinflammatory Drugs;Histone N-Acetyltransferase (HAT) Inhibitors;Microtubule-Associated Protein Tau (PHF-tau; MAPT) Aggregation Inhibitors;AP-1 Transcription Factor Complex Inhibitors;DNA Methyltransferase 1 (DNMT1) Inhibitors;Apoptosis Inducers;Prostaglandin G/H Synthase 1 (PTGS1; COX-1) Inhibitors;Antioxidants;Angiogenesis Inhibitors;EGFR Expression Inhibitors;Cell Division Protein FtsZ (Bacterial) Inhibitors;Free Radical Scavengers;Lipoxygenase Inhibitors;Wnt Signaling Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Arg-Leu-Arg-Gly-Gly-7-amino-4-methylcoumarin as substrate Coronavirus (SARS-associated) IC-50 5.70E-06 M RH-01 Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO 3C-Like Protease (NL63 Coronavirus) (HCoV-NL63) Inhibitors;3C-Like Protease (EMC Coronavirus) (HCoV-EMC) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Coronavirus IC-50 5.72E-06 M (-)-Savinin Cancer, lung (non-small cell) (NSCLC) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Drugs Acting on Tumor Necrosis Factor (TNF) Receptors Cancer, lung (non-small cell) (NSCLC) Dye assay (sulforhodamine B) A549 human non-small-cell lung carcinoma cells CC-50 5.75E-06 M Ferruginol Leishmaniasis remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Lipid Peroxidation Inhibitors;Antioxidants;Apoptosis Inducers Leishmaniasis Amastigote assay IC-50 5.90E-06 M Loperamide hydrochloride Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Signal Transduction Modulators;mu-Opioid Receptor Agonists;Atrial Natriuretic Peptide B (NPR2; Guanylate Cyclase B) Receptor Antagonists Severe acute respiratory syndrome (SARS-CoV) Dye assay (MTS) VeroE6 African green monkey kidney cells IC-50 5.90E-06 M Loperamide hydrochloride Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Signal Transduction Modulators;mu-Opioid Receptor Agonists;Atrial Natriuretic Peptide B (NPR2; Guanylate Cyclase B) Receptor Antagonists Severe acute respiratory syndrome (SARS-CoV) Viral replication assay IC-50 5.90E-06 M Papyriflavonol A Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Signal Transduction Modulators;Phospholipase A2 (PLA2) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Uncompetitive inhibition mode Coronavirus (SARS-associated) Ki 5.90E-06 M SG-85 Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO 3C-Like Protease (NL63 Coronavirus) (HCoV-NL63) Inhibitors;3C Protease (Enterovirus 71) Inhibitors;3C-Like Protease (EMC Coronavirus) (HCoV-EMC) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Coronavirus IC-50 6.06E-06 M SR9EK3 Nephrotoxicity induction, IN VITRO Nephrotoxicity Dye assay Vero African green monkey kidney cells CC-50 6.15E-06 M Pristimerine Melanoma, metastatic remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Melanoma, metastatic Dye assay (alamar blue) B16F10 mouse metastatic melanoma cells CC-50 6.30E-06 M Betulinic acid Cancer, colon (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, colon (adenocarcinoma) Dye assay (sulforhodamine B) SW480 human colon adenocarcinoma cells CC-50 6.40E-06 M Betulinic acid Cancer, colon (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, colon (adenocarcinoma) Dye assay (sulforhodamine B) SW480 human colon adenocarcinoma cells CC-50 6.40E-06 M Betulinic acid Cancer, colon (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, colon (adenocarcinoma) Dye assay (sulforhodamine B) SW480 human colon adenocarcinoma cells CC-50 6.40E-06 M Betulinic acid Cancer, colon (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, colon (adenocarcinoma) Dye assay (sulforhodamine B) SW480 human colon adenocarcinoma cells CC-50 6.48E-06 M Betulinic acid Cancer, colon (adenocarcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, colon (adenocarcinoma) Dye assay (sulforhodamine B) SW480 human colon adenocarcinoma cells CC-50 6.48E-06 M Chloroquine Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Severe acute respiratory syndrome (SARS-CoV) Vero African green monkey kidney cells IC-50 6.50E-06 M Betulinic acid Cancer, lung (non-small cell) (NSCLC) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, lung (non-small cell) (NSCLC) Dye assay A549 human non-small-cell lung carcinoma cells CC-50 6.65E-06 M Betulinic acid Cancer, thyroid, anaplastic remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, thyroid, anaplastic Dye assay (sulforhodamine B) 8505C human anaplastic thyroid carcinoma cells CC-50 6.70E-06 M Betulinic acid Cancer, thyroid, anaplastic remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, thyroid, anaplastic Dye assay (sulforhodamine B) 8505C human anaplastic thyroid carcinoma cells CC-50 6.70E-06 M Betulinic acid Cancer, thyroid, anaplastic remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, thyroid, anaplastic Dye assay (sulforhodamine B) 8505C human anaplastic thyroid carcinoma cells CC-50 6.70E-06 M Betulinic acid Cancer, thyroid, anaplastic remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, thyroid, anaplastic Dye assay (sulforhodamine B) 8505C human anaplastic thyroid carcinoma cells CC-50 6.70E-06 M Betulinic acid Cancer, thyroid, anaplastic remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, thyroid, anaplastic Dye assay (sulforhodamine B) 8505C human anaplastic thyroid carcinoma cells CC-50 6.70E-06 M Betulinic acid Cancer, thyroid, anaplastic remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, thyroid, anaplastic Dye assay (sulforhodamine B) 8505C human anaplastic thyroid carcinoma cells CC-50 6.70E-06 M Betulinic acid Cancer, thyroid, anaplastic remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, thyroid, anaplastic Dye assay (sulforhodamine B) 8505C human anaplastic thyroid carcinoma cells CC-50 6.70E-06 M Psoralidin Estrogen Receptor beta (ERbeta) agonism, IN VITRO Estrogen Receptor (ER) beta Agonists;Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitors;Estrogen Receptor (ER) alpha Agonists;5-Lipoxygenase Inhibitors;Signal Transduction Modulators;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Caspase Activators;Apoptosis Inducers Estrogen Receptor beta (ERbeta) Luciferine/luciferase assay CV1 African green monkey kidney fibroblasts transfected with ERbeta receptor EC-50 6.88E-06 M Quercetin Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Catechol-O-Methyl Transferase (COMT) Inhibitors;Drugs Targeting on Quorum Sensing Signaling;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;MAO-A Inhibitors;NAD-Dependent Protein Deacetylase Sirtuin-1 (SIRT1) Activators;Signal Transduction Modulators;Lysosomal alpha-Glucosidase (GAA) Inhibitors;Xanthine Oxidase Inhibitors;EGFR (HER1; erbB1) Inhibitors;Cytokine Production Inhibitors;Antioxidants;Steryl-Sulfatase (STS) Inhibitors;Aldose Reductase Inhibitors;Sodium Channel Protein Type 5 Subunit alpha (Nav1.5) Channel Blockers;Free Radical Scavengers;Epigenetic Modifier Modulators;Wnt Signaling Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Uncompetitive inhibition mode Coronavirus (SARS-associated) Ki 7.00E-06 M Betulinic acid Melanoma remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Melanoma Dye assay (MTS) SKMEL2 human melanoma cells CC-50 7.00E-06 M Pristimerine Cancer, stomach remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, stomach N87 human gastric carcinoma cells CC-50 7.00E-06 M Mucroporin-M1 Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO Cell Membrane Disrupting Agents Severe acute respiratory syndrome (SARS-CoV) Plaque assay HeLa human cervix adenocarcinoma cells IC-50 7.12E-06 M Betulinic acid Cancer, thyroid, anaplastic remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, thyroid, anaplastic Dye assay (sulforhodamine B) 8505C human anaplastic thyroid carcinoma cells CC-50 7.26E-06 M Betulinic acid Cancer, thyroid, anaplastic remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, thyroid, anaplastic Dye assay (sulforhodamine B) 8505C human anaplastic thyroid carcinoma cells CC-50 7.26E-06 M Isobavachalcone Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Steroid 5alpha-Reductase Inhibitors;Drugs Targeting Beta-Amyloid;Signal Transduction Modulators;Autophagy Inducers;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants Replicase Polyprotein 1ab (pp1ab) (SARS) Arg-Leu-Arg-Gly-Gly-7-amino-4-methylcoumarin as substrate Coronavirus (SARS-associated) IC-50 7.30E-06 M Papyriflavonol A Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Signal Transduction Modulators;Phospholipase A2 (PLA2) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Fluorescent assay Coronavirus (SARS-associated) IC-50 7.60E-06 M Betulinic acid Cancer, lung (non-small cell) (NSCLC) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, lung (non-small cell) (NSCLC) Dye assay (sulforhodamine B) A549 human non-small-cell lung carcinoma cells CC-50 7.60E-06 M Betulinic acid Cancer, breast (in situ ductal carcinoma) remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Cancer, breast (in situ ductal carcinoma) Clonogenic assay T47D human breast ductal carcinoma cells CC-50 7.66E-06 M Pristimerine Hepatoblastoma remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Hepatoblastoma Dye assay (alamar blue) HepG2 human hepatoblastoma cells CC-50 7.80E-06 M Pristimerine Cancer, breast (adenocarcinoma) remission/reduction, IN VITRO 3C-Like Protease (SARS-CoV) Inhibitors;Apoptosis Inducers;Microtubule Destabilizers (Tubulin Polymerization Inhibitors);Antimitotic Drugs Cancer, breast (adenocarcinoma) Dye assay (alamar blue) MCF7 human breast adenocarcinoma cells (hormone-dependent) CC-50 7.90E-06 M Isobavachalcone Cancer, ovary remission/reduction, IN VITRO Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Steroid 5alpha-Reductase Inhibitors;Drugs Targeting Beta-Amyloid;Signal Transduction Modulators;Autophagy Inducers;Papain-Like Protease (PLpro) (SARS-CoV) Inhibitors;Antioxidants Cancer, ovary Dye assay (MTT) OVCAR8 human ovary carcinoma cells CC-50 7.92E-06 M Broussochalcone A Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO Signal Transduction Modulators;Protein Kinase C (PKC) Inhibitors Replicase Polyprotein 1ab (pp1ab) (SARS) Uncompetitive inhibition mode Coronavirus (SARS-associated) Ki 8.00E-06 M Quercetin NTPase inhibition, IN VITRO Catechol-O-Methyl Transferase (COMT) Inhibitors;Drugs Targeting on Quorum Sensing Signaling;Tyrosine-Protein Phosphatase Non-Receptor Type 1 (PTPN1; PTP-1B) Inhibitors;MAO-A Inhibitors;NAD-Dependent Protein Deacetylase Sirtuin-1 (SIRT1) Activators;Signal Transduction Modulators;Lysosomal alpha-Glucosidase (GAA) Inhibitors;Xanthine Oxidase Inhibitors;EGFR (HER1; erbB1) Inhibitors;Cytokine Production Inhibitors;Antioxidants;Steryl-Sulfatase (STS) Inhibitors;Aldose Reductase Inhibitors;Sodium Channel Protein Type 5 Subunit alpha (Nav1.5) Channel Blockers;Free Radical Scavengers;Epigenetic Modifier Modulators;Wnt Signaling Inhibitors NTPase Fluorescent assay Coronavirus (SARS-associated) IC-50 8.10E-06 M Betulinic acid Melanoma remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Melanoma Dye assay (sulforhodamine B) 518A2 human melanoma cells CC-50 8.13E-06 M Betulinic acid Melanoma remission/reduction, IN VITRO Signal Transduction Modulators;3C-Like Protease (SARS-CoV) Inhibitors;Caspase 3 Activators;Caspase 8 Activators;NF-kappaB (NFKB) Activators;Apoptosis Inducers;DNA Topoisomerase I Inhibitors;Diacylglycerol Acyltransferase (DGAT) Inhibitors Melanoma Dye assay (sulforhodamine B) 518A2 human melanoma cells CC-50 8.13E-06 M Betulonic acid 3C-Like Protease (viral) inhibition, IN VITRO E3 Ubiquitin-Protein Ligase SIAH2 Inhibitors;Lysosomal alpha-Glucosidase (GAA) Inhibitors 3C-Like Protease (viral) Spectrophotometric assay Coronavirus (SARS-associated) Ki 8.20E-06 M Eckol 3C-Like Protease (viral) inhibition, IN VITRO Lipid Peroxidation Inhibitors;Tyrosinase Inhibitors;Free Radical Scavengers 3C-Like Protease (viral) Fluorescence resonance energy transfer (FRET) assay Coronavirus (SARS-associated) Ki 8.20E-06 M","title":"Annotated Set"},{"location":"CoV_Experiment_Data/#unannotated-set","text":"A collection of 816 records for 479 molecules from various sources. We current don't have the capability to annotate the sources or confirm the correctness of all datasets. This dataset may contains missing values and \"dirty\" data. Please use the data carefully and make your own effort to confirm the data source (journals, patents, websites) and extract useful (signal) information from the set. Some datasets use standardlized value PX=-log[M]. Full dataset Some subsets extracted: PX>6(measurement <1uM) active set IC50 values for 562 molecules Ki inhibition constant for 207 molecules Inhibition rate for 153 molecules EC50 values for 30 molecules pKi values for 14 molecules SMILES of 986 molecules tested for coronavirus, but we are not sure if they are active or inactive SMILES","title":"Unannotated Set"},{"location":"CoV_Experiment_Data/#literature-mining","text":"A comprehensive literature mining result kindly provided by Causaly , focusing on chemicals/drugs, genes and molecular mechanisms. This data includes 2090 relationships, 1229 aggregrate relationships, and 976 articles based on a search query of \"Chemicals&Drugs,Genes,Cellular&Molecular Mechanisms [AFFECTING] [Genus:Coronavirus]\" with the data source coming from MEDLINE and PubMedCentral. This search resulted in several Target Concepts including: sars coronavirus, middle east respiratory syndrome coronavirus, human coronavirus, etc. Full dataset The following figure is the keyword relationship network: Full Image The aggregate relationship data can be found in this dataset This data describes source concept items and classifies them into different categories. Some relevant categories include: Amino Acid Peptide Protein, Biologically Active Substance, Chemical, Nucleic Acid, etc. Literature articles and relationships data gives a list of 977 relevant articles and shows the evidence of the relationship from the original article. Dataset Literature evidence data lists all relevant source concepts (biological substances, chemicals, etc) and its relation to an article. Overall, there are over 2000 relevant pieces of information relevant to coronavirus. Dataset A few selected records Source Concept Source Concept Categories Relationship Type Target Concept Count of Evidence Evidence contains clinical studies? Count of Evidence per rel type cyclosporine \"Amino Acid, Peptide, or Protein\" DOWNREGULATE genus: coronavirus 11 no DOWNREGULATE: 11 \"rna, small interfering\" Biologically Active Substance DOWNREGULATE sars coronavirus 9 no DOWNREGULATE: 9 linoleic acid Biologically Active Substance DOWNREGULATE middle east respiratory syndrome coronavirus 3 no \"DOWNREGULATE: 2, UPREGULATE: 1\" resveratrol Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 7 no \"DOWNREGULATE: 6, UPREGULATE: 1\" chloroquine Organic Chemical DOWNREGULATE sars coronavirus 14 no \"DOWNREGULATE: 12, UPREGULATE: 2\" human leukocyte interferon \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 17 no \"DOWNREGULATE: 11, UNIDIRECTIONAL: 4, UPREGULATE: 1, NEG_UNIDIRECTIONAL: 1\" gs-5734 \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE genus: coronavirus 4 no DOWNREGULATE: 4 zinc Biologically Active Substance DOWNREGULATE sars coronavirus 4 no DOWNREGULATE: 4 linoleic acid Biologically Active Substance DOWNREGULATE human coronavirus 229e 2 no \"UPREGULATE: 1, DOWNREGULATE: 1\" fk-506 Organic Chemical DOWNREGULATE human coronavirus nl63 2 no DOWNREGULATE: 2 human leukocyte interferon \"Amino Acid, Peptide, or Protein\" DOWNREGULATE genus: coronavirus 8 no \"DOWNREGULATE: 5, UNIDIRECTIONAL: 2, UPREGULATE: 1\" lopinavir Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 4 no DOWNREGULATE: 4 ribavirin \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE middle east respiratory syndrome coronavirus 6 no \"DOWNREGULATE: 5, UNIDIRECTIONAL: 1\" cyclosporine \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 3 no DOWNREGULATE: 3 gs-5734 \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE sars coronavirus 3 no DOWNREGULATE: 3 recombinant interferon alfa \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 5 no \"DOWNREGULATE: 4, UNIDIRECTIONAL: 1\" \"5-(n,n-hexamethylene)amiloride\" Organic Chemical DOWNREGULATE human coronavirus 229e 4 no DOWNREGULATE: 4 chlorpromazine Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 3 no DOWNREGULATE: 3 chloroquine Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 3 no DOWNREGULATE: 3 interferon type i \"Amino Acid, Peptide, or Protein\" DOWNREGULATE genus: coronavirus 5 no \"DOWNREGULATE: 3, UNIDIRECTIONAL: 1, UPREGULATE: 1\" monoclonal antibodies \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 6 no \"DOWNREGULATE: 3, UNIDIRECTIONAL: 2, UPREGULATE: 1\" glycyrrhizic acid Organic Chemical DOWNREGULATE sars coronavirus 3 no DOWNREGULATE: 3 protease inhibitors Pharmacologic Substance DOWNREGULATE sars coronavirus 3 no DOWNREGULATE: 3 kinase inhibitor [epc] Pharmacologic Substance DOWNREGULATE middle east respiratory syndrome coronavirus 2 no DOWNREGULATE: 2 chloroquine Organic Chemical DOWNREGULATE genus: coronavirus 3 no \"DOWNREGULATE: 2, UNIDIRECTIONAL: 1\" emodin Biologically Active Substance DOWNREGULATE sars coronavirus 2 no DOWNREGULATE: 2 emodin Biologically Active Substance DOWNREGULATE \"coronavirus oc43, human\" 2 no DOWNREGULATE: 2 beta-thujaplicin Organic Chemical DOWNREGULATE genus: coronavirus 2 no DOWNREGULATE: 2 ubiquitin \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 3 no DOWNREGULATE: 3 nucleoside analogs \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE genus: coronavirus 3 no \"DOWNREGULATE: 2, UNIDIRECTIONAL: 1\" proteasome inhibitor Pharmacologic Substance DOWNREGULATE sars coronavirus 2 no DOWNREGULATE: 2 mycophenolic acid Antibiotic DOWNREGULATE middle east respiratory syndrome coronavirus 2 no DOWNREGULATE: 2 loperamide Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 2 no DOWNREGULATE: 2 cyclophilins \"Amino Acid, Peptide, or Protein\" DOWNREGULATE genus: coronavirus 2 no \"DOWNREGULATE: 1, UPREGULATE: 1\" cytokine \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 3 no \"DOWNREGULATE: 2, UNIDIRECTIONAL: 1\" lopinavir Organic Chemical DOWNREGULATE sars coronavirus 2 no DOWNREGULATE: 2 cyclosporine \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 2 no DOWNREGULATE: 2 alisporivir \"Amino Acid, Peptide, or Protein\" DOWNREGULATE genus: coronavirus 2 no DOWNREGULATE: 2 glycosyltransferase \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 2 no DOWNREGULATE: 2 methyltransferase \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 2 no DOWNREGULATE: 2 u 18666a Organic Chemical DOWNREGULATE \"coronavirus, feline\" 2 no DOWNREGULATE: 2 \"5-(n,n-hexamethylene)amiloride\" Organic Chemical DOWNREGULATE genus: coronavirus 2 no DOWNREGULATE: 2 niclosamide Organic Chemical DOWNREGULATE sars coronavirus 2 no DOWNREGULATE: 2 \"dpp4 protein, human\" \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 5 no \"DOWNREGULATE: 3, UPREGULATE: 1, UNIDIRECTIONAL: 1\" glycoproteins \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 2 no \"DOWNREGULATE: 1, UPREGULATE: 1\" fumaric acid Organic Chemical DOWNREGULATE genus: coronavirus 2 no DOWNREGULATE: 2 protease inhibitors Pharmacologic Substance DOWNREGULATE genus: coronavirus 2 no DOWNREGULATE: 2 adenoviral vector \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE sars coronavirus 2 no DOWNREGULATE: 2 tapi-2 Organic Chemical DOWNREGULATE sars coronavirus 2 no DOWNREGULATE: 2 monoclonal antibodies \"Amino Acid, Peptide, or Protein\" DOWNREGULATE porcine respiratory coronavirus 2 no DOWNREGULATE: 2 s antibody \"Amino Acid, Peptide, or Protein\" DOWNREGULATE bovine coronavirus 2 no DOWNREGULATE: 2 interferon-alpha2b \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 3 no \"DOWNREGULATE: 2, UNIDIRECTIONAL: 1\" human immunodeficiency virus 1 fusion inhibitor [epc] Pharmacologic Substance DOWNREGULATE middle east respiratory syndrome coronavirus 2 no DOWNREGULATE: 2 ribavirin \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE sars coronavirus 12 no \"DOWNREGULATE: 5, NEG_DOWNREGULATE: 4, UNIDIRECTIONAL: 2, UPREGULATE: 1\" platelets product Pharmacologic Substance DOWNREGULATE middle east respiratory syndrome coronavirus 2 no DOWNREGULATE: 2 tylophorine Organic Chemical DOWNREGULATE genus: coronavirus 2 no \"UPREGULATE: 1, DOWNREGULATE: 1\" riboflavin Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 2 no DOWNREGULATE: 2 recombinant interferon beta \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 \"antibodies, neutralizing\" \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 5 no \"DOWNREGULATE: 2, UPREGULATE: 1, NEG_UPREGULATE: 1, NEG_DOWNREGULATE: 1\" ribavirin \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE genus: coronavirus 2 no DOWNREGULATE: 2 immune sera \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 2 no DOWNREGULATE: 2 nim-811 \"Amino Acid, Peptide, or Protein\" DOWNREGULATE human coronavirus nl63 1 no DOWNREGULATE: 1 alisporivir \"Amino Acid, Peptide, or Protein\" DOWNREGULATE human coronavirus nl63 1 no DOWNREGULATE: 1 fk-506 Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 fk-506 Organic Chemical DOWNREGULATE human coronavirus 229e 1 no DOWNREGULATE: 1 s-nitroso-n-acetylpenicillamine Biologically Active Substance DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 hiv protease inhibitors Pharmacologic Substance DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 nelfinavir Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 phospholipase c \"Amino Acid, Peptide, or Protein\" DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 disulfiram Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 disulfiram Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 scorpion venoms Biologically Active Substance DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 interferon gamma [epc] \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 acetylglucosamine Organic Chemical DOWNREGULATE \"coronavirus oc43, human\" 1 no DOWNREGULATE: 1 gs-5734 \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE human coronavirus 1 no DOWNREGULATE: 1 terconazole Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 terconazole Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 phenanthrenes Organic Chemical DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 pyrithione Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 chloroquine Organic Chemical DOWNREGULATE \"coronavirus oc43, human\" 1 no DOWNREGULATE: 1 saikosaponin b2 Organic Chemical DOWNREGULATE human coronavirus 1 no DOWNREGULATE: 1 isobavachalcone Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 herbacetin Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 helichrysetin Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 isoquercitrin Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 fc receptor \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 alisporivir \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 decanoylrvkrchloromethylketone \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 gs-5734 \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 nucleoside analogs \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 nucleoside analogs \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 nucleoside analogs \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE human coronavirus 1 no DOWNREGULATE: 1 cardiotonic agents Pharmacologic Substance DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 sodium Biologically Active Substance DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 aminoquinoline antimalarial (product) Organic Chemical DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 interleukins \"Amino Acid, Peptide, or Protein\" DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 thiothixene Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 clomipramine Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 thioxanthenes Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 clomipramine Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 thiothixene Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 thioxanthenes Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 adenosine deaminase \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 chloroquine Organic Chemical DOWNREGULATE human coronavirus 1 no DOWNREGULATE: 1 tetra(4-n-methylpyridyl)porphine Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 alisporivir \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 teicoplanin \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 dalbavancin \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 telavancin \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 oritavancin \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 \"antibodies, monoclonal, humanized\" \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 ssya10-001 Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 protease inhibitors Pharmacologic Substance DOWNREGULATE \"coronavirus, feline\" 1 no DOWNREGULATE: 1 mercaptopurine \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 thioguanine Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 ssya10-001 Organic Chemical DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 pj-34 Organic Chemical DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 sb 203580 Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 interferon-alpha2b \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 synthetic peptide \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 chinese herbs Pharmacologic Substance DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 nitric oxide Biologically Active Substance DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 amiloride Organic Chemical DOWNREGULATE human coronavirus 229e 1 no DOWNREGULATE: 1 amiodarone Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 cystatins \"Amino Acid, Peptide, or Protein\" DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 glycine \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 anthelmintics Pharmacologic Substance DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 anthelmintics Pharmacologic Substance DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 interferon beta-1a \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 polypeptide c \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 hexachlorophene Organic Chemical DOWNREGULATE bovine coronavirus 1 no DOWNREGULATE: 1 hexachlorophene Organic Chemical DOWNREGULATE human enteric coronavirus 1 no DOWNREGULATE: 1 hexachlorophene Organic Chemical DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 palmitic acid Biologically Active Substance DOWNREGULATE human coronavirus 229e 1 no DOWNREGULATE: 1 mouse monoclonal antibody \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 gemcitabine \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 sotrastaurin Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 protein kinase c inhibitor Pharmacologic Substance DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 toremifene citrate Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 bcx4430 Biologically Active Substance DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 \"ifitm1 protein, human\" \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 glucose Biologically Active Substance DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 antiviral agents Pharmacologic Substance DOWNREGULATE human coronavirus 1 no DOWNREGULATE: 1 iota-carrageenan Biologically Active Substance DOWNREGULATE \"coronavirus oc43, human\" 1 no DOWNREGULATE: 1 protease inhibitors Pharmacologic Substance DOWNREGULATE tylonycteris bat coronavirus hku4 1 no DOWNREGULATE: 1 omacetaxine Organic Chemical DOWNREGULATE bovine coronavirus 1 no DOWNREGULATE: 1 omacetaxine Organic Chemical DOWNREGULATE human enteric coronavirus 1 no DOWNREGULATE: 1 omacetaxine Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 dna helicases \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 cysteine proteases \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 e 64 Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 camostate-mesilate Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 camostate-mesilate Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 e 64 Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 kinase inhibitor [epc] Pharmacologic Substance DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 protease inhibitors Pharmacologic Substance DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 bacillus intermedius ribonuclease \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 bacillus intermedius ribonuclease \"Amino Acid, Peptide, or Protein\" DOWNREGULATE human coronavirus 1 no DOWNREGULATE: 1 nafamostat Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 ritonavir Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 \"m protein, multiple myeloma\" \"Amino Acid, Peptide, or Protein\" DOWNREGULATE porcine respiratory coronavirus 1 no DOWNREGULATE: 1 u 18666a Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 human leukocyte interferon \"Amino Acid, Peptide, or Protein\" DOWNREGULATE human coronavirus 229e 1 no DOWNREGULATE: 1 glycyrrhizic acid Organic Chemical DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 nitazoxanide Organic Chemical DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 m nos antibody \"Amino Acid, Peptide, or Protein\" DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 antiviral agents Pharmacologic Substance DOWNREGULATE \"coronavirus, feline\" 1 no DOWNREGULATE: 1 camostat Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 baicalin Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 baicalein Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 zinc Biologically Active Substance DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 enzyme inhibitor drugs Pharmacologic Substance DOWNREGULATE human coronavirus hku1 1 no DOWNREGULATE: 1 paired basic amino acid cleaving enzyme \"Amino Acid, Peptide, or Protein\" DOWNREGULATE human coronavirus hku1 1 no DOWNREGULATE: 1 short hairpin rna \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 eosinophil cationic protein \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 mizoribine \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 aziridine Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 ritonavir Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 recombinant interferon beta-1a \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 veratridine Biologically Active Substance DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 dactinomycin \"Amino Acid, Peptide, or Protein\" DOWNREGULATE \"coronavirus, feline\" 1 no DOWNREGULATE: 1 stallimycin \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 recombinant interferon alfa \"Amino Acid, Peptide, or Protein\" DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 cytokine \"Amino Acid, Peptide, or Protein\" DOWNREGULATE human coronavirus 229e 1 no DOWNREGULATE: 1 protein domain Amino Acid Sequence DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 immunoglobulin domains Amino Acid Sequence DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 heparitin sulfate Biologically Active Substance DOWNREGULATE betacoronavirus 1 no DOWNREGULATE: 1 itraconazole Organic Chemical DOWNREGULATE \"coronavirus, feline\" 1 no DOWNREGULATE: 1 recombinant interferon beta \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 cysteine proteases \"Amino Acid, Peptide, or Protein\" DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 papillomavirus transforming protein e6 \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 1 no DOWNREGULATE: 1 memantine Organic Chemical DOWNREGULATE \"coronavirus oc43, human\" 1 no DOWNREGULATE: 1 heparin Biologically Active Substance DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 ethanol Organic Chemical DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 structural protein \"Amino Acid, Peptide, or Protein\" DOWNREGULATE \"coronavirus, feline\" 1 no DOWNREGULATE: 1 structural protein \"Amino Acid, Peptide, or Protein\" DOWNREGULATE \"coronavirus, canine\" 1 no DOWNREGULATE: 1 leupeptin \"Amino Acid, Peptide, or Protein\" DOWNREGULATE human coronavirus 229e 1 no DOWNREGULATE: 1 protein antibody \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 azauridine \"Nucleic Acid, Nucleoside, or Nucleotide\" DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 guanidine hydrochloride Organic Chemical DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 resveratrol Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus rna 1 no DOWNREGULATE: 1 \"antibodies, anti-idiotypic\" \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 phenothiazine Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 recombinant interleukin-4 \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 recombinant rantes \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 \"tnf protein, human\" \"Amino Acid, Peptide, or Protein\" DOWNREGULATE human coronavirus 229e 1 no DOWNREGULATE: 1 polyanion Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 ads j1 Organic Chemical DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 prostaglandin-endoperoxide synthase \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 plant extracts Biologically Active Substance DOWNREGULATE genus: coronavirus 1 no DOWNREGULATE: 1 hla complex \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 1 no DOWNREGULATE: 1 macrolides Organic Chemical DOWNREGULATE middle east respiratory syndrome coronavirus rna 2 no \"NEG_UPREGULATE: 1, NEG_DOWNREGULATE: 1\" \"antibodies, anti-idiotypic\" \"Amino Acid, Peptide, or Protein\" DOWNREGULATE middle east respiratory syndrome coronavirus 4 no \"DOWNREGULATE: 2, NEG_UPREGULATE: 2\" ssaa09e3 Organic Chemical DOWNREGULATE sars coronavirus 1 no NEG_DOWNREGULATE: 1 caspase \"Amino Acid, Peptide, or Protein\" DOWNREGULATE \"coronavirus, canine\" 1 no NEG_DOWNREGULATE: 1 phospholipase d \"Amino Acid, Peptide, or Protein\" DOWNREGULATE genus: coronavirus 1 no NEG_DOWNREGULATE: 1 proteolytic enzyme \"Amino Acid, Peptide, or Protein\" DOWNREGULATE sars coronavirus 2 no \"UPREGULATE: 1, NEG_DOWNREGULATE: 1\" dipeptidyl-peptidase iv inhibitors Pharmacologic Substance DOWNREGULATE middle east respiratory syndrome coronavirus 3 no \"NEG_DOWNREGULATE: 2, NEG_UNIDIRECTIONAL: 1\"","title":"Literature Mining"},{"location":"contact_us/","text":"Discussion You're welcome to join discussion at our Github Project . Leave Us Message For who not familiar with Github, you can also post your message HERE (function(h){function n(a){return null===a?null:a.scrollHeight>a.clientHeight?a:n(a.parentNode)}function t(b){if(b.data){var f=JSON.parse(b.data);!f.height||p||q||(d.style.height=+f.height+\"px\");if(f.getter){b={};var f=[].concat(f.getter),k,h=f.length,m,c,g,e;for(k=0;k<h;k++){m=k;c=f[k]||{};c.n&&(m=c.n);g=null;try{switch(c.t){case \"window\":e=window;break;case \"scrollParent\":e=n(a)||window;break;default:e=a}if(c.e)if(\"rect\"===c.v){g={};var l=e.getBoundingClientRect();g={top:l.top,left:l.left,width:l.width,height:l.height}}else g=e[c.v].apply(e,[].concat(c.e))||!0;else c.s?(e[c.v]=c.s,g=!0):g=e[c.v]||!1}catch(u){}b[m]=g}b.innerState=!p&&!q;a.contentWindow.postMessage(JSON.stringify({queryRes:b}),\"*\")}}}for(var r=h.document,b=r.documentElement;b.childNodes.length&&1==b.lastChild.nodeType;)b=b.lastChild;var d=b.parentNode,a=r.createElement(\"iframe\");d.style.overflowY=\"auto\";d.style.overflowX=\"hidden\";var p=d.style.height&&\"auto\"!==d.style.height,q=\"absolute\"===d.style.position||window.getComputedStyle&&\"absolute\"===window.getComputedStyle(d,null).getPropertyValue(\"position\")||d.currentStyle&&\"absolute\"===d.currentStyle.position;h.addEventListener&&h.addEventListener(\"message\",t,!1);a.src=\"http://ghddionlineform.mikecrm.com/A2r95sT\";a.id=\"mkinA2r95sT\";a.onload=function(){a.contentWindow.postMessage(JSON.stringify({cif:1}),\"*\")};a.frameBorder=0;a.scrolling=\"no\";a.style.display=\"block\";a.style.minWidth=\"100%\";a.style.width=\"100px\";a.style.height=\"100%\";a.style.border=\"none\";a.style.overflow=\"auto\";d.insertBefore(a,b)})(window);","title":"Community Discussion"},{"location":"contact_us/#discussion","text":"You're welcome to join discussion at our Github Project .","title":"Discussion"},{"location":"contact_us/#leave-us-message","text":"For who not familiar with Github, you can also post your message HERE (function(h){function n(a){return null===a?null:a.scrollHeight>a.clientHeight?a:n(a.parentNode)}function t(b){if(b.data){var f=JSON.parse(b.data);!f.height||p||q||(d.style.height=+f.height+\"px\");if(f.getter){b={};var f=[].concat(f.getter),k,h=f.length,m,c,g,e;for(k=0;k<h;k++){m=k;c=f[k]||{};c.n&&(m=c.n);g=null;try{switch(c.t){case \"window\":e=window;break;case \"scrollParent\":e=n(a)||window;break;default:e=a}if(c.e)if(\"rect\"===c.v){g={};var l=e.getBoundingClientRect();g={top:l.top,left:l.left,width:l.width,height:l.height}}else g=e[c.v].apply(e,[].concat(c.e))||!0;else c.s?(e[c.v]=c.s,g=!0):g=e[c.v]||!1}catch(u){}b[m]=g}b.innerState=!p&&!q;a.contentWindow.postMessage(JSON.stringify({queryRes:b}),\"*\")}}}for(var r=h.document,b=r.documentElement;b.childNodes.length&&1==b.lastChild.nodeType;)b=b.lastChild;var d=b.parentNode,a=r.createElement(\"iframe\");d.style.overflowY=\"auto\";d.style.overflowX=\"hidden\";var p=d.style.height&&\"auto\"!==d.style.height,q=\"absolute\"===d.style.position||window.getComputedStyle&&\"absolute\"===window.getComputedStyle(d,null).getPropertyValue(\"position\")||d.currentStyle&&\"absolute\"===d.currentStyle.position;h.addEventListener&&h.addEventListener(\"message\",t,!1);a.src=\"http://ghddionlineform.mikecrm.com/A2r95sT\";a.id=\"mkinA2r95sT\";a.onload=function(){a.contentWindow.postMessage(JSON.stringify({cif:1}),\"*\")};a.frameBorder=0;a.scrolling=\"no\";a.style.display=\"block\";a.style.minWidth=\"100%\";a.style.width=\"100px\";a.style.height=\"100%\";a.style.border=\"none\";a.style.overflow=\"auto\";d.insertBefore(a,b)})(window);","title":"Leave Us Message"},{"location":"drug_candidates/","text":"Drug candidates for 2019-nCoV The table below shows the identified candidates in no particular order. Only ones with preclinical and clinical records for 2019-nCoV were collected from different sources. Those suggested by expert systems or predictive models and traditional Chinese herbs were excluded. Drug Name Structure MoA Indication DrugBank URL Anti-2019nCoV Evidence Reference Remdesivir RNA polymerase inhibitor Anti-Ebola passed Phase III DB14761 In Vitro Assay, Clinical report 7 ; 8 Lopinavir Protease inhibitor Anti-HIV approved DB01601 Clinical trial 1 ; 2 ; 3 ; 4 ; 5 ; 6 Ritonavir Protease inhibitor Anti-HIV approved DB00503 Clinical trial 1 ; 2 ; 3 ; 4 ; 5 ; 6 Emtricitabine nucleoside reverse transcriptase inhibitor Anti-HIV approved, anti-HBV DB00879 Clinical trial 2 Tenofovir nucleoside reverse transcriptase inhibitor Anti-HIV Phase III, anti-HBV DB14126 Clinical trial 2 Ribavirin viral mRNA and protein synthesis inhibitor Anti-HCV, Anti-HBV, Anti-SARS, Anti-influenza, etc DB00811 Clinical trial 5 Umifenovir Influenza approved, nCoV Phase 4 DB13609 Clinical trial 9 Favipiravir RNA polymerase inhibitor Anti-influenza approved, anti-Ebola Phase II DB12466 Clinical trial 10 Darunavir Protease inhibitor Anti-HIV approved DB01264 Clinical trial 11 Cobicistat Anti-HIV approved DB09065 Clinical trial 11 Methylprednisolone Corticosteroid nCoV Phase II, allergic asthma and rheumatic disorders approved DB00959 Clinical trial 12 ; 13 IFN alpha-1b Immunomodulation Interferon Clinical trial 5 ; 6 Chloroquine Antimalarial approved, anti-HIV phase III, anti-HCV DB14761 In Vitro Assay 7 Download (including SMILES structures) Clinical Trials registration list A list of registered clinical trials related to 2019-nCoV is collected in the table below. This data was initially collected from Biocentury and sorted based on registration date. Registration number Intervention Type Registration date ChiCTR2000029308 Lopinavir/ritonavir; interferon \u03b1 2b Antiviral 2020/1/23 ChiCTR2000029386 Lopinavir/ritonavir; methylprednisolone; interferon \u03b1 Antiviral; Corticosteroid 2020/1/28 ChiCTR2000029387 Lopinavir/ritonavir; ribavirin; interferon \u03b1-1b Antiviral 2020/1/28 NCT04244591 Methylprednisolone Corticosteroid 2020/1/28 NCT04246242 Arbidol umifenovir Antiviral 2020/1/29 ChiCTR2000029468 Lopinavir/ritonavir; emtricitabine/tenofovir alafenamide fumarate Antiviral 2020/2/2 ChiCTR2000029496 Lopinavir/ritonavir; Novaferon Antiviral 2020/2/3 ChiCTR2000029539 Lopinavir/ritonavir Antiviral 2020/2/3 ChiCTR2000029541 Darunavir/cobicistat; Lopinavir/ritonavir; thymosin Antiviral 2020/2/3 Potential drug candidates by drug repuposing High-quality drug datasets were collected then curated based on anti-coronavirus indicators. These drugs could be used for drug repuposing. Datasets: Drugs in pipeline for SARS Drugs in pipeline for MERS Drugs in pipeline for Coronavirus Dataset: FDA approved set from Drugbank (Downloaded on 07.2018) Please visit Drugbank to download the most recent data References ChiCTR ChiCTR ChiCTR ChiCTR ChiCTR National Health Commission of the PRC Xinhua News New England Journal of Medicine NIH ClinicalTrials.gov Xinhua News ChiCTR ChiCTR NIH ClinicalTrials.gov","title":"Drug candidates"},{"location":"drug_candidates/#drug-candidates-for-2019-ncov","text":"The table below shows the identified candidates in no particular order. Only ones with preclinical and clinical records for 2019-nCoV were collected from different sources. Those suggested by expert systems or predictive models and traditional Chinese herbs were excluded. Drug Name Structure MoA Indication DrugBank URL Anti-2019nCoV Evidence Reference Remdesivir RNA polymerase inhibitor Anti-Ebola passed Phase III DB14761 In Vitro Assay, Clinical report 7 ; 8 Lopinavir Protease inhibitor Anti-HIV approved DB01601 Clinical trial 1 ; 2 ; 3 ; 4 ; 5 ; 6 Ritonavir Protease inhibitor Anti-HIV approved DB00503 Clinical trial 1 ; 2 ; 3 ; 4 ; 5 ; 6 Emtricitabine nucleoside reverse transcriptase inhibitor Anti-HIV approved, anti-HBV DB00879 Clinical trial 2 Tenofovir nucleoside reverse transcriptase inhibitor Anti-HIV Phase III, anti-HBV DB14126 Clinical trial 2 Ribavirin viral mRNA and protein synthesis inhibitor Anti-HCV, Anti-HBV, Anti-SARS, Anti-influenza, etc DB00811 Clinical trial 5 Umifenovir Influenza approved, nCoV Phase 4 DB13609 Clinical trial 9 Favipiravir RNA polymerase inhibitor Anti-influenza approved, anti-Ebola Phase II DB12466 Clinical trial 10 Darunavir Protease inhibitor Anti-HIV approved DB01264 Clinical trial 11 Cobicistat Anti-HIV approved DB09065 Clinical trial 11 Methylprednisolone Corticosteroid nCoV Phase II, allergic asthma and rheumatic disorders approved DB00959 Clinical trial 12 ; 13 IFN alpha-1b Immunomodulation Interferon Clinical trial 5 ; 6 Chloroquine Antimalarial approved, anti-HIV phase III, anti-HCV DB14761 In Vitro Assay 7 Download (including SMILES structures)","title":"Drug candidates for 2019-nCoV"},{"location":"drug_candidates/#clinical-trials-registration-list","text":"A list of registered clinical trials related to 2019-nCoV is collected in the table below. This data was initially collected from Biocentury and sorted based on registration date. Registration number Intervention Type Registration date ChiCTR2000029308 Lopinavir/ritonavir; interferon \u03b1 2b Antiviral 2020/1/23 ChiCTR2000029386 Lopinavir/ritonavir; methylprednisolone; interferon \u03b1 Antiviral; Corticosteroid 2020/1/28 ChiCTR2000029387 Lopinavir/ritonavir; ribavirin; interferon \u03b1-1b Antiviral 2020/1/28 NCT04244591 Methylprednisolone Corticosteroid 2020/1/28 NCT04246242 Arbidol umifenovir Antiviral 2020/1/29 ChiCTR2000029468 Lopinavir/ritonavir; emtricitabine/tenofovir alafenamide fumarate Antiviral 2020/2/2 ChiCTR2000029496 Lopinavir/ritonavir; Novaferon Antiviral 2020/2/3 ChiCTR2000029539 Lopinavir/ritonavir Antiviral 2020/2/3 ChiCTR2000029541 Darunavir/cobicistat; Lopinavir/ritonavir; thymosin Antiviral 2020/2/3","title":"Clinical Trials registration list"},{"location":"drug_candidates/#potential-drug-candidates-by-drug-repuposing","text":"High-quality drug datasets were collected then curated based on anti-coronavirus indicators. These drugs could be used for drug repuposing. Datasets: Drugs in pipeline for SARS Drugs in pipeline for MERS Drugs in pipeline for Coronavirus Dataset: FDA approved set from Drugbank (Downloaded on 07.2018) Please visit Drugbank to download the most recent data","title":"Potential drug candidates by drug repuposing"},{"location":"drug_candidates/#references","text":"ChiCTR ChiCTR ChiCTR ChiCTR ChiCTR National Health Commission of the PRC Xinhua News New England Journal of Medicine NIH ClinicalTrials.gov Xinhua News ChiCTR ChiCTR NIH ClinicalTrials.gov","title":"References"},{"location":"history/","text":"version 0.1.1 [2-5-2020] NEW : add useful links page UPDATE updated several pages version 0.1.0 [2-4-2020] NEW : add drug candidates page UPDATE : update targets data version 0.0.10 [2-3-2020] UPDATE : update targets data UPDATE : update research update version 0.0.9 [2-2-2020] UPDATE : update structures data UPDATE : update experimental data version 0.0.8 [2-1-2020] UPDATE : update structures data UPDATE : update targets data version 0.0.7 [2-1-2020] UPDATE : update structural modeling data UPDATE : update targets data UPDATE : update experimental data UPDATE : update research update MODIFIED : modify website nav map version 0.0.6 [1-31-2020] UPDATE : update structural modeling data version 0.0.5 [1-30-2020] UPDATE : update research update version 0.0.4 [1-29-2020] NEW : add contact us page UPDATE : update structural modeling data NEW : add auto-publish actions version 0.0.3 [1-28-2020] NEW : add discussion guide MODIFIED : improve index page version 0.0.2 [1-27-2020] NEW : add quick links NEW : add research progress page NEW : add assay records page version 0.0.1 [1-26-2020] NEW : All in scratch","title":"History"},{"location":"history/#version-011-2-5-2020","text":"NEW : add useful links page UPDATE updated several pages","title":"version 0.1.1 [2-5-2020]"},{"location":"history/#version-010-2-4-2020","text":"NEW : add drug candidates page UPDATE : update targets data","title":"version 0.1.0 [2-4-2020]"},{"location":"history/#version-0010-2-3-2020","text":"UPDATE : update targets data UPDATE : update research update","title":"version 0.0.10 [2-3-2020]"},{"location":"history/#version-009-2-2-2020","text":"UPDATE : update structures data UPDATE : update experimental data","title":"version 0.0.9 [2-2-2020]"},{"location":"history/#version-008-2-1-2020","text":"UPDATE : update structures data UPDATE : update targets data","title":"version 0.0.8 [2-1-2020]"},{"location":"history/#version-007-2-1-2020","text":"UPDATE : update structural modeling data UPDATE : update targets data UPDATE : update experimental data UPDATE : update research update MODIFIED : modify website nav map","title":"version 0.0.7 [2-1-2020]"},{"location":"history/#version-006-1-31-2020","text":"UPDATE : update structural modeling data","title":"version 0.0.6 [1-31-2020]"},{"location":"history/#version-005-1-30-2020","text":"UPDATE : update research update","title":"version 0.0.5 [1-30-2020]"},{"location":"history/#version-004-1-29-2020","text":"NEW : add contact us page UPDATE : update structural modeling data NEW : add auto-publish actions","title":"version 0.0.4 [1-29-2020]"},{"location":"history/#version-003-1-28-2020","text":"NEW : add discussion guide MODIFIED : improve index page","title":"version 0.0.3 [1-28-2020]"},{"location":"history/#version-002-1-27-2020","text":"NEW : add quick links NEW : add research progress page NEW : add assay records page","title":"version 0.0.2 [1-27-2020]"},{"location":"history/#version-001-1-26-2020","text":"NEW : All in scratch","title":"version 0.0.1 [1-26-2020]"},{"location":"nCov_Structures/","text":"We have built homology models for 2019-nCov targets that are highly homologous to SARS or other highly similar species, We further minimized and simulated some of the models to obtain better structural quality. The naming of the follow targets are based on templates, may not be accurate, please double check with the sequence. We will update the structrue list daily to provide more starting points for the research community. If you have structures to upload, please contact us here . We are working on a more interactive interface for your direct participation in the future. Surface Glycoprotein (Spike Protein) MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT Homology model of Spike protein alone and Spike-ACE2 based on SARS using https://swissmodel.expasy.org Full dataset Minimized model of Spike-ACE2 Full dataset MD simulated (37C, water, all-atom) model of Spike-ACE2 (Spike is a homo-trimer in color, human ACE2 is in yellow) Full dataset Envelope protein, E Protein MYSFVSEETGTLIVNSVLLFLAFVVFLLVTLAILTALRLCAYCCNIVNVSLVKPSFYVYSRVKNLNSSRVPDLLV Homology model of E protein based on SARS using https://swissmodel.expasy.org Full dataset Nucleocapsid Phosphoprotein MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTAAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA Homology model of N protein based on SARS using https://swissmodel.expasy.org Full dataset ORF1ab polyprotein Gene segments Replicase polyprotein 1ab EVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKP Homology model of Replicase polyprotein 1ab using https://swissmodel.expasy.org Full dataset 3C-like proteinase, Main Protease (Mpro) SGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQ Homology model of Mpro dimer using https://swissmodel.expasy.org Full dataset Minimized model of Mpro dimer PDB MD simulated (37C, water, all-atom) model of Mpro dimer PDB Helicase AVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQ Homology model of Helicase using https://swissmodel.expasy.org Full dataset Polyprotein 1ab QAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQ Homology model of Polyprotein 1ab using https://swissmodel.expasy.org Full dataset Uridylate-specific endoribonuclease SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ Homology model of Uridylate-specific endoribonuclease using https://swissmodel.expasy.org Full dataset NSP12 polymerase, RNA-directed RNA polymerase(RDRP) SADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQ Homology model of RNA-directed RNA polymerase (with Zn2+) using https://swissmodel.expasy.org Full dataset Minimized model of RNA-directed RNA polymerase PDB MD simulated (37C, water, all-atom) model of RNA-directed RNA polymerase PDB 2'-O-methyl transferase SSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN Homology model of 2'-O-methyl transferase using https://swissmodel.expasy.org Full dataset","title":"Structures"},{"location":"nCov_Structures/#surface-glycoprotein-spike-protein","text":"MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT Homology model of Spike protein alone and Spike-ACE2 based on SARS using https://swissmodel.expasy.org Full dataset Minimized model of Spike-ACE2 Full dataset MD simulated (37C, water, all-atom) model of Spike-ACE2 (Spike is a homo-trimer in color, human ACE2 is in yellow) Full dataset","title":"Surface Glycoprotein (Spike Protein)"},{"location":"nCov_Structures/#envelope-protein-e-protein","text":"MYSFVSEETGTLIVNSVLLFLAFVVFLLVTLAILTALRLCAYCCNIVNVSLVKPSFYVYSRVKNLNSSRVPDLLV Homology model of E protein based on SARS using https://swissmodel.expasy.org Full dataset","title":"Envelope protein, E Protein"},{"location":"nCov_Structures/#nucleocapsid-phosphoprotein","text":"MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTAAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA Homology model of N protein based on SARS using https://swissmodel.expasy.org Full dataset","title":"Nucleocapsid Phosphoprotein"},{"location":"nCov_Structures/#orf1ab-polyprotein-gene-segments","text":"","title":"ORF1ab polyprotein Gene segments"},{"location":"nCov_Structures/#replicase-polyprotein-1ab","text":"EVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKP Homology model of Replicase polyprotein 1ab using https://swissmodel.expasy.org Full dataset","title":"Replicase polyprotein 1ab"},{"location":"nCov_Structures/#3c-like-proteinase-main-protease-mpro","text":"SGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQ Homology model of Mpro dimer using https://swissmodel.expasy.org Full dataset Minimized model of Mpro dimer PDB MD simulated (37C, water, all-atom) model of Mpro dimer PDB","title":"3C-like proteinase, Main Protease (Mpro)"},{"location":"nCov_Structures/#helicase","text":"AVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQ Homology model of Helicase using https://swissmodel.expasy.org Full dataset","title":"Helicase"},{"location":"nCov_Structures/#polyprotein-1ab","text":"QAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQ Homology model of Polyprotein 1ab using https://swissmodel.expasy.org Full dataset","title":"Polyprotein 1ab"},{"location":"nCov_Structures/#uridylate-specific-endoribonuclease","text":"SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ Homology model of Uridylate-specific endoribonuclease using https://swissmodel.expasy.org Full dataset","title":"Uridylate-specific endoribonuclease"},{"location":"nCov_Structures/#nsp12-polymerase-rna-directed-rna-polymeraserdrp","text":"SADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQ Homology model of RNA-directed RNA polymerase (with Zn2+) using https://swissmodel.expasy.org Full dataset Minimized model of RNA-directed RNA polymerase PDB MD simulated (37C, water, all-atom) model of RNA-directed RNA polymerase PDB","title":"NSP12 polymerase, RNA-directed RNA polymerase(RDRP)"},{"location":"nCov_Structures/#2-o-methyl-transferase","text":"SSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN Homology model of 2'-O-methyl transferase using https://swissmodel.expasy.org Full dataset","title":"2'-O-methyl transferase"},{"location":"nCov_Targets/","text":"Protein targets related to the MERS and SARS virus is provided on this page. This data was extracted from the PDB database, UniProt , and other review article sources listed below. This figure from the \"Coronaviruses \u2014 drug discovery and therapeutic options\" (A. Zumla et al., 2016) review article describes the genome of SARS-CoV and MERS-CoV. The proteins targets are separated into two different categories: Non-structural and structural. There are four targets listed for each category of protein. SARS Gene Symbol Protein Name Other Names PDB IDs S Spike glycoprotein Spike protein S1, Spike protein S2, Receptor-binding domain 5X5B, 2GHV rep Replicase polyprotein 1ab 1. NSP12, NSP7 2. NSP8, NSP10/NSP14 3. NSP10/NSP16 PUTATIVE 2'-O-METHYL TRANSFERASE 4. NSP3 5. NSP7, NSP86. 3C-like proteinase (3CL(pro)) 6. 3C-like proteinase (3CL(pro)); 1. 6NUR 2. 5NFY 3. 2XYR 4. 2GRI 5. 2AHM 6. 2V6N, 1UK4, 3D62, 2Z94, 2Z9G, 2Z9J, 2Z9K, 2Z9L, 2Z3D, 2GX4, 2A5A 1a Replicase polyprotein 1a 1. NSP3 2. 3C-like proteinase (3CL(pro)) 3. Peptidase C16 1. 2W2G 2. 4TWW, 4TWY, 4WY3, 4MDS, 3V3M, 3VB3, 3VB4, 3VB5, 3VB6, 3VB7, 3ATW, 3AVZ, 3AW0, 3AW1, 3SNE 3. 5Y3Q, 5Y3E, 4OVZ N/A Peptidase C30 Orf1ab polyprotein 2OP9 N/A Orf1a polyprotein Pepidase C30 2GZ9 MERS Gene Symbol Protein Name Other Names PDB IDs S Spike glycoprotein 1. Spike receptor binding domain, Corona S2 2. Spike glycoprotein S1 1. 6Q04, 6Q05, 6Q06, 6Q07, 5X59, 5X5F, 4NJL, 4L3N 2. 5X4R orf1ab Polyprotein ORF1ab 1. NSP15 2. Peptidase C30 3. Peptidase C16 1. 5YVD 2. 4RSP 3. 4RNA, 4REZ, 4PT5, 4P16 1a Replicase polyprotein 1a 1. 3C-like proteinase (3CL(pro)) 2. Macro Domain of Papain-like proteinase 1. 5WKJ, 5WKM 2. 5HIH List of Targets A list of human targets related to SARS coronavirus is provided by Genecards using a keyword search query: Link","title":"Targets"},{"location":"nCov_Targets/#sars","text":"Gene Symbol Protein Name Other Names PDB IDs S Spike glycoprotein Spike protein S1, Spike protein S2, Receptor-binding domain 5X5B, 2GHV rep Replicase polyprotein 1ab 1. NSP12, NSP7 2. NSP8, NSP10/NSP14 3. NSP10/NSP16 PUTATIVE 2'-O-METHYL TRANSFERASE 4. NSP3 5. NSP7, NSP86. 3C-like proteinase (3CL(pro)) 6. 3C-like proteinase (3CL(pro)); 1. 6NUR 2. 5NFY 3. 2XYR 4. 2GRI 5. 2AHM 6. 2V6N, 1UK4, 3D62, 2Z94, 2Z9G, 2Z9J, 2Z9K, 2Z9L, 2Z3D, 2GX4, 2A5A 1a Replicase polyprotein 1a 1. NSP3 2. 3C-like proteinase (3CL(pro)) 3. Peptidase C16 1. 2W2G 2. 4TWW, 4TWY, 4WY3, 4MDS, 3V3M, 3VB3, 3VB4, 3VB5, 3VB6, 3VB7, 3ATW, 3AVZ, 3AW0, 3AW1, 3SNE 3. 5Y3Q, 5Y3E, 4OVZ N/A Peptidase C30 Orf1ab polyprotein 2OP9 N/A Orf1a polyprotein Pepidase C30 2GZ9","title":"SARS"},{"location":"nCov_Targets/#mers","text":"Gene Symbol Protein Name Other Names PDB IDs S Spike glycoprotein 1. Spike receptor binding domain, Corona S2 2. Spike glycoprotein S1 1. 6Q04, 6Q05, 6Q06, 6Q07, 5X59, 5X5F, 4NJL, 4L3N 2. 5X4R orf1ab Polyprotein ORF1ab 1. NSP15 2. Peptidase C30 3. Peptidase C16 1. 5YVD 2. 4RSP 3. 4RNA, 4REZ, 4PT5, 4P16 1a Replicase polyprotein 1a 1. 3C-like proteinase (3CL(pro)) 2. Macro Domain of Papain-like proteinase 1. 5WKJ, 5WKM 2. 5HIH","title":"MERS"},{"location":"nCov_Targets/#list-of-targets","text":"A list of human targets related to SARS coronavirus is provided by Genecards using a keyword search query: Link","title":"List of Targets"},{"location":"research_progress/","text":"2020 Gilead Sciences and 2019 Novel Coronavirus (2019-nCoV) Remdesivir from Gilead Sciences enters Phase III clinical trials in China on February 3, 2020. An official news release from Gilead expressing their committment to respond to this outbreak by testing their novel investigational compound remdesivir in a controlled clinical trial as a treatment for 2019-nCoV. \"Host and infectivity prediction of Wuhan 2019 novel coronavirus using deep learning algorithm\" Using deep learning algorithms, this article builds a virus host prediction model in order to predict the potential virus hosts. The built model suggests that 2019-nCoV has close infectivity with other human coronaviruses, especially SARS and MERS. Additionally, by comparing predicted infectivity patterns, bat coronaviruses are assigned with more similar infectivity patterns with 2019-nCoVs. It was also suggested that mink viruses show a closer infectivity pattern to 2019-nCov showing that bat and mink may be two candidate reservoirs of 2019-nCov. \"Functional assessment of cell entry and receptor usage for lineage B \u03b2-coronaviruses, including 2019-nCoV\" This article shares a recent development where researchers developed an approach to rapidly screen lineage B betacoronaviruses, and their ability to infect cell types from different species. They found that bypassing the host protease processing barrier allows several lineage B viruses to enter human cells. These different lineage B viruses can also recombine to gain entry into human cells with human ACE2 being the receptor for 2019-nCoV. \"From SARS-CoV to Wuhan 2019-nCoV Outbreak: Similarity of Early Epidemic and Prediction of Future Trends\" The ongoing outbreak in China caused by the 2019-nCoV is very similar in many aspects to SARS in 2003. This article, using epidemiological surveys and analyses from the early stage of the SARS outbreak, assesses and compares characteristics of these two outbreaks. Using the current data, the cumulative counts of 2019-nCoV cases was estimated about 2-3 times the total number of SARS, and the peak incidence is predicted to be in early or middle February. It is suggested that regional migration should be limited or prohibited to prevent the emergence and movement of a super-spreader. \"Sofosbuvir Can Inhibit the Newly Emerged Coronavirus (2019-nCoV) in Wuhan, China\" This article aims to study the effect of anti-polymeras drugs including Sofosbuvir and Ribavirin. Sequence analysis, modeling, and dociking are used to build a model for the 2019-nCoV. The results of this study suggests that Sofobuvir, IDX-184, and Ribavirin are able to tightly bind to the newly emerged coronavirus RdRp and contradict the function of the protein. Therefore, it is likely these drugs are an effective inhibitor of this virus. \"Cell Pyroptosis, a Potential Pathogenic Mechanism of 2019-nCoV Infection\" The initial infection characteristics of 2019-nCoV has been reported, including the symptoms and blood test results. Cell pyroptosis is a novel inflammatory form of programmed cell death, which has been largely studied recently. This article discusses the relationship between 2019-nCoV infection and cell pyroptosis and hypothesizes that 2019-nCoV is likely to cause cell pyroptosis, especially in lymphocytes, through the activation of NLRP3 inflammasome. \"Evolution and variation of 2019-novel coronavirus\" This article discusses the variation of the 2019-nCoV. The genomes were downloaded and analyzed with bioinformatics tools. It was found that through this analysis, there are at least two different viral strains of 2019-nCoV are involved in this outbreak, and the most recent common ancestor of 2019-nCoVs appeared about 0.253-0.594 year before the epidemic. Summary of 2019-nCoV research progress This article summarizes the recent advances made (as of January 29, 2020) regarding the 2019-nCoV outbreak. Many recent scientific publications are shared in this article. \"Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation\" This article shares progress regarding building homology models and docking small molecule drugs onto this structure. Based on the results, there were several drugs identified based on free energy calculations. One of which being nelfinavir which may be a potential inhibitor against 2019-nCoV. \"Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov\" This article goes into detail about the ACE2 receptor and its relation with the Wuhan 2019-nCoV. The results of thsi study indicates that ACE2 receptor expression is concentrated in a small population of type II alveolar cells, and these cells are also highly expressed with many other genes that positively regulate viral reproduction and transmission. This information may be of further use for future anti-ACE2 therapeutic research and development. \"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster\" The results of this study report the findings of 5 patients in a family cluster who were infected with the novel coronavirus. This study includes epidemiological, clinical, laboratory, radiological, and microbiological data regarding the patients. It was found that symptoms presented 3-6 days after exposure. Additionally, it was found through next-generation sequencing that the novel coronavirus is highly related to SARS coronaviruses. \"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China\" This article shares results about clinical findings regarding the 2019-nCoV. Common symptoms reported were fever, cough, myalgia, or fatigue. In was interpreted that this new infection causes severe respiratory illness similar to the SARS outbreak previously. Wuhan Institute of Virology, CAS identifies three potential drugs This article reports that the CAS Wuhan Institute of Virology has recently identified three potential drugs that can be used against 2019-nCoV. The three drugs identified are Remdesivir GS-5734, Chloroquine Sigma-C6628, and Ritonavir. All three identified are old drugs that are currently awaiting approval for this new usage. Chinese Academy of Sciences Shanghai Institute of Materia Medica and ShanghaiTech University release a list of compounds which can have an effect on 2019-nCoV This official article from CAS released a list of pharmaceutical compounds that may have a therapeutic effect on this new virus. This compounds come from old repurposed drugs or Traditional Chinese Medicine. National Microbiology Data Center 2019-nCov Data This is a link to the National Microbiology Data Center official website's information about the 2019-nCov virus. The official English name of this virus is C-Tan-nCov Wuhan strain 01. The link includes relevant information and images. Chinese Academy of Sciences Shanghai Institute of Materia Medica and ShanghaiTech University release the 2019-nCoV 3CL protein crystal structure This team at CAS Shanghai Institute of Materia Medica and ShanghaiTech University released the protein crystal structure for the 2019-nCoV 3CL protein. The Protein Data Bank ID is 6LU7. \"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission\" Analysis showed that the Wuhan CoV shared a common ancestor with SARS coronavirus that resembles the bat coronavirus HKU9-1. This work points to the RBD domain of the Wuhan CoV S-protein which supports strong interaction with human ACE2 molecules. \"Shenyang Pharmaceutical University, Huazhong University of Science and Technology, and Academy of Military Medical Sciences identified pharmaceuticals that can possibly treat 2019-nCoV\" This article reveals several pharmaceuticals that are candidates to be used to treat the recent 2019-nCoV outbreak. \"Learning from the Past: possible Urgent Prevention and Treatment Options for Severe Respiratory Infections Caused by 2019-nCov\" The spike protein used for host cell infection although shows mutations but remains a viable target for development of biologics. This paper suggests 3 potential drug candidates: remdesivir, 3CLpro-1, and novel sulfone protease inhibitor to possibly treat patients. \"Genomic and protein structure modelling analysis depicts the origin and infectivity of 2019-nCoV, a new coronavirus which caused a pneumonia outbreak in Wuhan, China\" The 2019-nCoV is revealed to be a new type of bat coronavirus and is genetically distant from the human SARS coronavirus. Its spike protein only binds weakly to the ACE2 receptor on human cells. 2018 \"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin\" This article provides evidence that a bat coronavirus and swine acute diarrhoea syndrome coronavirus is the aetiological agent that was responsible for a large outbreak resulting in the fatal disease of pigs in China. The SADS and SARS outbreaks had similarities in geographical, temporal, ecological, and aetiological settings. 2016 \"Coronaviruses \u2014 drug discovery and therapeutic options\" Review of epidemiology, virology, clinical features, and current treatment strategies of SARS and MERS in 2016. This review article also includes a discussion of the drug discovery and development of new therapeutic options for CoV infections. 2014 \"Cell-based antiviral screening against coronaviruses: Developing virus-specific and broad-spectrum inhibitors\" A 2014 review explaining cell-based assays using infectious virus (BSL-3) and surrogate assays (BSL-2) that can be implemented to accelerate antiviral development against SARS, MERS, and future emergent coronaviruses such as the recent 2019-nCoV. \"Severe acute respiratory syndrome vs. the Middle East respiratory syndrome\" This review compares clinical features, laboratory aspects, and treatment options of SARS-like coronaviruses which typically come from bats. This article compares the similarities and differences of SARS to MERS. 2013 \"Novel Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Entry That Act by Three Distinct Mechanisms.\" There are no approved treatments as of this article for SARS coronavirus. This article reports the discovery and characterization of several small-molecule inhibitors of SARS-CoV replication through several mechanisms. It showed that their mechanisms of action revealed that the compounds act by three distinct mechanisms: (i) SSAA09E2 { N -[[4-(4-methylpiperazin-1-yl)phenyl]methyl]-1,2-oxazole-5-carboxamide} acts through a novel mechanism of action, by blocking early interactions of SARS-S with the receptor for SARS-CoV, angiotensin converting enzyme 2 (ACE2); (ii) SSAA09E1 {[( Z )-1-thiophen-2-ylethylideneamino]thiourea} acts later, by blocking cathepsin L, a host protease required for processing of SARS-S during viral entry; and (iii) SSAA09E3 [ N -(9,10-dioxo-9,10-dihydroanthracen-2-yl)benzamide] also acts later and does not affect interactions of SARS-S with ACE2 or the enzymatic functions of cathepsin L but prevents fusion of the viral membrane with the host cellular membrane. 2004 \"Structure-Based Discovery of a Novel Angiotensin- Converting Enzyme 2 Inhibitor\" The Angiotensin-converting enzyme 2 (ACE2) is an important therapeutic target for cardiovascular diseases and SARS outbreaks. This study identifies the molecules with the highest predicted binding scores and assays them for ACE2 enzymatic inhibitory activity and for SARS coronavirus spike protein-mediated cell fusion inhibition.","title":"Research Update"},{"location":"research_progress/#2020","text":"Gilead Sciences and 2019 Novel Coronavirus (2019-nCoV) Remdesivir from Gilead Sciences enters Phase III clinical trials in China on February 3, 2020. An official news release from Gilead expressing their committment to respond to this outbreak by testing their novel investigational compound remdesivir in a controlled clinical trial as a treatment for 2019-nCoV. \"Host and infectivity prediction of Wuhan 2019 novel coronavirus using deep learning algorithm\" Using deep learning algorithms, this article builds a virus host prediction model in order to predict the potential virus hosts. The built model suggests that 2019-nCoV has close infectivity with other human coronaviruses, especially SARS and MERS. Additionally, by comparing predicted infectivity patterns, bat coronaviruses are assigned with more similar infectivity patterns with 2019-nCoVs. It was also suggested that mink viruses show a closer infectivity pattern to 2019-nCov showing that bat and mink may be two candidate reservoirs of 2019-nCov. \"Functional assessment of cell entry and receptor usage for lineage B \u03b2-coronaviruses, including 2019-nCoV\" This article shares a recent development where researchers developed an approach to rapidly screen lineage B betacoronaviruses, and their ability to infect cell types from different species. They found that bypassing the host protease processing barrier allows several lineage B viruses to enter human cells. These different lineage B viruses can also recombine to gain entry into human cells with human ACE2 being the receptor for 2019-nCoV. \"From SARS-CoV to Wuhan 2019-nCoV Outbreak: Similarity of Early Epidemic and Prediction of Future Trends\" The ongoing outbreak in China caused by the 2019-nCoV is very similar in many aspects to SARS in 2003. This article, using epidemiological surveys and analyses from the early stage of the SARS outbreak, assesses and compares characteristics of these two outbreaks. Using the current data, the cumulative counts of 2019-nCoV cases was estimated about 2-3 times the total number of SARS, and the peak incidence is predicted to be in early or middle February. It is suggested that regional migration should be limited or prohibited to prevent the emergence and movement of a super-spreader. \"Sofosbuvir Can Inhibit the Newly Emerged Coronavirus (2019-nCoV) in Wuhan, China\" This article aims to study the effect of anti-polymeras drugs including Sofosbuvir and Ribavirin. Sequence analysis, modeling, and dociking are used to build a model for the 2019-nCoV. The results of this study suggests that Sofobuvir, IDX-184, and Ribavirin are able to tightly bind to the newly emerged coronavirus RdRp and contradict the function of the protein. Therefore, it is likely these drugs are an effective inhibitor of this virus. \"Cell Pyroptosis, a Potential Pathogenic Mechanism of 2019-nCoV Infection\" The initial infection characteristics of 2019-nCoV has been reported, including the symptoms and blood test results. Cell pyroptosis is a novel inflammatory form of programmed cell death, which has been largely studied recently. This article discusses the relationship between 2019-nCoV infection and cell pyroptosis and hypothesizes that 2019-nCoV is likely to cause cell pyroptosis, especially in lymphocytes, through the activation of NLRP3 inflammasome. \"Evolution and variation of 2019-novel coronavirus\" This article discusses the variation of the 2019-nCoV. The genomes were downloaded and analyzed with bioinformatics tools. It was found that through this analysis, there are at least two different viral strains of 2019-nCoV are involved in this outbreak, and the most recent common ancestor of 2019-nCoVs appeared about 0.253-0.594 year before the epidemic. Summary of 2019-nCoV research progress This article summarizes the recent advances made (as of January 29, 2020) regarding the 2019-nCoV outbreak. Many recent scientific publications are shared in this article. \"Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation\" This article shares progress regarding building homology models and docking small molecule drugs onto this structure. Based on the results, there were several drugs identified based on free energy calculations. One of which being nelfinavir which may be a potential inhibitor against 2019-nCoV. \"Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov\" This article goes into detail about the ACE2 receptor and its relation with the Wuhan 2019-nCoV. The results of thsi study indicates that ACE2 receptor expression is concentrated in a small population of type II alveolar cells, and these cells are also highly expressed with many other genes that positively regulate viral reproduction and transmission. This information may be of further use for future anti-ACE2 therapeutic research and development. \"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster\" The results of this study report the findings of 5 patients in a family cluster who were infected with the novel coronavirus. This study includes epidemiological, clinical, laboratory, radiological, and microbiological data regarding the patients. It was found that symptoms presented 3-6 days after exposure. Additionally, it was found through next-generation sequencing that the novel coronavirus is highly related to SARS coronaviruses. \"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China\" This article shares results about clinical findings regarding the 2019-nCoV. Common symptoms reported were fever, cough, myalgia, or fatigue. In was interpreted that this new infection causes severe respiratory illness similar to the SARS outbreak previously. Wuhan Institute of Virology, CAS identifies three potential drugs This article reports that the CAS Wuhan Institute of Virology has recently identified three potential drugs that can be used against 2019-nCoV. The three drugs identified are Remdesivir GS-5734, Chloroquine Sigma-C6628, and Ritonavir. All three identified are old drugs that are currently awaiting approval for this new usage. Chinese Academy of Sciences Shanghai Institute of Materia Medica and ShanghaiTech University release a list of compounds which can have an effect on 2019-nCoV This official article from CAS released a list of pharmaceutical compounds that may have a therapeutic effect on this new virus. This compounds come from old repurposed drugs or Traditional Chinese Medicine. National Microbiology Data Center 2019-nCov Data This is a link to the National Microbiology Data Center official website's information about the 2019-nCov virus. The official English name of this virus is C-Tan-nCov Wuhan strain 01. The link includes relevant information and images. Chinese Academy of Sciences Shanghai Institute of Materia Medica and ShanghaiTech University release the 2019-nCoV 3CL protein crystal structure This team at CAS Shanghai Institute of Materia Medica and ShanghaiTech University released the protein crystal structure for the 2019-nCoV 3CL protein. The Protein Data Bank ID is 6LU7. \"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission\" Analysis showed that the Wuhan CoV shared a common ancestor with SARS coronavirus that resembles the bat coronavirus HKU9-1. This work points to the RBD domain of the Wuhan CoV S-protein which supports strong interaction with human ACE2 molecules. \"Shenyang Pharmaceutical University, Huazhong University of Science and Technology, and Academy of Military Medical Sciences identified pharmaceuticals that can possibly treat 2019-nCoV\" This article reveals several pharmaceuticals that are candidates to be used to treat the recent 2019-nCoV outbreak. \"Learning from the Past: possible Urgent Prevention and Treatment Options for Severe Respiratory Infections Caused by 2019-nCov\" The spike protein used for host cell infection although shows mutations but remains a viable target for development of biologics. This paper suggests 3 potential drug candidates: remdesivir, 3CLpro-1, and novel sulfone protease inhibitor to possibly treat patients. \"Genomic and protein structure modelling analysis depicts the origin and infectivity of 2019-nCoV, a new coronavirus which caused a pneumonia outbreak in Wuhan, China\" The 2019-nCoV is revealed to be a new type of bat coronavirus and is genetically distant from the human SARS coronavirus. Its spike protein only binds weakly to the ACE2 receptor on human cells.","title":"2020"},{"location":"research_progress/#2018","text":"\"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin\" This article provides evidence that a bat coronavirus and swine acute diarrhoea syndrome coronavirus is the aetiological agent that was responsible for a large outbreak resulting in the fatal disease of pigs in China. The SADS and SARS outbreaks had similarities in geographical, temporal, ecological, and aetiological settings.","title":"2018"},{"location":"research_progress/#2016","text":"\"Coronaviruses \u2014 drug discovery and therapeutic options\" Review of epidemiology, virology, clinical features, and current treatment strategies of SARS and MERS in 2016. This review article also includes a discussion of the drug discovery and development of new therapeutic options for CoV infections.","title":"2016"},{"location":"research_progress/#2014","text":"\"Cell-based antiviral screening against coronaviruses: Developing virus-specific and broad-spectrum inhibitors\" A 2014 review explaining cell-based assays using infectious virus (BSL-3) and surrogate assays (BSL-2) that can be implemented to accelerate antiviral development against SARS, MERS, and future emergent coronaviruses such as the recent 2019-nCoV. \"Severe acute respiratory syndrome vs. the Middle East respiratory syndrome\" This review compares clinical features, laboratory aspects, and treatment options of SARS-like coronaviruses which typically come from bats. This article compares the similarities and differences of SARS to MERS.","title":"2014"},{"location":"research_progress/#2013","text":"\"Novel Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Entry That Act by Three Distinct Mechanisms.\" There are no approved treatments as of this article for SARS coronavirus. This article reports the discovery and characterization of several small-molecule inhibitors of SARS-CoV replication through several mechanisms. It showed that their mechanisms of action revealed that the compounds act by three distinct mechanisms: (i) SSAA09E2 { N -[[4-(4-methylpiperazin-1-yl)phenyl]methyl]-1,2-oxazole-5-carboxamide} acts through a novel mechanism of action, by blocking early interactions of SARS-S with the receptor for SARS-CoV, angiotensin converting enzyme 2 (ACE2); (ii) SSAA09E1 {[( Z )-1-thiophen-2-ylethylideneamino]thiourea} acts later, by blocking cathepsin L, a host protease required for processing of SARS-S during viral entry; and (iii) SSAA09E3 [ N -(9,10-dioxo-9,10-dihydroanthracen-2-yl)benzamide] also acts later and does not affect interactions of SARS-S with ACE2 or the enzymatic functions of cathepsin L but prevents fusion of the viral membrane with the host cellular membrane.","title":"2013"},{"location":"research_progress/#2004","text":"\"Structure-Based Discovery of a Novel Angiotensin- Converting Enzyme 2 Inhibitor\" The Angiotensin-converting enzyme 2 (ACE2) is an important therapeutic target for cardiovascular diseases and SARS outbreaks. This study identifies the molecules with the highest predicted binding scores and assays them for ACE2 enzymatic inhibitory activity and for SARS coronavirus spike protein-mediated cell fusion inhibition.","title":"2004"},{"location":"useful_links/","text":"Useful links A list of useful links is provided for general information about drug discovery and coronavirus Updates from WHO regarding novel coronavirus: WHO Research updates from Elsevier NCBI ChEMBL ZINC database: ZINC15 RCSB PDB Drug Information: Drugbank UniProt Pharmacology data: ChEMBL Clinical Trial Information BindingDB Epidemic updates (DXY.cn) \u4e2d\u56fd\u75be\u75c5\u9884\u9632\u63a7\u5236\u4e2d\u5fc3 \u65b0\u51a0\u72b6\u75c5\u6bd2\u56fd\u5bb6\u79d1\u6280\u8d44\u6e90\u670d\u52a1\u7cfb\u7edf(\u56fd\u5bb6\u5fae\u751f\u7269\u79d1\u5b66\u6570\u636e\u4e2d\u5fc3\u548c\u56fd\u5bb6\u75c5\u539f\u5fae\u751f\u7269\u8d44\u6e90\u5e93) 2019\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u4fe1\u606f\u5e93(\u56fd\u5bb6\u751f\u7269\u4fe1\u606f\u4e2d\u5fc3\u548c\u56fd\u5bb6\u57fa\u56e0\u7ec4\u79d1\u5b66\u6570\u636e\u4e2d\u5fc3)","title":"Useful Links"},{"location":"useful_links/#useful-links","text":"A list of useful links is provided for general information about drug discovery and coronavirus Updates from WHO regarding novel coronavirus: WHO Research updates from Elsevier NCBI ChEMBL ZINC database: ZINC15 RCSB PDB Drug Information: Drugbank UniProt Pharmacology data: ChEMBL Clinical Trial Information BindingDB Epidemic updates (DXY.cn) \u4e2d\u56fd\u75be\u75c5\u9884\u9632\u63a7\u5236\u4e2d\u5fc3 \u65b0\u51a0\u72b6\u75c5\u6bd2\u56fd\u5bb6\u79d1\u6280\u8d44\u6e90\u670d\u52a1\u7cfb\u7edf(\u56fd\u5bb6\u5fae\u751f\u7269\u79d1\u5b66\u6570\u636e\u4e2d\u5fc3\u548c\u56fd\u5bb6\u75c5\u539f\u5fae\u751f\u7269\u8d44\u6e90\u5e93) 2019\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u4fe1\u606f\u5e93(\u56fd\u5bb6\u751f\u7269\u4fe1\u606f\u4e2d\u5fc3\u548c\u56fd\u5bb6\u57fa\u56e0\u7ec4\u79d1\u5b66\u6570\u636e\u4e2d\u5fc3)","title":"Useful links"}]}